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Leishmania parasites cause leishmaniasis, a group of diseases that range 
in manifestations from skin lesions to fatal visceral disease. The parasite's life 
cycle is divided between its insect vector and its mammalian host, where it 
resides primarily inside of macrophages. Once intracellular, Leishmania parasites 
must avoid being killed by the innate and adaptive immune responses. We 
performed transcriptomic profiling using RNA-seq to simultaneously identify 
global changes in gene expression in Leishmania parasites across multiple 
lifecycle stages and in infected macrophages from both murine and human hosts. 
Using a novel approach based on a dual statistical test to identify genes that 
were differentially expressed relative to both uninfected macrophages and 
macrophages that had ingested inert particles, we were able to filter out genes 
that were differentially regulated as part of a general phagocytic response and 
thereby select genes specific to Leishmania infection. The most substantial and 
dynamic Leishmania-specific differential expression responses were observed 
during early infection, while changes observed later were common to 
  
phagocytosis more generally. An evaluation of RNA processing events within the 
parasite revealed precise UTR boundaries for a majority of genes and 
widespread alternative trans-splicing and polyadenylation. Collection of data from 
multiple biological replicates, the use of matched host control samples, careful 
statistical analysis of variation, and removal of batch effects enabled the 
detection of biological differences between samples and timepoints with high 
confidence and sensitivity. Pathway and gene ontology analyses provided 
insights into the higher level processes activated across parasite developmental 
stages and during intracellular infection to reveal signatures of Leishmania 
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Leishmania major and related species are the causative agents of 
leishmaniasis, a group of diseases that vary in severity from self-healing skin 
lesions to disfiguring mucosal manifestations to fatal visceral disease. More than 
a million new cases are reported annually, mostly concentrated in the Middle 
East and Central and South America (Alvar, 2012). The Leishmania life cycle is 
divided between its insect vector, the phlebotomine sand fly, and its mammalian 
host, where it resides primarily inside of macrophages, although neutrophils, 
dendritic cells, and fibroblasts have also been implicated at various stages of 
infection (Bogdan, 2000; Laufs, 2002; Moll, 1995; Peters, 2008; Sarkar, 2013) 
(see Figure 1). The developmental stages of Leishmania parasites can be 
distinguished by cell size and shape, position of the nucleus, proliferation state, 
and the presence and length of an external flagellum. Upon being bitten by a 
sand fly, non-proliferating, flagellated metacyclic promastigotes are introduced 
into the bloodstream of the mammalian host and are quickly phagocytosed by 
host immune cells. They come to reside inside of macrophage lysosome-derived 
parasitophorous vacuoles where they undergo differentiation into the small, 
aflagellated amastigote stage. Amastigotes divide rapidly inside of the 
phagolysosomes of infected macrophages and are then released from the cells 
to infect other host macrophages. When an infected host is bitten by a sand fly, 
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amastigotes are transmitted into the abdominal midgut of the sand fly where they 
differentiate into proliferative procylic promastigotes and then further into large, 
slender (nectomonad) promastigotes that are cell cycle-arrested. The 
nectomonad promastigotes migrate to the thoracic midgut of the sand fly where 
they change into proliferative (leptomonad) promastigotes, which secrete a 
promastigote secretory gel (PSG) that causes the sand fly to regurgitate them 
during its subsequent blood meal. The leptomonad promastigotes differentiate 
into the metacyclic promastigotes that are transmitted back to the mammalian 
host, thus perpetuating the cycle (Bates, 2007; Kramer, 2012). 
 
     
Figure 1: The lifecycle of Leishmania parasites. 
The lifecycle of Leishmania parasites is divided between its insect vector, the female 
phlebotomine sand fly (left) and its mammalian host (right), where it resides inside of 
macrophages [from http://www.cdc.gov/parasites/leishmaniasis/biology.html]. 
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When responding to changes in the environment as it moves through its 
lifecycle, such as upon leaving the sand fly vector and infecting host cells, the 
parasite must alter its gene expression to adapt to the new surroundings. In 
particular, the parasite must respond to changes in temperature, pH, and 
osmolarity and withstand assault from the host immune system. Many of the 
changes that the parasite undergoes are reflected in changes in its morphology 
(size, shape, position of organelles) and variations in cell surface components 
(Ambit, 2011; Beverley, 1998; Wheeler, 2011). Less is known about changes that 
take place at the transcriptional level. 
Trypanosomatid gene expression 
Unlike most other eukaryotes, Leishmania and other trypanosomatids, 
including Trypanosoma brucei and Trypanosoma cruzi, do not regulate the 
expression levels of individual genes by the differential recruitment of RNA 
polymerase II influenced by cellular transcription factors. Rather, their genes are 
arranged as polycistronic clusters of tens to hundreds of functionally unrelated 
genes that are transcribed at roughly the same rate across the genome. The 
long, polycistronic pre-mRNAs are then split into component mature mRNAs 
through the processes of trans-splicing and polyadenylation (Sutton, 1986). 
While the genome sequence of L. major was completed in 2005 (Ivens, 2005), 
much remains unknown about gene boundaries, the mechanisms directing the 
expression levels of individual genes, or how Leishmania genes influence or are 
influenced by host gene expression during an infection.  
 4 
 
Previous studies of leishmaniasis 
Studies using microarrays or SAGE tags have started to elucidate 
changes that occur within the parasite or within the host as infection occurs 
(Akopyants, 2004; Almeida, 2004; Buates, 2001; Chaussabel, 2003; Cohen-
Freue, 2007; Depledge, 2009; Ettinger, 2008; Giraud, 2012; Gregory, 2008; 
Guerfali, 2008; Holzer, 2006; Lahav, 2011; Leifso, 2007; McNicoll, 2006; Novais, 
2015; Osorio y Fortéa, 2009; Probst, 2012; Rabhi, 2012; Ramírez, 2012; 
Rochette, 2008; Rochette, 2009; Rodriguez, 2004; Saxena, 2003; Saxena, 
2007), but have so far not sought to look at the transcriptomes of both 
simultaneously and over the course of an intracellular infection. While very 
informative, microarray-based approaches have several inherent limitations such 
as hybridization and cross-hybridization artifacts, the restriction on genes 
interrogated to probes included on the array (inhibiting the identification of 
previously unannotated genes), dye-based detection issues, the need for large 
amounts of input RNA, and the inability to detect 5´ and 3´ UTRs boundaries.  
Previous studies have identified genes that are differentially regulated 
upon infection with various Leishmania species, sometimes with opposing 
results. Some of these differences may be attributable to the parasite species 
and host systems used, the severity of the resulting infection, and the timepoints/ 
developmental stages examined. Additionally, studies of Leishmania amastigotes 
have often used axenic cultures (Holzer, 2006; Lahav, 2011; McNicoll, 2006; 
Rochette, 2009; Saxena, 2007) or lesion-derived amastigotes (Akopyants, 2004; 
Almeida, 2004; Holzer, 2006; Leifso, 2007; Maretti-Mira, 2012; Rochette, 2008). 
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The former have been shown to significantly differ from the intracellular biological 
state (Holzer, 2006; Rochette, 2009) while the latter contain a mixture of 
amastigotes at various timepoints post-infection, making it difficult to differentiate 
between changes that take place during early versus later intracellular infection. 
These limitations likely resulted in the identification of an incomplete list of genes 
that are up- or down-regulated in the parasite and host prior to and during an 
infection. RNA-seq, which enables a precise and sensitive measurement of 
mRNA transcript abundance, has begun to be applied to this problem (Rastrojo, 
2013), and additional, comprehensive, well-replicated studies examining gene 
expression across multiple conditions and in multiple host systems are needed to 
more fully understand both the gene expression signatures of the parasite and 
host during an infection and how these change over time. 
Study overview 
Transcriptomic profiling using RNA-seq was performed to interrogate gene 
structure and expression signatures within Leishmania developmental stages 
and to concurrently identify transcriptomic changes in the parasite's mammalian 
hosts. Specifically, we were able to precisely delineate the 5´ and 3´ UTR 
boundaries for a majority of Leishmania genes and to detect widespread 
alternative trans-splicing and polyadenylation. We were able to identify global 
changes in gene expression that occur as Leishmania major undergoes 
metacyclogenesis from the non-infective procyclic promastigote form to the 
infective metacyclic promastigote form, and to simultaneously identify global 
changes in host and parasite gene expression over the first 72 hours of a 
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synchronized intracellular infection of murine peritoneal macrophages or primary 
human macrophages by either Leishmania major or Leishmania amazonensis. 
Subsequent pathway and gene ontology analyses provided insights into the 
higher level processes activated as the parasite achieves infectivity and during 
an infection. 
A paired-end mRNA sequencing approach was used to allow high 
confidence read mapping and transcript assembly. Careful study design which 
included the collection of data from multiple biological replicates, consistency 
between biological systems evaluated, the use of matched control samples, 
robust statistical analysis of replicates, and consideration of technical sources of 
variation (batch effects) enabled the detection of biological differences between 
samples and timepoints with high confidence and sensitivity. This work builds on 
and improves existing expression datasets and gene structure annotations and 
allows insights into how Leishmania is able to evade host defenses and cause 
modulations in the host transcriptome in order to survive in the mammalian 
intracellular environment. The datasets generated provide a substantially more 
detailed interpretation of L. major biology that will inform the field and potentially 
provide additional data for drug discovery and vaccine development efforts. 
Dissertation overview and contributions 
 This dissertation describes analyses done to identify RNA processing sites 
in Leishmania major, to characterize changes in gene expression throughout the 
Leishmania lifecycle, and to describe changes in gene expression in Leishmania-
infected mammalian macrophages. Chapters 2-3 describe analyses of the 
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procyclic and metacyclic promastigote stages of L. major to identify and 
characterize RNA processing sites (Chapter 2) and to quantify differential 
expression (Chapter 3). Chapter 4 describes differential expression analyses for 
L. major-infected murine macrophages. Chapter 5 describes similar analyses in 
human macrophages and additionally describes L. amazonensis infection of 
macrophages and changes that occur when macrophages ingest latex beads. 
Chapter 6 describes proposed future directions for this research. 
 Cell samples for the promastigote analyses and murine infections 
(Chapters 2-4) were prepared by Rahul Suresh. For these samples, total RNA 
was isolated and cDNA libraries were prepared by Laura Dillon. For the human 
experiments (Chapter 5), all samples were generated by Cecilia Fernandes (cell 
culture, RNA isolation, and cDNA library preparation). The pipeline used to 
identify trans-splicing and polyadenylation sites (Chapter 2) was developed and 
implemented by Keith Hughitt. The scripts used to characterize alternative RNA 
processing were originally conceived and written by Yuan Li with additional 
adaptations by Laura Dillon for the specific purposes of the Leishmania analysis. 
The novel ORF dataset (Chapters 2-3), Leishmania GO mapping reference 
dataset (Chapters 3-5), and human-mouse/L. major-L. amazonensis orthology 
tables (Chapter 5) were provided by Trey Belew. Imaging and quantification of 
the metacyclic stage enrichment was done by Cecilia Fernandes (Chapter 3). 
The pipelines for sample diagnostics, batch effect detection, and differential 
expression analysis (Chapters 3-4) were developed in collaboration with Kwame 
Okrah and Hector Corrada Bravo, and were run by Laura Dillon. The dual 
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statistical test used to test for differential expression after accounting for the 
phagocytosis effect was developed by Hector Corrada Bravo and implemented 
by Laura Dillon. GOseq analyses (Chapters 3-5) and KEGG analyses (Chapters 
4-5) were done by Laura Dillon. The results of the analyses, including the 
differentially expressed gene lists and GO and KEGG enrichments, were 
interpreted by Laura Dillon (Chapters 2-5), Cecilia Fernandes (Chapter 5), Najib 
El-Sayed (Chapters 2-5), and David Mosser (Chapters 3-5). 
 The analyses described in Chapters 2-3 were published in Nucleic Acids 
Research in July 2015 (Dillon et al. Transcriptomic profiling of gene expression 
and RNA processing during Leishmania major differentiation. 2015. PMID: 
26150419). A manuscript describing the analyses in Chapter 4 is under revision 
at BMC Genomics (October 2015). A manuscript describing the analyses in 






RNA processing events during Leishmania differentiation 
Introduction 
The genomes of Leishmania and other kinetoplastid organisms – including 
T. cruzi and T. brucei – are composed of polycistronic clusters of functionally-
unrelated genes that are transcribed at roughly the same rate across the 
genome. Transcription initiation occurs at divergent 'strand switch regions' where 
polycistronic units originate in opposite directions on opposing DNA strands (El-
Sayed, 2005; Ivens, 2005; Martinez-Calvillo, 2003; McDonagh, 2000; Myler, 
1999). The trans-splicing of a capped 39-nucleotide (nt) spliced leader (SL) mini-
exon sequence to the 5´ end of each nuclear mRNA and the polyadenylation of 
the 3´ end are used to separate each polycistronic pre-mRNA transcript into its 
component mature mRNAs (Sutton, 1986) (see Figure 2). Trans-splicing and 
polyadenylation events are coupled temporally and spatially such that the SL 
acceptor site of the downstream gene determines the location of the 
polyadenylation site of the upstream gene and both modification events occur 
simultaneously during post-transcriptional processing (LeBowitz, 1993; 
Matthews, 1994; Ullu, 1993). Spliced leader acceptor sites contain a consensus 
AG dinucleotide that is preceded by polypyrimidine-rich sequence and a G 
nucleotide excluded from the -3 position (Kolev, 2010; LeBowitz, 1993; 
Matthews, 1994). Polyadenylation sites do not appear to contain a specific signal 




Figure 2: Trans-splicing and polyadenylation in Trypanosomatids 
Leishmania and related species utilize polycistronic transcription followed by the trans-splicing of 
a capped 39-nt spliced leader sequence to the 5´ end of each component RNA coupled with 
polyadenylation of the 3´ end of the upstream gene to separate pre-mRNAs into their component 
mature mRNAs. The illustration shows the transcription and subsequent RNA processing of two 
polycistronic units (green and orange) by the addition of the capped spliced leader (blue) and 
polyA tail (AAAA). A stretch of pyrimidine residues, known as the polypyrimidine tract (black) is 
involved in the regulation of RNA processing. The use of different nucleotide positions for the 
trans-splicing and polyadenylation events leads to alternative RNA processing. 
of the coupled trans-splicing acceptor site (LeBowitz, 1993). Trans-splicing of a 
specific SL sequence is not itself unique to trypanosomatids, but has evolved in 
parallel in a range of diverse organisms including Euglenozoa and 
dinoflagellates, C. elegans and related nematodes, Platyhelminthes, and 
primitive chordates (Derelle, 2010). However, trypanosomatids are distinct in 
their reliance on trans-splicing to express all genes transcribed by RNA 




Since the transcription of Leishmania genes occurs fairly uniformly across 
the genome, steady-state mRNA levels for individual genes are largely 
dependent on gene copy number and the rate of mRNA degradation, with mRNA 
deadenylation preceding degradation for most mRNAs. Sequence motifs 
contained in the 3´ UTRs greatly influence mRNA stability and the recruitment of 
the cellular degradation machinery (Brittingham, 2001; Charest, 1996; Fadda, 
2014; Folgueira, 2005; Manful, 2011; Michaeli, 2011; Peacock, 2007; Rogers, 
2011; Zilka, 2001; Coughlin, 2000; Quijada, 2000). Since kinetoplastids lack 
introns (with very few exceptions), they do not control gene expression by 
alternative cis-splicing (Ivens, 2005; Mair, 2000). Gene expression is thus 
predominantly controlled, not at the transcriptional level through the 
developmental regulation of RNA polymerase II activity, but by gene copy 
number, post-transcriptional mRNA processing, rates of mRNA degradation, and 
translational efficiency (see (Clayton, 2007) for review). 
The genome of Leishmania major, which defined the boundaries of coding 
sequence for the large majority of L. major genes, was completed in 2005 (Ivens, 
2005). While it has been an invaluable resource for researchers in the field, the 
lack of defined UTR boundaries has hampered the ability to look for sequence 
motifs contained in the UTRs that may be involved in directing the post-
transcriptional regulation of individual mRNAs - including degradation, storage, 
and translation rate. Deep sequencing of L. major procyclic and metacyclic 
promastigote samples by RNA-seq presented an opportunity to comprehensively 
annotate transcript boundaries, thereby enhancing the structural annotation of L. 
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major genes and providing a substantial additional resource for the Leishmania 
research community. We exploited the signal sequences generated by trans-
splicing and polyadenylation events to accurately map the 5′ and 3′ UTR 
boundaries of transcripts by comparing reads containing these signals to the 
reference genome sequence. The UTR boundaries identified were used to 
identify alternative RNA processing events within and between L. major 
developmental stages. 
Identification of transcript boundaries 
 Distinct transcript boundaries were determined for a large majority of 
previously annotated protein-coding genes and novel genes for which there was 
evidence of translation by ribosome profiling (Table 12). RNA was isolated from 
cultured L. major grown to log phase (procyclic form) or enriched for metacyclic 
forms using: 1) a Ficoll gradient or 2) negative selection using peanut agglutinin 
(PNA). PolyA enriched cDNA libraries were generated using the Illumina TruSeq 
protocol and 100-bp paired end sequences were generated. RNA-seq reads 
which did not map to the L. major genome due to RNA processing events were 
examined separately for evidence of spliced leader (SL) sequence and a polyA 
tail. Of the ~960 million reads from 13 L. major samples (5 procyclic promastigote 
samples and 8 metacyclic promastigote samples), ~3.9% contained evidence of 
trans-splicing and ~0.05% contained evidence of polyadenylation (Table 11). 
Once the SL and polyA sequences were removed, the remainders of the reads 
were mapped to the genome, allowing the identification of coordinates for at least 
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one trans-splicing site for 8,981 genes (94.2% of a total of 9,530 genes) and at 
least one polyadenylation site for 8,841 genes (92.8%). 
A sampling of the trans-splicing and polyadenylation sites identified here 
was compared to existing data in TriTrypDB (Peter Myler’s group, Seattle 
Biomed) that were generated using an RNA-seq method that specifically 
enriched for SL-containing sequences (biological sample type unknown). Our 
trans-splicing site data were highly concordant with these previously reported 
data. This high degree of agreement is remarkable given the differences in 
sample type, culture, and preparation across different labs and may potentially 
indicate that the usage of trans-splicing sites in Leishmania is fairly consistent 
across various biological conditions. The observed variability is likely attributable 
to the differences in coverage, RNA-seq approach, and data analysis 
methodology. Our polyA site data did not generally match the existing data on 
TriTrypDB down to the specific nucleotide. This could be due to the extreme 
heterogeneity of these sites (previously reported for T. brucei (Kolev, 2010)), 
differences in the biological samples studied, or differences in the methods used 
to identify and assign sites. 
Gene structure features  
 We sought to determine the length distribution of the elements of each 
gene - 5´ UTR, coding sequence (CDS), and 3´ UTR - as well as the intergenic 
region, including the polypyrimidine (polyPy) tract, for previously annotated 
protein-coding genes and the novel ORFs. Start and stop coordinates for L. 
major genes were used to determine a median CDS length of 1,241 nt with a 
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range from 64 to 52,178 nt (Figure 3A). The boundaries of 5′ UTRs were defined 
using the coordinates of the SL addition sites and start codon annotations and a 
similar analysis was done to determine the lengths of 3´ UTRs using stop codon 
and polyadenylation site coordinates. The median length of all identified 5′ UTRs 
(not including the 39 nt SL sequence) and 3´ UTRs was 547 and 729 nt, 
respectively (Figure 3B and Figure 3C). When only the most-utilized (primary) 
trans-splicing or polyadenylation site for each gene was considered, these values 
were reduced to 233 and 517 nt, respectively (see alternative RNA processing 
section below). The distribution of both the 5′ and 3´ UTR lengths was similar in 
both stages (Figure 4) and there did not appear to be a correlation between CDS 
length and either UTR length or between corresponding UTR lengths. 
 The length distribution analysis was extended to examine the polyPy tract, 
which is known to be involved in the regulation of RNA processing events in 
trypanosomatids (Günzl, 2010; Huang, 1991; Siegel, 2005). In this analysis, the 
polyPy tract was identified as the longest stretch of pyrimidine residues located 
upstream of each of the (primary) trans-splicing sites and interrupted by no more 
than one purine. PolyPy tracts ranged from 7 to 123 nt in length, with a median 
value of 21 nt (Figure 3D) and a clear usage preference for cytosine (54%) over 
thymine (42%) residues. This observation, which runs counter to what has been 
found in related species (Greif, 2013; Kolev, 2010) (Li Y, Caradonna KL, Belew 
AT, Corrada Bravo H, Burleigh BA, El-Sayed NM, in revision), is unsurprising 
given the higher GC content of Leishmania relative to the other trypanosomatids 




Figure 3: Length and position distribution of gene structure components. 
Data from procyclic and metacyclic promastigote samples were combined to describe the gene 
structure elements of L. major. (A) Distribution of CDS lengths. Start and stop coordinates for 
coding sequences for previously annotated protein-coding genes (TriTrypDB v. 6.0) and novel 
ORFs were used to compute CDS lengths. For genes with multiple isoforms, the first isoform 
listed in TriTrypDB was included in the analysis. (B) Distribution of 5′ UTR lengths. The exact 
trans-splicing sites associated with each CDS were used to determine the coordinates and 
lengths of 5´ UTRs. A total of 154,046 trans-splicing sites were identified, corresponding to 5´ 
UTRs ranging from 0 to 7,252 nt in length. (C) Distribution of 3′ UTR lengths. An analysis of 
polyadenylation sites associated with each CDS was performed to determine 3´ UTR coordinates 
and lengths. A total of 84,331 polyadenylation sites were identified, corresponding to 3´ UTRs 
ranging from 0 to 7,133 bases in length. (D) Distribution of polypyrimidine (polyPy) tract lengths. 
A window of 250 nt upstream of the each primary trans-splicing site (8,981 total) was scanned to 
identify its corresponding polyPy tract, defined as the longest stretch of pyrimidine residues 
interrupted by no more than one purine. (E) Distribution of distances between each primary trans-
splicing site and its corresponding polypyrimidine (polyPy) tract. (F) Distribution of distances 
between each polyPy tract and the polyadenylation site of the upstream gene. A total of 6,174 
instances of a neighboring polyadenylation site and polyPy tract were identified. (G) Diagram of a 
“typical” L. major genic region. The median lengths of the gene structure components of L. major 
were used to construct the structure of a “typical” gene region (2 genes and the intergenic 
region). The median values of each component are shown. Colors correspond to the features 




Figure 4: UTR length distribution by developmental stage. 
Trans-splicing sites were identified for each developmental stage and used to determine the 
coordinates and lengths of 5´ UTRs for procyclic promastigotes (A) and metacyclic promastigotes 
(B). An analysis of polyadenylation sites in each developmental stage was performed to 
determine 3´ UTR coordinates and lengths for procyclic promastigotes (C) and metacyclic 
promastigotes (D). 
downstream SL addition site was 64 nt (Figure 3E) and the median distance 
between the polyPy tract and the upstream polyadenylation site (if both were 
detected; 6,174 instances) was 558 nt (Figure 3F). When considering only 
intergenic regions that were bound by both a detectable upstream 
polyadenylation site and a detectable downstream SL addition site (6,152 
instances), a median intergenic distance of 556 nt was observed.  
 The median values of each gene structure element were used to 
determine a representative gene structure for L. major genes, with a median 
mRNA length of 2,517 nt, of which the 5′ UTR, CDS, and 3′ UTR account for 
22%, 49%, and 29%, respectively (corresponding to a 5′ UTR of 547 nt, a CDS of  
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1,241 nt, and a 3′ UTR of 729 nt) (Figure 3G). The median intergenic length was 
643 nt. This observed gene structure indicates significantly longer 5´ and 3´ 
UTRs and longer intergenic distances than what has been reported in either T. 
cruzi and T. brucei (Kolev, 2010; Siegel, 2010) (Li Y, Caradonna KL, Belew AT, 
Corrada Bravo H, Burleigh BA, El-Sayed NM, in revision), and is consistent with 
previous observations regarding the relative compactness of the species’ 
genomes (El-Sayed, 2005). 
Alternative RNA processing events 
The sequencing depth of our L. major transcriptomic profiling experiments 
allowed not only the identification of the SL-addition and polyadenylation sites at 
a single-base resolution, but also the quantification of alternative RNA processing 
events. Of the 8,981 genes with SL-addition sites detected, 8,777 (~98%) used 
more than one trans-splicing site in at least one developmental stage. We were 
able to detect alternative splicing in L. major with a greater sensitivity than has 
been previously reported (Rastrojo, 2013), presumably due to the deeper 
coverage of this dataset. Indeed, for genes with detectable trans-splicing events, 
alternative trans-splicing was pervasive with 88%, 56%, and 18% of genes using 
at least 5, 10, or 20 sites, respectively, in at least one developmental stage. This 
observation indicates that L. major exhibits a somewhat higher degree of 
alternative splicing than related species T. cruzi and T. brucei where <90% of 
genes were identified as alternatively spliced (Kolev, 2010) (Li Y, Caradonna KL, 
Belew AT, Corrada Bravo H, Burleigh BA, El-Sayed NM, in revision). This 
observation persisted even after accounting for differences in sequencing depth. 
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The distribution of the distances between the primary and minor trans-splicing 
sites revealed that almost half (~48%) of the alternative splice sites are located 
within 200 bases of the primary site in either direction. Even so, a significant 
percentage (18%) of minor sites were observed more than 1000 bp from the 
primary site, with most of these (78%) occurring upstream of the primary site. 
 An examination of the trans-splicing sites revealed a propensity for usage 
of the canonical acceptor sequence (AG) at both the primary (~97%) and minor 
(~43%) splicing sites (Table 1), consistent with previous findings in T. cruzi and 
T. brucei () (Li Y, Caradonna KL, Belew AT, Corrada Bravo H, Burleigh BA, El-
Sayed NM, in revision). A sequence composition analysis of the region upstream 
of the SL-addition site allowed the visualization of the tail end of the 
polypyrimidine tract through the trans-splicing acceptor site (Figure 5D). As 
reported previously (Rastrojo, 2013; Requena, 2003), a C nucleotide was 
preferred prior to the AG acceptor sequence. When considering minor sites that 
are located within 1 kb of the primary site, a majority (64.2%) of minor sites that 
use the canonical AG acceptor are located downstream of the primary site 
(Figure 5A). This observation supports a model (based on a study of mammalian 
introns) that proposes that the 3´ splice site is located by a scanning process that 
recognizes the first AG downstream of the branch point in a sequence-specific 
context (Smith, 1989; Smith, 1993). When minor sites that do not use the 
canonical AG acceptor sequence were considered, this phenomenon was largely 





Figure 5: Characterization of alternative RNA processing. 
Alternative RNA processing events were detected in both promastigote developmental stages 
and pooled for this analysis. The distribution of distances between primary and minor trans-
splicing sites is shown for minor splice sites that use (A) the canonical AG acceptor sequence or 
(B) an acceptor sequence other than AG. Panel (C) depicts the distribution of distances between 
primary and minor polyadenylation sites. Only minor sites within 1000 nt of the primary site are 
plotted. The full ranges for A, B, and C, are -7234 to 5973, -7178 to 5,876, and -6429 to 5993, 
respectively. About 18% (11,201 of 62,098), 29% (24,303 of 82,947), and 10% (7,301 of 75,487) 
of values fell outside of the plotted range for A, B, and C, respectively. (D) Sequence composition 
of the region spanning from 90 nt upstream to 10 nt downstream of each primary trans-splicing 
site. (E) Sequence composition of the region spanning from 50 nt upstream to 50 nt downstream 



















TA 0.04% 1.19%  
Table 1: Dinucleotide acceptor site usage frequency. 




drops to 36.3% (Figure 5B). This observation was maintained when procyclic and 
metacyclic promastigotes were considered separately.  
Alternative polyadenylation sites were detected for 8,391 (~95%) of the 
8,841 genes for which polyadenylation events were observed with 61%, 21%, 
and 5% of genes using at least 5, 10, or 20 polyadenylation sites. As observed 
for trans-splicing events, this observation indicates a higher degree of alternative 
polyadenylation in L. major than what has been reported in either T. cruzi or T. 
brucei where 63% and 92% of genes had detectable alternative polyadenylation, 
respectively (Li Y, Caradonna KL, Belew AT, Corrada Bravo H, Burleigh BA, El-
Sayed NM, in revision). A sequence composition analysis was done to visualize 
the region surrounding the polyA-addition site. Even though no consensus motif 
was observed upstream of the polyadenylation site, such as the AAUAAA 
required for polyadenylation in higher eukaryotes, we did note an (A/G)(A/G) 
motif preceded by 1-2 thymines abutting the polyA addition site for both primary 
and minor polyadenylation sites (Figure 5E). Similar to what was found for SL 
addition sites above, the analysis of the distribution of the distances between 
primary and alternative sites revealed that ~49% of the minor polyadenylation 
sites were located within a 200 nt window of the primary site (Figure 5C).  
 Alternative trans-splicing or polyadenylation are suspected to play a role in 
the regulation of gene expression in L. major, but instances of regulation through 
alternative RNA processing between developmental stages have not been 
systematically identified. We sought to identify the subset of genes that change 
the use of their primary trans-splicing or polyadenylation sites between the 
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procyclic and metacyclic stages and to investigate possible correlations between 
these changes and differential expression. We were specifically interested in 
genes that showed a strong preferential usage for the primary site over other 
sites within a given stage (dominance), as determined using the ratio of reads 
that map to the primary site to those that map to the secondary site (P/S). Of the 
8,797 genes that had at least one trans-splicing site identified in both stages, 523 
showed preferential usage of different primary trans-splicing sites between the 
stages. We plotted the lengths of the UTRs for each gene, as determined by the 
primary trans-splicing site in each stage (Figure 6A). Each gene was represented 
by a single point with the color indicating the average P/S ratio for the two stages 
(thereby providing a measure of a primary site’s dominance) and the size 
indicating the average number of reads mapping to that gene’s primary sites 
(thereby indicating expression level and an indirectly providing confidence in the 
data). Data points along the diagonal represent genes that did not exhibit a 
change in the primary trans-splicing site between the stages. Largely, genes that 
had high dominance did not exhibit a change in primary site location between the 
stages, but instead used the same primary site in both procyclic and metacyclic 
promastigotes. Genes that did change primary site tended to have only a slight 
preference for each stage-specific primary site. A few interesting genes did not 
follow this trend and showed both a change in primary site (location away from 
the diagonal), high dominance (red), and high confidence/expression (large). 
Examples of the alternative usage of trans-splicing sites for a subset of these 
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interesting genes - LmjF.31.0710, LmjF.33.0310, and LmjF.36.3810 - are 
depicted in Figure 7. 
 We compared the expression profiles (see Chapter 3) for genes that 
displayed a change in trans-splicing site preference versus those that did not. 
The proportion of differentially expressed genes in both sets was nearly identical 
(39.4% for genes that changed primary site and 37.0% for genes that did not), 
 
 
Figure 6: Preferential usage of primary site across developmental stages. 
(A) For each gene, the length of the 5´ UTR determined by the primary trans-splicing site for the 
metacyclic stage was plotted against the length of the 5´ UTR determined by the primary trans-
splicing site for the procyclic stage. Each point represents a single gene. Points that do not fall 
along the diagonal represent a change in the primary site between the stages. The color of each 
point represents the dominance of the primary site (preference for usage of the primary site over 
other sites within a stage), as determined by the ratio of primary site read counts to secondary 
site read counts (P/S), averaged for both stages. The size of each point depicts average read 
count for the primary sites from both stages, thereby showing expression levels and providing a 
measure of confidence in the data. Three genes highlighted in Figure 7 are circled with the gene 
identifier labeled in blue. (B) A similar plot was done for 3´ UTR length as determined by the 





Figure 7: Visualization of changes in primary trans-splicing sites across 
developmental stages. 
The Integrative Genomics Viewer (IGV) (Robinson, 2011) was used to visualize the number of 
reads that mapped to each trans-splicing site for three genes which showed a change in the 
preferred primary site between developmental stages and had a significant number of reads 
mapped to each primary site - LmjF.31.0710 (A), LmjF.33.0310 (B), and LmjF.36.3810 (C). The 
number of reads that mapped to each primary site (bold) and secondary site are shown for both 
procyclic promastigotes (blue text) and metacyclic promastigotes (orange text). 
indicating that there was no association between changes in primary site used by 
individual genes and their expression levels (χ2 = 0.28).  
 A similar analysis was done to assess alternative polyadenylation between 
procyclic and metacyclic promastigotes (Figure 6B). Strikingly, this analysis 
revealed that most of the genes that showed high dominance (red) and high 
confidence (large) of their primary polyA sites did not exhibit a change in primary 
site location between the stages. For the large number of genes that showed a 
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change in the primary polyA site between developmental stages (4,377 of 8,337), 
very few reads were mapped to the primary sites, resulting in low confidence in 
these data points. The low numbers of mapped polyA-containing reads was likely 
due to the extensive heterogeneity of polyadenylation sites or the relative low 
coverage of polyA-containing reads mapping at unique sites. Of the 4,377 genes 
that changed primary polyadenylation sites between stages, the portion that was 
differentially expressed (37.2%) was remarkably similar to the portion that was 
not (38.7%; χ 2 = 0.15). This lack of systematic association with differential 
expression also supports that conclusion that differences in expression levels in 
the samples examined by this study cannot be attributed to stage-regulated 
alternative RNA processing. 
Conclusion 
Since Leishmania and related trypanosomatids employ polycistronic 
transcription across their entire genomes, post-transcriptional RNA processing is 
thought to be a likely mechanism for regulating the levels of individual mRNAs. 
We were able to exploit signal sequences added during the processing of 
polycistronic pre-mRNAs to identify trans-splicing and polyadenylation sites in 
Leishmania major with unprecedented depth and reliability. In addition, we were 
able to evaluate how transcript structure compares to related species, to examine 
trans-splicing and polyadenylation events within and between L. major 
developmental stages, and to assess the possible relationship between 




The RNA-seq datasets generated in this work enabled us to precisely 
delineate the 5´ and 3´ UTR boundaries of L. major transcripts, providing a 
substantial resource for the Leishmania research community. While we were able 
to detect widespread alternative trans-splicing and polyadenylation for the large 
majority of genes, the observed heterogeneity of RNA processing sites was not 
systematically associated with the differential expression of the genes that 
showed the alternative RNA processing. Thus, in this analysis, alternative 
processing of pre-mRNA did not appear to be a driving force for determining the 
expression levels of individual genes. Even so, insights into trans-splicing and 
polyadenylation in trypanosomatids may shed light on gene regulation in others 
species that rely on similar mechanisms of post-transcriptional control, even if 
only for a subset of genes. Additionally, the precise definition of UTR boundaries 
opens up opportunities for regulatory motif analyses and comparative analyses of 






Transcriptomic profiling of Leishmania metacyclogenesis 
Introduction 
Leishmania parasites are taken up from the skin of an infected 
mammalian host upon blood feeding by a female phlebotomine sand fly. Within 
the sand fly midgut, these aflagellated amastigote-form parasites transform into 
flagellated procyclic promastigotes that replicate within the sand fly midgut. 
Further differentiation events occur and result in the generation of infective 
metacyclic promastigote parasites by the process of metacyclogenesis. These 
metacyclic promastigotes are able to infect a new mammalian host when 
deposited on the host's skin as the sand fly takes a subsequent blood meal 
(Bates, 2007). 
Transcriptomic profiling by RNA-seq was used to identify global changes 
in gene expression as Leishmania major undergoes metacyclogenesis from the 
proliferative, non-infective procyclic promastigote form to the non-dividing, 
infective metacyclic promastigote form, a developmental progression that is well 
mimicked in vitro using axenic cultivation methods (Sacks, 1984). A differential 
expression analysis of relative RNA abundance between the promastigote forms 
was carried out to identify a robust set of markers for each developmental stage 
and to reveal genes and processes involved in the transition between stages as 
the parasite becomes capable of infecting mammalian host cells. This analysis 
resulted in the generation of reliable and substantially deep lists of differentially 
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expressed genes that include RNAs of low abundance which may have fallen 
outside of the limits of detection in past studies. Hundreds of genes of unknown 
function were also implicated in the developmental transition from the procyclic to 
metacyclic promastigote developmental forms, providing possible evidence for 
their function by guilt-through-association inferences.  
Experimental design 
 RNA was isolated from cultured L. major grown to log phase (procyclic 
form) or enriched for metacyclic forms using: 1) a Ficoll gradient or 2) negative 
selection using peanut agglutinin (PNA). These two methods for metacyclic 
promastigote enrichment were used to test whether different methods for the 
procurement of metacyclic parasites could be responsible for different findings in 
previous studies (Akopyants, 2004; Depledge, 2009; Guerfali, 2008; Saxena, 
2003). PolyA enriched cDNA libraries were generated using the Illumina TruSeq 
protocol and 100-bp paired end sequences were generated. A total of 6 procyclic 
promastigote biological replicates and 9 metacyclic promastigote biological 
replicates were collected (Table 11). Each procyclic replicate was matched to 
one or two metacyclic replicates from the same batch/expansion of cells. Phase 
contrast images, promastigote sample quantification, and an infectivity curve for 
the parasites in murine macrophages are provided in Figure 8. 
 A total of ~1.1 billion sequence reads were produced across the 15 
samples, 91% of which mapped to the L. major reference genome (Table 11). 




Figure 8: Sample characterization. 
(A) Phase contrast images of log-phase procyclic promastigotes, stationary phase promastigotes 
prior to enrichment for metacyclics, promastigotes following negative selection by PNA, and 
Ficoll-purified promastigotes. The bar in each panel represents 5 µm. (B) Relative percentages of 
procyclic and metacyclic promastigotes in culture prior to and after the application of enrichment 
methods, as determined by counting 15 fields. (C) Infections were established in peritoneal 
macrophages isolated from C57BL/6 mice using Ficoll-purified metacyclic promastigotes at an 
MOI of 5:1 in the presence of C5-deficient serum from DBA mice. Plots show the number of 
parasites observed per macrophage and the percentage of infected macrophages observed over 
the first 48 hours of the infection from one representative experiment. Asterisks indicate a 
significant difference in the number of parasites per 100 cells at 48 hours. 
determined. The resulting count table was restricted to the 8,486 protein-coding 
genes in the TriTrypDB L. major annotation v. 6.0.  
Statistical evaluation of biological replicates and batch effects 
 We used multiple robust statistical methods to evaluate the global 
characteristics of samples and to identify outlier samples that should be removed 
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prior to differential expression and gene structure analysis (Figure 9). Box plots 
were used to compare the distribution of per-gene read counts within each 
sample. All 15 samples showed a similar distribution of these counts with median 
steady-state expression levels of ~7.2 log2 counts per million and very few genes 
(5-10 per sample) expressed at levels of <4 counts per million. This observation 
is consistent with a lack of gene regulation at the level of transcription and may 
indicate that very few protein-coding transcripts are completely degraded 
following polycistronic transcription. A heatmap of Pearson correlations was used 
to visualize the relationship between each pair of samples. While all samples 
showed a pairwise correlation (r) of at least 0.85, samples prepared on one 
experimental date (batch A) were less correlated to samples from other batches, 
which largely showed r values of >0.95 when compared to one another. Median 
pairwise correlation was also computed to assess global correlation between 
samples and a standard outlier identification method was applied to establish a 
cut-off for the identification of outliers. Consistent with observations from the 
Pearson correlation heatmap analysis, this method identified the two samples 
from batch A as outliers. These 2 samples were excluded from further analyses. 
 The dataset used for differential expression analysis was further restricted 
to genes expressed at a level of at least 1 read per million in at least 5 of the 13 
remaining samples. Of the 8,486 protein-coding genes analyzed, 8,475 met this 
threshold, consistent with observations described above that few genes were 
completely degraded after transcription. No statistical difference was found in 




Figure 9: Sample diagnostics to globally assess data similarities and identify 
outliers. 
RNA-seq was carried out using the Illumina platform on L. major procyclic and metacyclic 
promastigotes. Letters (A-F) in the sample name refer to experimental batch. Numbers are 
unique identifiers as shown in Table 11. Samples identified as outliers are indicated with an 
asterisk. (A) Distribution of normalized gene counts by sample. For each sample, counts were 
normalized for sequencing library size and a box plot was generated to compare the distribution 
of per-gene counts (log2 counts per million with an offset of 1). The ends of the whiskers 
represent the lowest datum still within 1.5 interquartile range (IQR) of the lower quartile, and the 
highest datum still within 1.5 IQR of the upper quartile. Gene features with extremely high or low 
expression levels are shown as open circles above and below the whiskers, respectively. (B) 
Heatmap of Pearson correlation between samples. Raw count data were used to generate a 
heatmap to illustrate the Pearson correlation between samples. The color key and histogram for 
the frequency of correlation values (range of 0.85-1) is shown below the heatmap. (C) Median 
pairwise correlation. Raw count data were used to compute the median pairwise correlation 
between each sample and all other samples. The median pairwise correlation across all samples 
was used to establish a cutoff value to identify outlier samples (dotted line). Samples are colored 
according to stage (blue=procyclic, orange=metacyclic). 
prepared using the Ficoll or PNA protocols. Consequently, all metacyclic 
promastigote samples were pooled together for the remainder of the analyses. 
The large number of biological replicates used for the analysis 
necessitated the evaluation of the dataset for batch effects. A batch effect 
represents experimental variation caused by sub-groups of measurements that 
are independent of the underlying biology of the system being studied. They 
have been shown to introduce unwanted variability into biological studies and 
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confound the results, leading to erroneous conclusions. Previous analyses of 
high-throughput data, like those produced by RNA-seq, have indicated the need 
to assess and correct batch effects (Leek, 2010). In this study, we used 
experimental start date as a surrogate for batch when testing for differential 
expression between developmental stages of L. major. 
Principal component analysis (PCA) and Euclidean distance heatmap 
analysis were used to visualize the relationship between samples both prior to 
and after accounting for batch effects (Figure 10). PCA reduces the 
dimensionality of a dataset while allowing variability to be represented to the 
greatest extent possible (Jolliffe, 2002). The PCA plots showed the first two 
principal components, which account for the greatest percent of variability in the 
data, on the X and Y axes, respectively, with each of the 13 samples represented 
as a single point. When batch was accounted for, a clear separation between 
procyclic promastigote and metacyclic promastigote samples was seen along the 
X axis of the PCA plot (Figure 10C). Separation between the stages was not as 
pronounced when batch was not considered (Figure 10A). Indeed, prior to 
accounting for batch effects, 25% of the variance represented by principal 
component (PC) 1 and 77% of the variance represented by PC2 were 
attributable to the batch of the samples. 
Likewise, when Euclidean distance between samples was computed and 
used to create a heatmap color image and dendrogram depicting the closeness 
between samples, a clear separation between procyclic promastigote and 




Figure 10: Global gene expression profiles of the procyclic and metacyclic 
promastigote forms of Leishmania major. 
RNA-seq was carried out on L. major procyclic (log phase) promastigotes and metacyclic 
promastigotes isolated after enrichment using Ficoll or PNA. A principal component analysis 
(PCA) plot (A,C) and heatmap of a hierarchical clustering analysis using the Euclidean distance 
metric (B,D) are shown prior to (A-B) and after (C-D) accounting for batch effects in the statistical 
model. Analyses were performed using all L. major annotated genes after filtering for low counts 
and quantile normalization (8,475 genes). In the PCA plot, each point represents an experimental 
sample with point color indicating L. major developmental stage (blue = procyclic promastigote, 
orange = metacyclic promastigote) and point shape indicating batch/experimental date. Colors 
along the top of the heatmap indicate the developmental stage (blue = procyclic promastigote, 
orange = metacyclic promastigote) and colors along the left side of the heatmap indicate the 
batch/experimental date. 
 (Figure 10D) but not before (Figure 10B). As a result of these analyses, batch 
effects were controlled for in the subsequent differential expression analysis by 




Identification of genes differentially expressed between stages  
Differential expression (DE) analysis identified 3,138 genes that were 
expressed at significantly different levels between procyclic and metacyclic 
promastigotes at an adjusted P value cutoff of <0.05. Fold change differences 
ranged from 3.1-fold downregulated to 3.6-fold upregulated in metacyclic 
promastigotes. These genes were visualized using an MA plot showing the 
relationship between mean expression and fold change for each gene (Figure 
11). Almost 60% of the DE genes (1,829 of 3,138) are annotated as hypothetical 
proteins. The remaining gene products have been characterized to different 
extents, albeit not always in the context of their possible role(s) in 
metacyclogenesis.  
We extended our DE analysis to a set of 1,044 novel open reading frames 
(ORFs) of at least 90 nt in length identified based on evidence of translation in L. 
major by ribosome profiling data (Table 12). The addition of these ORFs lead to 
an increase in the list of differentially expressed genes by ~12% (a total of 368, 
from 3,138 to 3,506) with fold changes ranging from 5.7-fold downregulated to 
3.6-fold upregulated in the metacyclic stage. The top 25 down- and up-regulated 
genes are shown in Table 2. Of these, 8 are novel ORFs, including the most 
downregulated gene. 
The list of DE genes was used as input into gene ontology (GO) analysis 
to identify cellular functions and processes that are enriched during L. major 
metacyclogenesis. Genes downregulated in metacyclic promastigotes were 
considered separately from upregulated genes. Forty GO categories were  
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Figure 11: MA plot of differentially expressed genes in the L. major procyclic to 
metacyclic promastigote transition. 
Differential expression analysis of L. major procyclic and metacyclic promastigotes was done 
using limma after voom transformation, taking experimental batch into account as part of the 
limma statistical model. The MA plot shows the relationship between mean expression (log2 
counts per million with an offset of 0.5) and fold change. Each point represents one gene. Points 
colored in red represent 3115 genes expressed at significantly different levels between procyclic 
and metacyclic promastigotes at an adjusted P value of <0.05, with genes upregulated in the 
metacyclic stage relative to the procyclic stage exhibiting positive fold changes. 
identified as being significantly enriched (P value cutoff of <0.05) for genes 
downregulated (33 categories) and upregulated (7 categories) in metacyclic 
promastigotes (Table 3). 
Examination of gene lists and gene ontology-based enrichment analyses 
 Many novel genes were identified among the most downregulated during 
metacyclogenesis, including multiple genes with unknown function. GO 
enrichment analysis of these genes reflected a clear reduction in a number of 
cellular processes including DNA replication and nucleosome assembly, 
translation-related activities (initiation and elongation), protein metabolism, and 
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ID Product Description Fold Change
LmjF.23_3931 novel ORF, LmjF.23, 477090-477218 (-) 5.65
LmjF.31.3070 iron/zinc transporter protein-like protein (LIT1) 3.14
LmjF.35.1310 histone H4 2.90
LmjF.36.0020 histone H4 2.74
LmjF.35.2160 adenine aminohydrolase (AAH) 2.72
LmjF.31.3180 histone H4 2.68
LmjF.33.1760 hypothetical protein, unknown function 2.66
LmjF.14.0470 hypothetical protein, conserved 2.65
LmjF.21.0740 ATPase subunit 9, putative 2.57
LmjF.35.2130 hypothetical protein, unknown function 2.56
LmjF.33.3240 h1 histone-like protein 2.56
LmjF.25.2450 histone H4 2.48
LmjF.32_7004 novel ORF, LmjF.32, 1161019-1161147 (-) 2.39
LmjF.36.5845 kinetoplast-associated protein, putative 2.37
LmjF.36.3080 lipoate protein ligase, putative 2.35
LmjF.35.4760 hypothetical protein, conserved 2.34
LmjF.02.0020 histone H4 2.34
LmjF.32.2940 hypothetical protein, conserved 2.33
LmjF.23.0200 endoribonuclease L-PSP (Pb5) 2.22
LmjF.35_8354 novel ORF, LmjF.35, 877847-877972 (+) 2.20
LmjF.25.1470 cyclin (CYCA) 2.20
LmjF.20.0030 histone-lysine N-methyltransferase, putative (DOT1) 2.20
LmjF.19_3054 novel ORF, LmjF.19, 382655-382816 (+) 2.16
LmjF.13_1846 novel ORF, LmjF.13, 171578-171685 (+) 2.16
LmjF.36.3910 S-adenosylhomocysteine hydrolase 2.16
ID Product Description Fold Change
LmjF.34.0070 ascorbate peroxidase (APX) 3.61
LmjF.19_3059 novel ORF, LmjF.19, 395719-395889 (+) 3.31
LmjF.02.0460 voltage-dependent anion-selective channel, putative 3.04
LmjF.17.0890 META domain containing protein (META1) 3.03
LmjF.23.0730 RNA-binding protein, putative 2.97
LmjF.12.0480 hypothetical protein, unknown function 2.95
LmjF.28.0980 P27 protein, putative (P27) 2.77
LmjF.23.0780 hypothetical protein, conserved 2.68
LmjF.29.1350 RNA binding protein, putative 2.68
LmjF.16.0500 hypothetical protein, unknown function 2.68
LmjF.22.0250 phosphoinositide phosphatase 2.63
LmjF.29.1360 RNA binding protein, putative 2.63
LmjF.36.2290 serine/threonine protein kinase 2.61
LmjF.34.1940 amastin-like surface protein, putative 2.54
LmjF.17_2659 novel ORF, LmjF.17, 423627-423884 (+) 2.53
LmjF.04.0350 hypothetical protein, conserved 2.52
LmjF.16.1050 hypothetical protein, conserved 2.52
LmjF.34.2500 protein phosphatase 2C-like protein 2.49
LmjF.35.5000 hypothetical protein, conserved 2.46
LmjF.04.1210 casein kinase I, putative 2.45
LmjF.34.1820 amastin-like surface protein, putative 2.44
LmjF.12.0460 hypothetical protein, unknown function 2.43
LmjF.09_1121 novel ORF, LmjF.09, 124955-125314 (+) 2.41





Table 2: Top differentially expressed genes in the L. major procyclic to metacyclic 
promastigote transition. 
A total of 3,506 previously annotated genes and novel ORFs were differentially expressed (DE) 
between procyclic and metacyclic promastigotes. The top 25 down- and up-regulated 
genes/novel ORFs are shown. 
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GO ID GO term P Value
GO:0015986 ATP synthesis coupled proton transport 7.36E-11
GO:0005737 cytoplasm 5.33E-09
GO:0015991 ATP hydrolysis coupled proton transport 2.00E-08
GO:0046961 proton-transporting ATPase activity, rotational mechanism 2.79E-08
GO:0004812 aminoacyl-tRNA ligase activity 6.96E-08
GO:0006418 tRNA aminoacylation for protein translation 6.96E-08
GO:0046933 proton-transporting ATP synthase activity, rotational mechanism 7.26E-08
GO:0044267 cellular protein metabolic process 1.41E-07
GO:0003746 translation elongation factor activity 1.55E-07
GO:0005634 nucleus 3.38E-07
GO:0006260 DNA replication 1.25E-06
GO:0005525 GTP binding 1.42E-06
GO:0003677 DNA binding 1.94E-06
GO:0003924 GTPase activity 2.64E-06
GO:0043234 protein complex 1.64E-05
GO:0051258 protein polymerization 1.64E-05
GO:0003743 translation initiation factor activity 1.74E-05
GO:0045261 proton-transporting ATP synthase complex, catalytic core F(1) 5.23E-05
GO:0006457 protein folding 7.78E-05
GO:0051082 unfolded protein binding 8.59E-05
GO:0005874 microtubule 1.07E-04
GO:0004298 threonine-type endopeptidase activity 1.37E-04
GO:0005839 proteasome core complex 1.37E-04
GO:0051603 proteolysis involved in cellular protein catabolic process 1.37E-04
GO:0006334 nucleosome assembly 1.47E-04
GO:0006413 translational initiation 1.93E-04
GO:0046982 protein heterodimerization activity 2.60E-04
GO:0003887 DNA-directed DNA polymerase activity 3.45E-04
GO:0006414 translational elongation 6.65E-04
GO:0005198 structural molecule activity 9.43E-04
GO:0004175 endopeptidase activity 9.86E-04
GO:0016272 prefoldin complex 1.07E-03
GO:0050660 flavin adenine dinucleotide binding 1.09E-03
GO ID GO term P Value
GO:0004674 protein serine threonine kinase activity 4.61E-22
GO:0006468 protein phosphorylation 1.91E-21
GO:0004672 protein kinase activity 8.67E-20
GO:0004713 protein tyrosine kinase activity 1.28E-18
GO:0005524 ATP binding 3.82E-11
GO:0006950 response to stress 2.77E-10




Table 3: Gene ontology (GO) categories enriched during the L. major procyclic to 
metacyclic promastigote transition. 
GOseq (Young, 2010) was used to perform gene ontology analysis using differentially expressed 
genes identified as the parasite undergoes metacyclogenesis. Using a P value cut off of <0.05, a 
total of 33 GO categories were enriched among genes that were downregulated in metacyclic 
promastigotes and a total of 7 GO categories were enriched among genes that were upregulated 




energy metabolism (i.e., ATP synthesis) while enriched GO categories for genes 
upregulated in metacyclic promastigotes indicated an increase in cell signaling 
and stress response (Table 3).  
A close examination of differentially expressed genes and genome 
ontology enrichments confirmed earlier findings and, more importantly, revealed 
new insights into the parasite’s transformation at a critical stage of its life cycle. 
The top downregulated gene in metacyclic promastigotes, LIT1 (LmjF.31.3070) is 
an iron transporter previously reported to be upregulated by the parasite upon 
iron depletion (Huynh, 2006). Its downregulation in metacyclics is consistent with 
the low metabolic rate and low demand for ATP in this developmental stage of 
the parasite. Interestingly, its paralogous copy (LmjF.31.3060) was regulated to a 
lesser extent (downregulated only ~1.5-fold in metacyclics). Multiple histones 
(H2A, H2B, H4, and H1 histone-like protein) previously identified as 
downregulated during metacyclogenesis (Genske, 1991; Soto, 2004) were also 
identified as such in this analysis with H4 mRNA levels particularly depleted. The 
decrease in histone transcripts as the parasite enters the non-dividing stationary 
phase suggests a mode of regulation that is dependent on the cell cycle and is 
consistent with observations in higher eukaryotes that histone gene expression 
decreases in differentiated cells (Gerbaulet, 1992; Stein, 1996). Also consistent 
with previous findings, multiple β-tubulin family members were identified as 
downregulated ~1.4-fold as the parasite becomes infective (Coulson, 1996). The 
downregulation of β-tubulin as the parasite undergoes metacyclogenesis 
correlates with morphological changes of the parasite as it prepares to enter host 
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cells. Additionally, the steady-state RNA level for adenine aminohydrolase (AAH), 
a purine metabolism protein that converts adenine to hypoxanthine and lacks 
homologs in humans as well as T. cruzi and T. brucei (Boitz, 2013), was found to 
be reduced in L. major metacyclic promastigotes in our study, as were cyclin A 
and DOT1, which are both involved in cell cycle progression (Hochegger, 2008; 
Kim, 2014). 
The top upregulated gene, ascorbate peroxidase (APX), is protective 
against both endogenous and exogenous H2O2 and appears to play a role in 
differentiation to the metacyclic form as well as in protecting the cell against 
oxidative stress-induced apoptosis (Pal, 2010). Other genes that were 
upregulated in metacyclic promastigotes include casein kinase 1, a 
serine/threonine protein kinase that exists in multiple isoforms and has been 
identified as playing a role in Leishmania infectivity (Allocco, 2006), and meta1, 
which encodes a protein that localizes in the region of the flagellar pocket of 
stationary phase promastigotes and is thought to play a role in virulence, 
potentially through altering secretory processes (Nourbakhsh, 1996; Puri, 2011). 
The p27 gene, which encodes a mitochondrial membrane protein that is an 
important component of the cytochrome oxidase complex, was also more 
abundantly expressed in metacyclic promastigotes. This result is consistent with 
previous findings reporting its upregulation in both metacyclics and intracellular 
amastigotes and its role in promoting parasite survival and virulence in the host 
(Dey, 2010) and supports the hypothesis that metacyclic promastigotes are pre-
adapted to survival within the mammalian host (Sacks, 1989). Finally, two known 
 39 
 
differentiation markers of metacyclic promastigotes, SHERP and HASPB (Flinn, 
1994; Knuepfer, 2001; Sádlová, 2010), were also identified in this analysis, with 
SHERP upregulated ~1.9-fold and HASPB upregulated ~2.3-fold in metacyclic 
promastigotes. 
The results of the differential expression analysis were compared to the 
list of differentially expressed genes identified in an earlier study by Saxena et al. 
(Saxena, 2003) that used microarrays of PCR-amplified fragments from genomic 
survey sequence (GSS) clones. Only GSS clones whose 5´ and 3´ sequences 
could be mapped to the same gene in the L. major Friedlin genome sequence 
(31 in total) were considered in our comparison and 19 of the corresponding 
genes showed a similar differential expression trend, albeit to varying degrees 
and levels of significance. Given the disparate platforms, the level of agreement 
was reasonable.  
Conclusion 
This work represents a comprehensive characterization of the global 
transcriptional changes that define the transition of the human pathogen 
Leishmania major from its non-infective to human-infective forms. Through the 
exploitation of massively parallel sequencing to detect subtle changes in steady-
state levels of mRNA, the use multiple biological replicates to derive robust 
statistical analyses, and the careful consideration of batch effects that often 
confound and mask true biological signal, we observed changes in expression 
profiles between the procyclic promastigote and metacyclic promastigote forms 
of L. major. Indeed, since the individual fold changes observed were relatively 
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modest (3.1-fold downregulated to 3.6-fold upregulated in metacyclics), they may 
have been missed except for the sensitivity afforded by the RNA-seq technology 
and the statistical power provided by the use of 5 biological replicates. The 
extension of the differential expression analysis to novel ORFs identified from 
ribosome profiling data pointed to some genes that were not included in the initial 
annotation of L. major which may have functionally important roles in the 
differentiation of the parasite. These genes should be added to the list of 
candidates to be included in future analyses. 
GO analysis using the lists of differentially expressed genes revealed how 
they are collectively involved in a number of cellular processes as the parasite 
transforms into its infective form. Specifically, as the parasites become infective, 
processes including cell signaling and stress responses increased while 
translation, replication, and metabolism decreased. The transcriptome profiles 
reported here set the stage for the construction of co-expression networks, which 
are useful for identifying driver mechanisms underlying co-regulation and for 





Transcriptomic profiling of Leishmania-infected murine 
macrophages 
Introduction 
In order to survive and replicate, intracellular pathogens must survive the 
innate and adaptive immune responses of the host. A number of human 
pathogens - including Leishmania sp., Trypanosoma cruzi, Mycobacterium 
tuberculosis, Toxoplasma gondii, Francisella tularensis, Legionella pneumophila, 
and Ehrlichia - have evolved mechanisms not only to evade the host immune 
system, but to infect the very immune cells that are recruited to clear an infection. 
Leishmania is used here as a model of intracellular infection of immune cells to 
study transcriptomic changes that take place in both the host and the pathogen 
over the course of an infection. 
Leishmania enter mammalian macrophages by receptor-mediated 
phagocytosis and are thought to do so in a quiescent manner, failing to produce 
a significant oxidative burst and to activate the innate immune system (Bennett, 
2001; Laskay, 2003; Locksley, 1988; Zhang, 2010). It has previously been shown 
that a Th1 response by the host leads to parasite killing while a Th2 response 
leads to parasite growth (Etges, 1998; Reiner, 1995; Scharton-Kersten, 1995). 
Leishmania thus attempt to prevent their killing by altering cytokine expression 
(thereby influencing T cell responses), impeding antigen display by MHC class II 
molecules, and hindering nitric oxide production (reviewed in (Kaye, 2011; 
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Olivier, 2005; Sacks, 2002)). Less is known about the mechanisms used by the 
parasite to influence the host response and the global changes that take place at 
the transcriptomic level in both the parasite and host over the course of an 
infection. 
Previous studies using microarrays or SAGE tags have started to 
elucidate changes that occur within Leishmania or within the mammalian host as 
infection occurs, but have been hindered by technical limitations that have 
prevented the interrogation of both systems simultaneously. In this study, we 
performed transcriptomic profiling of L. major-infected murine macrophage cells 
to identify genes that were differentially expressed by both the parasite and host 
cells as Leishmania entered and persisted within macrophages during the first 72 
hours of an infection.  
Infection dynamics and global transcription patterns 
 Transcriptomic profiling by RNA-seq was used to identify global changes 
in gene expression over the course of the first 72 hours of an infection of murine 
macrophages with Leishmania major. Peritoneal macrophages from C57BL/6 
mice were infected with L. major metacyclic promastigotes and samples collected 
at 4, 24, 48, and 72 hours post-infection (hpi). The dynamics of the infection were 
monitored by counting the number of parasites per 100 macrophages (Figure 
12). RNA sequencing was carried out for each sample and for matched 
uninfected controls, as well as for the L. major metacyclic promastigotes used for 
the infection. Over 2.4 billion sequence reads were collected across three 
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independent experiments (biological replicates) and labeled as batches A-C 
(Table 13).  
 Since there is little sequence conservation between mouse and L. major, 
we were able to unambiguously map reads from mouse and parasite RNAs from 
the mixed sample to their respective genomes. For uninfected samples, the 
percentage of reads mapping to the mouse genome ranged from 88.9% to 
95.9%. Greater heterogeneity was observed for the percentage of reads mapping 
to L. major in the infected samples, providing clues about the transcriptional 
activity of both parasite and host (Figure 12). For each batch, the percentage of 
reads mapping to the parasite decreased over the course of the infection. 
Interestingly, this decrease in the relative portion of parasite reads did not match 
the parasite load of the infected cells, which decreased sharply between 4 and 
24 hours for each batch, but slowly rose again from 24 through 72 hours (Figure 
12). Possible explanations for the mismatch between the increasing number of 
parasites and the decreasing percentage of parasite reads is that the individual 
parasites are less transcriptionally active as the infection progresses or that the  
mouse cells became more transcriptionally active over the course of the 
infection, thereby diluting the proportion of reads attributable to the parasite. 
 Samples from host and from parasite showed a similar distribution of per-
gene read counts per sample, as visualized by box plots (Figure 13), but striking 
differences were observed when comparing the two organisms. The median 
steady-state expression level was elevated in L. major compared to mouse (6.0 v 




Figure 12: Characterization of L. major intracellular growth and proportion of RNA 
from the parasite. 
Mouse macrophages infected with L. major were collected at 4, 24, 48, and 72 hpi and subjected 
to transcriptional profiling by RNA-seq. Bar plots are used to illustrate (A) the number of parasites 
observed per 100 host cells (available for 2 of 3 replicates) and (B) the percentage of trimmed 
RNA-seq reads that map to the L. major genome. Data from each experimental batch is shown 
using a different shade of gray. 
distribution (interquartile ranges of 5.6 to 6.5 for L. major and 0 to 6.8 for mouse). 
Additionally, when non- and lowly-expressed genes were removed from the 
datasets prior to differential expression analysis, this filter led to the removal of 
10,548 genes from the mouse dataset, but only 7 genes from the parasite one. 
 The differences in the distribution of genes between mouse and L. major 
are consistent with differences in how each organism controls gene expression - 
mouse employs both transcriptional and post-transcriptional mechanisms to 
control the expression levels of individual genes, resulting in many genes that are 
not expressed and a wide dynamic range for those that are. This differs from 
Leishmania, which employs polycistronic transcription by RNA polymerase II at 




Figure 13: Global assessment of data distribution. 
For each sample, the counts of reads mapping to L. major (A) and mouse (B) were normalized for 
sequencing library size and a box plot was generated to compare the distribution of per-gene 
counts (log2 counts per million with an offset of 1). The ends of the whiskers represent the lowest 
datum still within 1.5 interquartile range (IQR) of the lower quartile, and the highest datum still 
within 1.5 IQR of the upper quartile. Gene features with extremely high or low expression levels 
are shown as open circles above and below the whiskers, respectively. Samples are named 
according to sample type, timepoint, and experimental batch. 
The resulting polycistronic mRNAs are split into their component mature mRNAs 
by coupled trans-splicing and polyadenylation events (LeBowitz, 1993; Matthews, 
1994; Ullu, 1993). Parasite mRNAs levels are thus not determined by the amount 
of transcription, but by post-transcriptional processes such as RNA processing 
and degradation (reviewed in (Clayton, 2007)). The dearth of lowly expressed L. 
major genes may indicate that very few mRNAs are completely degraded 
following polycistronic transcription.  
Statistical assessment of biological replicates and batch effects 
 The use of multiple biological replicates necessitated the evaluation of the 
data to assess reproducibility and account for batch effects, i.e. experimental 
variation caused by sub-groups of measurements that are not related to the 
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underlying biology of the system being studied. Previous analyses of high-
throughput data, like those produced by RNA-seq, have indicated the need to 
assess and correct batch effects in order to prevent misinterpretation of results 
(Dillon, 2015; Leek, 2010). In this study, experimental start date was used as a 
surrogate for batch when testing for differential expression. 
 We used principal component analysis (PCA) and Euclidean distance 
heatmap analysis to visualize the relationship between experimental datasets 
both prior to and after adjusting for batch effects (Figure 14 and Figure 15, 
respectively). The PCA plots revealed that samples from the same experimental 
condition (hpi and infection status) grouped together for the parasite and mouse 
macrophages demonstrating a high level of reproducibility between replicates. 
The dendrograms associated with the Euclidean distance heatmaps further 
illustrated this point, with like samples clustering most closely with one another. 
The grouping of samples by experimental condition was partially obscured when 
batch effects were not considered, illustrating the benefits of this approach. Batch 
effects were therefore controlled for in the subsequent differential expression 
analyses by including experimental batch in the statistical models used. 
 The PCA and clustering analysis also suggested interesting biological 
relationships between the samples. The global profile of L. major gene 
expression changed over the time course of the experiment, moving from left to 
right across principal component (PC) 1 (Figure 15A). The clear separation 
between promastigote and amastigote samples along PC1 highlights the 




Figure 14: Principal Component Analysis (PCA) and hierarchical clustering 
analysis prior to accounting for batch effects. 
RNA-seq was carried out on mouse macrophages infected with L. major at 4, 24, 48, and 72 hpi 
as well as on the metacyclic promastigotes used for the infection. Principal component analysis 
(PCA) plots and heatmaps of hierarchical clustering analyses using Euclidean distance are 
shown for the L. major (A, C) and mouse (B, D) transcriptomes over the course of the experiment. 
The analyses were performed using all annotated protein-coding genes following filtering for low 
counts and quantile normalization prior to accounting for batch effects in the statistical model 
(8,479 genes for L. major and 12,552 genes for mouse). In the PCA plots, the first two principal 
components are shown on the X and Y axes, respectively, with the proportion of total variance 
attributable to that PC indicated. Each experimental sample is represented as a single point with 
color indicating sample type/timepoint and shape indicating experimental batch. Colors along the 
tops of the heatmaps indicate the sample type/timepoint and colors along the left sides of the 
heatmaps indicate the experimental batch. Samples are named according to sample type, 




Figure 15: Principal Component Analysis (PCA) and hierarchical clustering 
analysis after accounting for batch effects. 
RNA-seq was carried out on mouse macrophages infected with L. major at 4, 24, 48, and 72 hpi 
as well as on the metacyclic promastigotes used for the infection. Principal component analysis 
(PCA) plots and heatmaps of hierarchical clustering analyses using Euclidean distance are 
shown for the L. major (A, C) and mouse (B, D) transcriptomes over the course of the experiment. 
The analyses were performed using all annotated protein-coding genes following filtering for low 
counts and quantile normalization after accounting for batch effects in the statistical model (8,479 
genes for L. major and 12,552 genes for mouse). In the PCA plots, the first two principal 
components are shown on the X and Y axes, respectively, with the proportion of total variance 
attributable to that PC indicated. Each experimental sample is represented as a single point with 
color indicating sample type/timepoint and shape indicating experimental batch. Colors along the 
tops of the heatmaps indicate the sample type/timepoint and colors along the left sides of the 
heatmaps indicate the experimental batch. Samples are named according to sample type, 
timepoint, and experimental batch. 
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be seen within the intracellular amastigote samples, some intermixing of samples 
from different timepoints was observed beyond 4 hpi (Figure 15C), suggesting an 
overlap in the gene expression profiles for these samples.  
 A time progression was also seen in the mouse macrophage data for both 
infected and uninfected samples (Figure 15B and Figure 15D). This observation 
underscored the necessity of collecting uninfected controls from each timepoint 
studied rather than relying on a control from a single timepoint. In addition, all 
infected macrophages from 24-72 hpi clustered more closely with the uninfected 
macrophages while the 4 hpi infected macrophages clustered apart. This is 
especially apparent in the heatmap dendrogram where the 4 hpi infected 
macrophages appear as a major outgroup.  
Differential expression and pathway enrichment analyses in murine 
macrophages 
 While clustering analyses provided a high level overview of the behavior of 
the murine macrophage and parasite transcriptomes during the infection, further 
analyses were needed to evaluate changes in the expression levels of individual 
genes. A differential expression analysis was carried out to closely dissect the 
host murine macrophage response to infection by Leishmania major at 4, 24, 48, 
and 72 hours after infection. Pairwise analyses were conducted within and 
across individual timepoints with infected macrophages evaluated against 
matched uninfected macrophages for each timepoint. 
 The most substantial response to infection by the macrophage was 
observed at 4 hpi, with 6897 genes differentially expressed (DE) between 
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uninfected and infected cells with fold changes (FC) ranging from 29-fold 
downregulated to 56-fold upregulated. The response is reduced in later 
timepoints as reflected in smaller numbers of DE genes - 931, 1813, and 1460 
genes at 24, 48, and 72 hpi, respectively - and in reduced fold changes with no 
downregulation beyond 12-fold or upregulation beyond 18-fold for these 
timepoints. The breakdown of up- and down-regulated genes for each timepoint 
comparison is illustrated in Figure 16 and Figure 17 (top).  
 A direct comparison of the overlap in DE genes at each timepoint revealed 
that the macrophage response to infection at 4 hpi was vastly different from the 
response at the later timepoints (Figure 17B and Figure 18). Of the 6897 DE 
genes at 4 hpi, 93% (6418 genes) were unique to 4 hpi. This is in contrast to 
40% of genes at 24 hpi (377), 33% of genes at 48 hpi (598), and 33% of genes at 
72 hpi (484) that were DE only at that specific timepoint. Indeed, only 47 genes 
were consistently up- or down-regulated at all 4 timepoints (38 genes 
upregulated at all timepoints and 9 genes downregulated at all timepoints). 
These genes do not appear to be functionally related, although the list does 
include the heavy metal transporters metallothionein 1 and 2. The latter has 
previously been associated with Leishmania resistance to treatment with 
antimonial drugs (Gómez, 2014). Interestingly, two genes associated with Bcl2 
(Bnip3 and Bcl2a1b), an inhibitor of apoptosis, are also on this list, suggesting 
that infection by L. major may induce changes in host gene expression to prevent 





Figure 16: MA plot of differentially expressed genes in murine macrophages upon 
infection by L. major. 
Differential expression analysis was done to compare infected mouse macrophages and 
uninfected controls at 4, 24, 48, and 72 hpi using limma after voom transformation, taking 
experimental batch into account as part of the limma statistical model. The MA plots show the 
relationship between mean expression (log2 counts per million with an offset of 0.5) and fold 
change (log2) for each timepoint. Each point represents one gene. Genes upregulated in infected 
samples relative to uninfected samples exhibit positive fold changes, while downregulated genes 
exhibit negative fold changes. Points colored in gray represent genes that were not significantly 
different between uninfected and infected macrophages (P value < 0.05) while points colored in 
shades of red represent significant genes, with those showing a < 2-fold difference (logFC < 1) 





Figure 17: Differentially expressed genes in L. major parasites and their murine 
macrophage host cells. 
Pairwise comparisons were done to determine differentially expressed (DE) genes from 
uninfected vs. infected mouse samples at each timepoint (A, top) and between timepoints (A, 
middle), and for L. major parasite samples between timepoints (A, bottom). Box length depicts the 
number of DE genes either downregulated (left) or upregulated (right) at an adjusted P value of < 
0.05 with the total number of down- and up-regulated genes shown. Color hue indicates sample 
type/timepoint as defined in Figure 14 and Figure 15 and color shade indicates the proportion of 
genes with > 4-fold differential expression (dark), between 2- and 4-fold differential expression 
(medium), or 2-fold differential expression (light). The DE gene lists for uninfected vs. infected 




Figure 18: Expression patterns for the top up- and down-regulated genes in L. 
major-infected murine macrophages. 
A heatmap is used to illustrate the pattern of changes in gene expression over time for the top 
differentially expressed genes in uninfected vs. L. major-infected murine macrophages. The top 
20 significantly up-regulated (A) and down-regulated (B) genes at each timepoint (P value < 0.05) 
were selected for inclusion. A color key and histogram for the frequency of fold change values is 
shown with each panel. 
In order to detect statistically significant differences in gene expression 
over time, we conducted differential expression analysis across timepoints. 
Contrasts between successive timepoints revealed a large number of DE genes 
 54 
 
during the 4 to 24 hpi transition (5674 DE genes), but almost no statistically 
significant genes between 24 and 48 hpi (1 gene) or between 48 and 72 hpi (0 
genes) (Figure 17A middle and Figure 19). This suggests that the large initial 
response of the murine macrophages to L. major infection reached a plateau by 
24 hpi, which persisted for the remainder of the time course as the infected cells 
mostly maintain their expression profile relative to matched uninfected cells. 
The cellular processes most affected at each timepoint were characterized 
by KEGG pathway enrichment analysis using ConsensusPathDB (Kamburov, 
2011). Genes that were DE >2-fold were used as input with upregulated and 
downregulated genes considered separately. The results of this analysis are 
reported in Table 4, Table 5, and Table 6. 
 
 
Figure 19: MA plot of differentially expressed genes in murine macrophages over 
time upon infection by L. major. 
Differential expression analysis was done to compare changes in L. major-infected mouse 
macrophages relative to uninfected controls over the time course of the experiment (4, 24, 48, 
and 72 hpi). Comparisons were done using limma after voom transformation, taking 
experimental batch into account as part of the limma statistical model. The MA plots show the 
relationship between mean expression (log2 counts per million with an offset of 0.5) and fold 
change (log2). Each point represents one gene. Genes upregulated in the second of the specified 
timepoints relative to the first are shown as exhibiting positive fold changes, while downregulated 
genes exhibit negative fold changes. Points colored in gray represent genes that were not 
significantly different between the tested conditions (P value < 0.05) while points colored in 
shades of red represent significant genes, with those showing a < 2-fold difference (logFC < 1) 
colored in pink, 2 to 4-fold difference colored in red, and > 4-fold difference colored in burgundy. 
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 The enriched KEGG pathways were considered alongside the DE gene 
lists to gain insights into the cellular response to infection and how it differs 
between early and later infection. Early in the infection (4 hpi), many of the 
KEGG pathways that are most highly induced in infected macrophages are 
related to immune responses, specifically cytokine-cytokine receptor interactions 
and arginine and proline metabolism, glycolysis, and multiple signaling pathways 
including those for TNF, HIF-1, NF-kappa B, Jak-STAT, PI3K-Akt, and MAPK. A 
closer look at the DE genes in the immune response-related pathways reveals an 
interesting picture of the murine macrophage response to infection at 4 hpi. 
Infected macrophages produce a set of transcripts with paradoxical functions 
involved in both activating immune responses and promoting tissue regeneration 
and wound healing. Many of the DE genes associated with enriched pathways 
are anti-inflammatory in character or are involved in tissue growth and repair, 
including Csf1, Csf3, Il10, Il11r, Il1rn, Socs3, Hmox1, Egfr, Vegf, and fos-induced 
growth factor (Figf). The product of each of these genes has either been 
associated with reducing inflammation or promoting cell survival or differentiation. 
Therefore, macrophages infected with L. major appear to assume an 
immunoregulatory phenotype that resembles previously described macrophages 
treated with LPS and immune complex (Fleming, 2015). However, not all of the 
differentially induced genes in infected macrophages at 4 hpi were anti-
inflammatory. There was also an upregulation of transcripts encoding well-
described inflammatory cytokines and their receptors including Il1, Il6, Tnf, and 
Nos2, as well as Il1rap and Il18r1. The pro-inflammatory NOD-like receptor  
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Cytokine-cytokine receptor interaction 43 266 3.49E-12
TNF signaling pathway 24 111 3.05E-09
Transcriptional misregulation in cancer 24 180 5.72E-09
HIF-1 signaling pathway 20 113 4.57E-07
Hematopoietic cell lineage 16 87 5.84E-07
NF-kappa B signaling pathway 19 102 1.55E-06
Jak-STAT signaling pathway 22 155 2.24E-06
Legionellosis 13 59 1.05E-05
PI3K-Akt signaling pathway 37 353 6.29E-05
MAPK signaling pathway 28 257 2.57E-04
Salmonella infection 12 79 9.24E-04
Malaria 9 49 1.00E-03
NOD-like receptor signaling pathway 10 59 1.03E-03
Rheumatoid arthritis 12 84 1.60E-03
Glycolysis / Gluconeogenesis 9 65 2.19E-03
Mineral absorption 8 46 2.72E-03
ECM-receptor interaction 11 87 6.42E-03
Tuberculosis 18 177 6.45E-03
Gap junction 11 88 7.00E-03
Axon guidance 14 129 8.88E-03
Arginine and proline metabolism 8 56 9.30E-03
Prion diseases 6 35 9.77E-03





Osteoclast differentiation 21 126 2.99E-06
Terpenoid backbone biosynthesis 7 21 7.30E-05
Staphylococcus aureus infection 11 52 7.61E-05
Steroid biosynthesis 6 17 1.71E-04
NOD-like receptor signaling pathway 10 59 2.51E-04
Peroxisome 12 81 1.18E-03
PPAR signaling pathway 12 81 1.18E-03
Chagas disease (American trypanosomiasis) 14 104 1.24E-03
Biosynthesis of unsaturated fatty acids 6 25 1.69E-03
Leishmaniasis 10 66 2.50E-03
ABC transporters 8 46 2.75E-03
Axon guidance 15 129 3.69E-03
Leukocyte transendothelial migration 14 121 5.16E-03
Fc gamma R-mediated phagocytosis 11 89 7.70E-03





Table 4: KEGG pathways enriched in L. major-infected murine macrophages at 4 
hpi. 
KEGG pathway analysis using ConsensusPathDB (Kamburov, 2011) identified signaling and 
metabolic pathways that were over-represented in L. major-infected mouse macrophages at 4 hpi 
(P value < 0.01) relative to uninfected controls. Genes that were differentially expressed (DE) by 
more than 2-fold were used as input with up- and down-regulated genes considered separately. 
For each enriched KEGG pathway, the number of DE genes assigned to that pathway, the total 
number of genes in the pathway, and the P value for the enrichment are reported. 
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signaling pathway is enriched among both up-regulated and down-regulated 
genes at 4 hpi with some members of the pathway upregulated (Tnf, Il6, Il1β, 
Cxcl2) and others downregulated (NLRP-family members, Pycard, Card9, and 
Il18). It is unclear to what extent the observed expression patterns are being 
driven by the parasite as it is taken into the host cell, or are being promoted by 
the host as it attempts to limit infection or to protect itself from the negative 
effects of a robust immune response. 
 Pathway analysis also showed an upregulation of glycolysis/ 
gluconeogenesis at 4 hpi. Upregulated genes encode glycolytic enzymes, 
including hexokinases, enolase, phosphoglycerate kinase, glyceraldehyde-3- 
phosphate dehydrogenase, and lactate dehydrogenase A. An increase in 
anaerobic glycolysis has been associated with the stimulation of inflammatory 
responses in macrophages following toll-like receptor (TLR) ligation (Tannahill, 
2013). Glycolytic pathways were also enriched among upregulated genes at 24 
hpi, but this effect was not seen at 48 and 72 hpi. Thus, following phagocytosis of 
L. major, macrophages undergo transient metabolic alterations that result in an 
increase in glycolysis and the generation of ATP. 
 KEGG pathways downregulated at 4 hpi are mostly related to lipid 
metabolism and biogenesis and include osteoclast differentiation, terpenoid 
backbone biosynthesis, steroid biosynthesis, PPAR signaling, and biosynthesis 
of unsaturated fatty acids. Decreases in the receptors and signaling molecules 
involved in the process of phagocytosis itself (“Fc gamma R-mediated 
phagocytosis” KEGG pathway) were also observed at 4 hpi. Transcripts 
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encoding all four Fcγ receptors (Fcgr1, Fcgr2b, Fcgr3, and Fcgr4), complement 
component 1 q subcomponent polypeptides (C1q family), and the C5a receptors 
(C5ar1 and C5ar2) were downregulated following L. major phagocytosis. It has 
been previously shown that phagocytosis of Leishmania and other pathogens via 
Fc gamma receptors leads to parasite killing while phagocytosis via pathways 
mediated by complement receptor 3 (CR3) leads to parasite survival 
(Babadjanova, 2015; Da Silva, 1989; Fadul, 1995; Mosser, 1987; Woelbing, 
2006). The downregulation of Fc gamma receptors may be a mechanism by 
which the parasite induces changes in host cells to promote alternative entry 
mechanisms that will support its survival. 
An examination of the enriched KEGG pathways at 24, 48, and 72 hpi 
reveals different enrichment patterns from those observed at 4 hpi (Table 5 and 
Table 6). There are a greater number of pathways downregulated than 
upregulated during each of these later timepoints, but we see no clear picture 
that otherwise emerges. 
While a significant number of disease-specific KEGG pathways are 
enriched among up-and down-regulated genes reported at various timepoints in 
this study (i.e., leishmaniasis, Chagas disease, tuberculosis, malaria, 
legionellosis, amoebiasis, Salmonella infection, Staphylococcus aureus infection, 
Fanconi anemia, prion diseases, and cancer subtypes; see Table 4, Table 5, and 
Table 6), a linkage between these disease and our dataset may not be 
particularly meaningful. This is because the KEGG pathways for these individual 
diseases appear to be constructed using a combination of heterogeneous  
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KEGG pathway Number DE genes
Pathway 
Size P Value
Glycolysis / Gluconeogenesis 4 65 2.88E-06
Chemical carcinogenesis 6 95 2.62E-05
Metabolism of xenobiotics by cytochrome P450 6 96 2.78E-05
Drug metabolism - cytochrome P450 6 97 2.95E-05
Starch and sucrose metabolism 4 54 3.44E-04
Glutathione metabolism 4 55 3.70E-04
Staphylococcus aureus infection 3 52 4.11E-03
HIF-1 signaling pathway 2 113 5.33E-03
Natural killer cell mediated cytotoxicity 2 119 6.40E-03
Osteoclast differentiation 4 126 7.80E-03
KEGG pathway Number DE genes
Pathway 
Size P Value
Osteoclast differentiation 8 126 9.58E-07
KEGG pathway Number DE genes
Pathway 
Size P Value
Osteoclast differentiation 10 126 4.94E-08
Staphylococcus aureus infection 5 52 1.68E-04
Calcium signaling pathway 8 183 5.06E-04
Chemokine signaling pathway 8 199 8.78E-04
Hematopoietic cell lineage 5 87 1.81E-03
Nicotinate and nicotinamide metabolism 3 32 3.99E-03
Leishmaniasis 4 66 4.34E-03
Amoebiasis 5 120 7.19E-03
Salivary secretion 4 77 7.49E-03
Complement and coagulation cascades 4 77 7.49E-03
Tuberculosis 6 177 8.87E-03
Upregulated genes, 24 hpi
Upregulated genes, 48 hpi
Upregulated genes, 72 hpi
 
Table 5: KEGG pathways enriched among genes upregulated in L. major-infected 
murine macrophages at 24, 48, and 72 hpi. 
KEGG pathway analysis using ConsensusPathDB identified signaling and metabolic pathways 
that were over-represented among genes upregulated > 2-fold in L. major-infected mouse 
macrophages at 24, 48, and 72 hpi (P value < 0.01) relative to uninfected controls. For each 
enriched KEGG pathway, the number of differentially expressed (DE) genes belonging to that 
pathway, the total number of genes in the pathway, and the P value for the enrichment are 
reported. 
observations from multiple studies of individual genes using data from different 
experiments, hosts, cell types, and timepoints, rather than using gene lists 
derived from a single or set of genome-wide studies, and as a result paint an 
incomplete picture of the global changes in gene expression. Therefore, while it 
is interesting to note small overlaps between the comprehensive DE profiles in 
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Transcriptional misregulation in cancer 10 180 2.10E-05
Pathways in cancer 13 326 4.09E-05
Focal adhesion 10 206 6.63E-05
Melanoma 6 73 1.21E-04
PI3K-Akt signaling pathway 12 353 3.64E-04
Proteoglycans in cancer 9 228 7.14E-04
Glycosaminoglycan biosynthesis - chondroitin sulfate/dermatan sulfate 3 20 1.17E-03
Small cell lung cancer 5 86 2.20E-03
Thyroid cancer 3 29 3.51E-35
Wnt signaling pathway 6 143 4.18E-03
Colorectal cancer 4 64 4.74E-03
Hippo signaling pathway 6 156 6.36E-03
Amoebiasis 5 120 9.04E-03





Cell cycle 20 128 7.91E-14
Progesterone-mediated oocyte maturation 9 88 4.20E-06
p53 signaling pathway 8 69 2.25E-05
Oocyte meiosis 10 112 4.28E-05
ECM-receptor interaction 8 87 7.47E-04
Focal adhesion 13 206 7.82E-04
Pathways in cancer 17 326 1.13E-03
Hippo signaling pathway 10 156 2.78E-03
Small cell lung cancer 7 86 3.21E-03
Homologous recombination 4 28 3.37E-03
HTLV-I infection 13 279 4.30E-03
Amoebiasis 8 120 5.71E-03
Fanconi anemia pathway 5 52 6.12E-03





ECM-receptor interaction 15 87 1.08E-10
Focal adhesion 20 206 3.31E-09
PI3K-Akt signaling pathway 21 353 5.47E-06
Pathways in cancer 20 326 5.86E-06
Protein digestion and absorption 10 88 7.90E-06
p53 signaling pathway 7 69 5.63E-05
Cell cycle 9 128 2.02E-04
Small cell lung cancer 8 86 2.69E-04
Amoebiasis 9 120 5.66E-04
Oocyte meiosis 8 112 1.57E-03
Progesterone-mediated oocyte maturation 6 88 1.65E-03
Hippo signaling pathway 9 156 3.53E-03
Tyrosine metabolism 4 43 9.68E-03
Downregulated genes, 24 hpi
Downregulated genes, 48 hpi
Downregulated genes, 72 hpi
 
 
Table 6: KEGG pathways enriched among genes downregulated in L. major-
infected murine macrophages at 24, 48, and 72 hpi. 
KEGG pathway analysis using ConsensusPathDB identified signaling and metabolic pathways 
that were over-represented among genes downregulated > 2-fold in L. major-infected mouse 
macrophages at 24, 48, and 72 hpi (P value < 0.01) relative to uninfected controls. For each 
enriched KEGG pathway, the number of differentially expressed (DE) genes belonging to that 




this study and genes included in these pathways, the differences in scope 
between the lists limit the usefulness of comparisons to disease KEGG pathways 
as currently defined. 
 We compared the results of our differential expression analysis to 
previously published reports on the murine macrophage response to Leishmania 
infection. Since global transcriptome studies of L. major infection of macrophages 
isolated from C57BL/6 mice are not available, we compared our results to studies 
that used either the same mouse strain or the same Leishmania species. In a 
study detailing the infection of C57BL/6 peritoneal macrophages with L. 
amazonensis (Probst, 2012), 105 genes were identified as DE (FC > 1.5) 
between infected and uninfected macrophages at 18 hpi. This number compares 
to 3972 and 546 DE genes (FC > 1.5) at 4 and 24 hpi, respectively, in our 
dataset with an overlap of only 42 genes (of the 105) differentially expressed in 
the same direction at 4 or 24 hpi. Similarly, we compared the infection of Balb/c 
bone marrow-derived macrophages with L. major as reported in two recent 
studies. Of the 769 genes identified when comparing the transcriptomes of L. 
major-infected Balb/c macrophages to macrophages that had ingested latex 
beads (24 hpi timepoint), only 53 were in common with our 24 hpi timepoint 
(Gregory, 2008). However, 446 genes were in common with our 4 hpi timepoint, 
indicating that the time progression observed between the two systems may be 
somewhat offset. Of the 40 genes identified as DE by more than 1.5-fold during 
the 24 hr timecourse experiment reported by Rabhi et al. (Rabhi, 2012), 29 
genes were also found to be differentially expressed in the same direction in our 
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dataset at either 4 or 24 hpi with the greatest number of genes found in common 
with our 4 hpi dataset (26 genes). The limited agreement between the previously 
reported DE genes and our dataset is likely a reflection of the differences in study 
design (e.g., combination of mouse strain and parasite species, macrophage 
source, parasite opsonization), batch effects between laboratories, technical 
platforms, and data analysis methods. 
Differential expression and gene ontology enrichment analyses in L. major 
 While past studies have used microarrays and other methods to 
study changes in Leishmania gene expression between promastigotes and 
amastigotes (Akopyants, 2004; Almeida, 2004; Depledge, 2009; Holzer, 2006; 
Leifso, 2007; McNicoll, 2006; Quijada, 2005; Rochette, 2008; Saxena, 2007; 
Walker, 2006), this study provided a unique opportunity to additionally 
characterize gene expression patterns within amastigotes over the course of an 
intracellular infection. Differential expression analysis revealed a large number of 
genes (2962) to be DE between metacyclic promastigotes and 4-hr amastigotes 
at an adjusted P value cutoff of <0.05, reflecting the significant differentiation 
event that occurs as the parasite enters host cells. Significantly fewer changes in 
expression were observed in amastigotes across timepoints, with 301 DE genes 
found between 4- and 24-hr amastigotes and no DE genes between either 24- 
and 48-hr amastigotes or between 48- and 72-hr amastigotes (Figure 17 and 
Figure 20). This pattern of differential gene expression is consistent with 
observations of gene expression over time in the mouse macrophages and 
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suggests that the initial reprogramming that occurs upon infection had largely 




Figure 20: MA plot of differentially expressed genes in L. major across 
developmental stages and intracellular timepoints. 
Differential expression analysis was done to compare in L. major metacyclic promastigotes 
and intracellular amastigote gene expression over time during a murine macrophage 
infection (4, 24, 48, and 72 hpi). Comparisons were done using limma after voom transformation, 
taking experimental batch into account as part of the limma statistical model. The MA plots show 
the relationship between mean expression (log2 counts per million with an offset of 0.5) and fold 
change (log2). Each point represents one gene. Genes upregulated in the second of the specified 
timepoints relative to the first are shown as exhibiting positive fold changes, while downregulated 
genes exhibit negative fold changes. Points colored in gray represent genes that were not 
significantly different between the tested conditions (P value < 0.05) while points colored in 
shades of red represent significant genes, with those showing a < 2-fold difference (logFC < 1) 
colored in pink, 2 to 4-fold difference colored in red, and > 4-fold difference colored in burgundy. 
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 Gene ontology (GO) analysis was used to identify cellular functions and 
processes that characterize the entry and survival of L. major in the murine 
macrophage system. These results were considered alongside the lists of DE 
genes to draw insights into how the parasite adapts to its new environment. 
Efforts were made to compare the results of this study to previous work, though 
our ability to conduct meaningful systematic comparisons was constrained due to 
the use of different parasite systems (e.g., Leishmania species, source of 
amastigotes, developmental stages and timepoints collected), host systems (e.g., 
mice strains, cell lines), experimental platforms (e.g., microarrays, number of 
genes interrogated), and methods for assessing and reporting differential 
expression (fold change vs. statistical cut-offs; details of reported gene lists). 
 GO analysis of the up- and down-regulated genes identified during the 
metacyclic promastigote to 4-hr amastigote transition revealed a total of 20 
enriched GO categories. Enriched GO terms for genes upregulated during this 
transition were primarily related to mitigating the effects of an oxidative response 
by the host immune system and the regulation of proteins (Table 7). Heat shock 
proteins, especially HSP83, multiple tryparedoxin peroxidase family members, 
and multiple cyclophilins were upregulated upon entry of metacyclic 
promastigotes into host cells and contributed strongly to the GO enrichment 
results for the upregulated genes. HSP83, the cytoplasmic form of HSP90, is 
known to stabilize transcription factors and kinases and is thus largely involved in 
the regulation of signaling networks involved in differentiation (Hombach, 2014; 
Requena, 2015), and tryparedoxin peroxidase is known to contribute to 
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GO ID GO term P value
GO:0006950 response to stress 5.50E-13
GO:0006486 protein glycosylation 9.95E-09
GO:0006457 protein folding 5.70E-06
GO:0051920 peroxiredoxin activity 2.72E-05
GO:0051082 unfolded protein binding 9.44E-05
GO:0016209 antioxidant activity 1.04E-04
GO:0004386 helicase activity 2.06E-04
GO:0004713 protein tyrosine kinase activity 6.68E-12
GO:0004674 protein serine/threonine kinase activity 2.15E-11
GO:0004672 protein kinase activity 3.40E-10
GO:0006468 protein phosphorylation 3.43E-10
GO:0005516 calmodulin binding 2.76E-08
GO:0009434 microtubule-based flagellum 1.93E-07
GO:0005840 ribosome 8.85E-07
GO:0006412 translation 1.42E-06
GO:0003735 structural constituent of ribosome 1.81E-06
GO:0006633 fatty acid biosynthetic process 2.72E-05
GO:0009190 cyclic nucleotide biosynthetic process 8.29E-05
GO:0016849 phosphorus-oxygen lyase activity 8.29E-05
GO:0007165 signal transduction 2.66E-04
GO:0005874 microtubule 3.25E-09
GO:0043234 protein complex 5.80E-09
GO:0051258 protein polymerization 5.80E-09
GO:0005198 structural molecule activity 3.32E-08
GO:0006184 GTP catabolic process 3.91E-07
GO:0007018 microtubule-based movement 9.88E-06
GO:0003924 GTPase activity 1.81E-05
GO:0055114 oxidation-reduction process 8.81E-08
GO:0006096 glycolytic process 1.24E-07
GO:0020015 glycosome 4.22E-07
GO:0004743 pyruvate kinase activity 1.50E-05
GO:0050661 NADP binding 2.36E-05
GO:0004365 GAPDH (NAD+) (phosphorylating) activity 5.91E-05
GO:0006006 glucose metabolic process 1.45E-04
Metacyclics to 4-hr amastigotes, upregulated
Metacyclics to 4-hr amastigotes, downregulated
4-hr to 24-hr amastigotes, upregulated
4-hr to 24-hr amastigotes, downregulated
 
Table 7: Gene ontology categories enriched across L. major stages/timepoints. 
GOseq (Young, 2010) was used to identify enriched GO categories for the transition between 
metacyclic promastigotes and 4-hr amastigotes and between 4-hr amastigotes and 24-hr 
amastigotes at a P value cutoff of < 0.05. For each transition, up- and down-regulated genes 




Leishmania virulence and resistance to antimonial drugs (Iyer, 2008). Less is 
known about the role of cyclophilins in Leishmania, though these peptidyl-prolyl 
cis/trans isomerases have been shown to reactivate cellular proteins by 
promoting their disaggregation (Chakraborty, 2002). The upregulation of 
cyclophilin in L. major amastigotes has been previously observed (compared to 
procyclic promastigotes) (Leifso, 2007). Many types of surface antigens were 
highly upregulated, as was the zinc-metalloprotease GP63 (a known virulence 
factor that subverts macrophage signaling) (Olivier, 2012), and phosphoglycan 
beta 1,3 galactosyltransferase (SCG) family members, which are responsible for 
modifications to the Leishmania lipophosphoglycan (LPG) surface molecule side 
chains (Dobson, 2003) and have been previously observed to be upregulated in 
Leishmania amastigotes (Rochette, 2008). That there are significant changes 
taking place on the surface of the parasite is not surprising given the 
transformation that takes place as differentiation progresses from the 
promastigote to amastigote forms. Other genes upregulated during the 
metacyclic promastigote to 4-hr amastigote transition included meta1, which is 
thought to play a role in virulence and was previously found to be upregulated in 
infective metacyclic promastigotes relative to non-infective procyclic 
promastigotes (Dillon, 2015; Nourbakhsh, 1996; Puri, 2011), and inositol-3-
phosphate synthase (ino1), which synthesizes myo-inositol, a precursor molecule 
for the backbone of the GPI anchors used by many Leishmania surface proteins, 
including multiple virulence factors (Ilg, 2002). Interestingly, the gene encoding 
the transporter for myo-inositol (mit1) (Drew, 1995) was among the most down-
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regulated during the transition, perhaps indicating that the parasite favors 
synthesizing de novo rather than importing this important substrate once it enters 
mammalian cells. 
 GO terms that were enriched among downregulated genes during the 
metacyclic promastigote to 4-hr amastigote transition were related to translation, 
cell signaling, fatty acid biosynthesis, and flagellum structure (Table 7). A number 
of genes were responsible for driving the GO results, including ribosomal 
proteins, casein kinase, receptor-type adenylate cyclase, fatty acid elongase, 
sphingolipid delta desaturase, and paraflagellar rod protein. The downregulation 
of ribosomal proteins during the Leishmania promastigote to amastigote 
transition is consistent with previous reports (Almeida, 2004) and may reflect a 
reduction in translation taking place within the cell. Casein kinase is thought to 
play a role in Leishmania promastigote growth and parasite virulence via 
interactions with host proteins, though its exact function is unclear (Allocco, 2006; 
Dan-Goor, 2013). Likewise, adenylate cyclase is a suspected regulator of cAMP 
signaling during Leishmania differentiation (Biswas, 2011; Sanchez, 1995), but 
the exactly signaling pathways through which this is accomplished are unknown. 
Fatty acids have many potential roles within the cell related to membrane 
structure and composition, signaling, and energy. Fatty acid elongase family 
members are involved in fatty acid synthesis and may be involved in GPI 
anchoring (Ramakrishnan, 2013), while sphingolipid delta 4 desaturase is 
involved in the degradation of sphingolipids, a process that has been linked to 
enabling Leishmania to survive the acidic environment of the phagolysosome 
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once it is taken into host cells (Xu, 2011). Genes that influence microtubule 
length and dynamics were systematically downregulated, including those that 
encode paraflagellar rod proteins, calmodulin-related proteins (Ginger, 2013), 
multiple kinesins (Blaineau, 2007; Vicente, 2015), NIMA-related kinases (Cao, 
2009), and mitogen-activated protein (MAP) kinase kinases (Bengs, 2005; 
Erdmann, 2006; Wiese, 2003). These genes have been implicated in the 
regulation of flagellum length and mitotic spindle formation and may reflect 
changes in morphology and cell division that take place as the flagellated 
promastigote stage parasites transform into the aflagellated amastigotes. 
Consistent with previous microarray-based studies (Akopyants, 2004; Almeida, 
2004), we also detected the downregulation of the known metacyclic markers 
SHERP and HASP as the parasite transformed from promastigotes to 
amastigotes. 
 Of the 14 GO categories enriched during the transition from 4-hr to 24-hr 
amastigotes, those related to microtubules and protein complexes were specific 
to upregulated genes with many copies of β-tubulin, the primary component of 
microtubules, almost exclusively driving the GO analysis results. The 
upregulation of β-tubulin in early amastigotes compared to metacyclic 
promastigotes is noteworthy considering its downregulation in metacyclic 
promastigotes compared to procyclic promastigotes (Coulson, 1996; Dillon, 
2015). Besides β-tubulin, many other top upregulated genes encoded surface 
antigens, including the developmentally-regulated amastigote-enriched protein 
amastin (Akopyants, 2004; Holzer, 2006; Rochette, 2008; Wu, 2000). GO 
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categories related to glucose metabolism and oxidation-reduction processes 
were enriched among downregulated genes with many of the downregulated 
genes contributing to these categories belonging to the glycolysis pathway 
(GAPDH, pyruvate kinase, ENOL, triosephosphate isomerase, ALD, and 
glucose-6-phosphate isomerase) or related to cholesterol/sterol metabolism 
(NSDHL, HMGR, FPPS, CYP51) or purine metabolism (XRPT). This may 
indicate a change in the metabolic requirements or preferences of Leishmania 
once the parasites have survived their initial entry into the mammalian cell. Other 
highly downregulated genes included heat shock proteins, biopterin transporters, 
and meta1 (Dillon, 2015; Nourbakhsh, 1996; Puri, 2011). 
 A very significant dataset resulting from this study includes the large 
proportion of the DE genes that have no known function and are annotated as 
hypothetical proteins. Those make up 58% (1724 of 2962) of the DE genes in the 
metacyclic to 4-hr amastigote transition and 49% (147 of 301) of the DE genes in 
the 4- to 24-hr amastigote transition. While hypothetical genes have largely been 
overlooked to date, they almost certainly constitute an integral part of the 
transcriptomic signature of the parasites as members of co-expressed gene 
networks which are involved in common functional pathways or regulated by 
shared regulatory mechanisms. 
Conclusion 
In this study, we performed transcriptomic profiling to identify L. major and 
mouse genes that were differentially expressed as the parasite entered and 
persisted within murine macrophages. The generation of RNA-seq data followed 
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by the unambiguous mapping of reads from infected samples to the genomes of 
both the host and the parasite enabled us to identify genes that changed over the 
first 72 hours of an infection in the real-time context of a dynamic dual biological 
system, and to a much greater depth and sensitivity than has been previously 
reported. Collection of data from multiple biological replicates, the use of 
matched host control samples, careful statistical analysis of variation, and 
removal of batch effects provided us with a unique ability to detect biological 
differences between samples and timepoints with high confidence and sensitivity. 
General patterns of transcription in both the mouse and the parasite 
revealed robust transcriptional responses early in infection but suggested a 
stabilization in the transcriptional response by around 24 hpi, with few genes 
showing statistically significant changes in expression levels after that point. At 4 
hpi, host pathways related to pro- and anti-inflammatory immune signaling and 
interactions and metabolism were upregulated while pathways related to lipid 
metabolism and biogenesis were downregulated. The parasite showed 
upregulation of genes involved in antioxidant responses and the regulation of 
proteins and downregulation of genes related to translation, cell signaling, fatty 
acid biosynthesis, and flagellum structure. In addition to providing robust sets of 
markers for multiple developmental stages of L. major parasites and Leishmania-
infected macrophages over several timepoints, this work contributes to a growing 






Transcriptomic profiling of Leishmania-infected human 
macrophages 
Introduction 
Leishmania infection causes a wide range of clinical outcomes, with some 
species causing cutaneous, mucocutaneous, or diffuse cutaneous leishmaniasis 
where symptoms remain localized to the skin or mucosal surfaces, and other 
Leishmania species causing visceral leishmaniasis after migration to internal 
organs such as the liver, spleen, and bone marrow. Propensity for rapid self-
cure, dissemination, persistence, latency, and reactivation include factors related 
to the species of the parasite, and also to the host’s acquired and innate 
immunities (Herwaldt, 1999; Murray, 2005). Despite the striking variability in 
pathogenicity and tissue tropism of different Leishmania species, their genomes 
are remarkably similar, displaying a high degree of conservation in gene content 
and synteny (Ivens, 2005; Peacock, 2007; Real, 2013; Rogers, 2011). 
Macrophages had been widely regarded as primary host cells of 
Leishmania parasites, although recent studies have established that neutrophils 
(Laskay, 2003; Peters, 2008) and dendritic cells (Charmoy, 2010; León, 2007; 
Ng, 2008) can also be infected, acting therefore as potentially important players 
in the host-pathogen interplay. Nonetheless, it is within the mononuclear 
phagocytes - a hostile environment that is lethal to other microbes - that there is 
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the most documented evidence for the parasite’s replication and long-term 
survival (Bogdan, 1996). 
A limited number of studies have been performed to determine 
transcriptional changes that occur within macrophages harboring different 
pathogens including Mycobacterium tuberculosis, Mycobacterium bovis, 
Mycobacterium avium, Yersinia enterocolitica, Escherichia coli, Legionella 
pneumophila and Leptospira interrogans (Bent, 2015; Blumenthal, 2005; Kabara, 
2010; Magee, 2012; Mavromatis, 2015; Nalpas, 2013; Price, 2014; Subbian, 
2015; Xue, 2013). While an inflammatory response is reported in all cases, the 
availability of partial gene lists of differentially expressed genes hinders the 
comparison of global profiles and the identification of specific response(s) to 
these pathogens. These studies stand in contrast to a number of studies on 
Leishmania-infected macrophages which report that macrophages are impaired 
in their response to INF-γ and attribute chronic infections to macrophage 
deactivation (Forget, 2001; Kwan, 1992; Nandan, 1995; Nandan, 1999; Olivier, 
1992; Reiner, 1994). Overall results from recent transcriptome analyses of 
human or murine macrophages infected by different species of Leishmania and 
generated mostly using microarray platforms indicate that infected cells down-
modulate the expression of many pro-inflammatory genes and up-regulate the 
expression of several genes implicated in anti-inflammatory responses 
(Chaussabel, 2003; Ettinger, 2008; Gregory, 2008; Osorio y Fortéa, 2009; 
Ovalle-Bracho, 2015; Rabhi, 2012; Ramírez, 2012; Rodriguez, 2004). Whether a 
general suppression of gene expression in infected human macrophages occurs 
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has yet to be elucidated and the current reports remain contradictory (Buates, 
2001; Chaussabel, 2003; Ettinger, 2008; Gregory, 2008; Ramírez, 2012; 
Rodriguez, 2004). Since data collected to date represent a miscellany of 
experiments carried out using different macrophage types, host backgrounds, 
parasite species, and timepoints, and because the interpretations of most results 
have been focused on a limited set of markers, it is not possible to integrate 
these findings to describe the comprehensive state of Leishmania-infected 
macrophages.  
Here we carried out a study on human macrophages infected with one of 
two species of Leishmania that cause cutaneous leishmaniasis with potentially 
different clinical manifestations: L. major (cutaneous self-healing) and L. 
amazonensis (cutaneous self-healing/cutaneous diffuse). We utilized a well-
defined time course to simultaneously and comprehensively interrogate the 
transcriptome profiles of both the host and the parasites over time. The 
concurrent collection of samples from macrophages fed latex beads allowed us 
to discern the pathogen-specific response from a more general response that 
can be attributed to large particle phagocytosis. By analyzing data from multiple 
biological replicates and employing careful statistical analyses to account for 
batch effects, we were able to generate robust datasets that represent the 
comprehensive signatures of Leishmania infection in a human host.  
 Study design 
In order to capture the global transcriptional response during the initiation 
and maintenance of intramacrophage infection by 2 distinct species of 
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Leishmania, the transcriptomes of the parasite and the infected human 
macrophage were simultaneously profiled using RNA-seq at 4, 24, 48, and 72 
hours post-infection (hpi). CD14+ monocytes were obtained from 4 donors and 
differentiated into macrophages after an 8-day incubation period in CSF-1 
(Figure 21). In accordance with the recently proposed standards for macrophage-
activation nomenclature (Murray, 2014), we consider these cells to be CSF-1 
monocyte-derived macrophages and we refer to them simply as "macrophages" 
throughput the manuscript. These macrophages were neither polarized nor  
 
Figure 21: Study design, donors, and timepoints. 
Monocyte-derived human macrophages were infected with the metacyclic promastigote form of L. 
major (dark blue) or L. amazonensis (light blue) parasites. Following phagocytosis, metacyclic 
promastigotes transform into the amastigote form (3-10 hpi) and reside in membrane bound 
compartments called phagosomes. As amastigotes divide starting at ~24 hpi, each phagosome 
matures into a membrane bound singular (L. major) or communal (L. amazonensis) vacuole 
inside the macrophage. Samples were collected from infected macrophages, macrophages that 
were allowed to phagocytose latex beads (red), and uninfected controls over 4 timepoints 
spanning from 4 to 72 hpi, as pictured. Total RNA was isolated from each sample and analyzed 
by RNA-seq. A total of 4 biological replicates were collected from 4 different human donors (H2-
H5), and are represented in differing shades of green. A second collection from two of the donors 
was used as a technical replicate within the L. major/uninfected dataset (H2’ and H3’) and for a L. 
amazonensis and latex bead experiment that constituted a later addition to the study design. The 
experimental design is further detailed in Table 14. 
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activated with additional cytokine stimulation and were chosen precisely due to 
their potential for a broad range of responses. 
Macrophages from each donor were infected with purified metacyclic 
promastigotes from Leishmania major or Leishmania amazonensis in the 
presence of human serum. In parallel, macrophages were allowed to 
phagocytose opsonized latex beads to evaluate the effect of inert particle 
phagocytosis on global gene expression (hereafter referred to as the 
“phagocytosis effect”). Uninfected macrophages were used as controls. The 
dynamics of the infection were monitored at each timepoint by determining the 
number of parasites per 100 macrophages and the percentage of infected cells 
(Figure 22 and Table 14). Both Leishmania species infected macrophages at 
similar percentages (~90% for L. major, ~80% for L. amazonensis; Figure 22).  
 
 
Figure 22: Dynamics and characterization of CSF1-induced human macrophage 
infection with Leishmania. 
CSF1-induced human macrophages were infected with either L. major (A) or L. amazonensis (B) 
for 4 h, washed and further incubated until 24 hpi, 48 hpi and 72 hpi. Samples collected at 4, 24, 
48, and 72 hpi were subjected to transcriptional profiling by RNA-seq. The number of internalized 
parasites and percentage of infected cells were determined microscopically. Bars indicate the 
percentage of trimmed RNA-seq reads that map to the respective parasite reference genome. 
Red lines indicate the number of parasites per 100 macrophages and cyan lines indicate % of 
infected macrophages. The graphs incorporate data from all experiments +/- SD. A star (*) 
represents a P value < 0.05 using a Student's t test to compare each timepoint to 4 hpi. 
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The overall parasite loads (parasite per infected cell) were slightly higher for L. 
major-infected macrophages (ranging from 6.3 to 18) than for L. amazonensis-
infected cells (ranging from 6.1 to 8). The intracellular growth rate of each 
species was evaluated by determining the number of parasites per 100 cells. L. 
major showed a significant increase in growth between 4 hpi and the remaining 
timepoints and L. amazonensis growth remaining somewhat constant. It is not 
clear whether the different growth behavior of the two parasites can be attributed 
to an intrinsically different behavior in human cells or simply reflects a lower 
preference of L. amazonensis for the medium used to maintain the human 
macrophages.  
Global transcriptome profiles of Leishmania and its human macrophage 
host cell 
The global transcriptome profiles of the parasites and host cells were 
characterized using RNA-seq. PolyA-enriched cDNA libraries were generated for 
each macrophage sample (uninfected, infected with L. major or L. amazonensis, 
or following ingestion of latex beads) at all timepoints as well as for the 
promastigotes from both species that were used for the infection. Paired-end 
sequence reads of 100 nucleotides were generated for a total of 74 samples, 
representing an average of 4 independent biological replicates for each condition 
and yielding a total of 6.3 billion high-quality reads (see Table 14 for details). 
Each sample from infected cells consisted of a pool of mixed RNAs from 
Leishmania and human macrophages. To resolve these, the RNA-seq reads 
generated from these samples were mapped against the corresponding 
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reference genomes. The fraction of reads mapping to the parasite or human 
reference genomes yielded an estimate of the proportion of RNA molecules from 
each source. While the proportion of L. major reads in parasite-infected 
macrophages did not vary significantly across timepoints, the number of 
intracellular parasites increased over the course of infection (Figure 22A). This 
may reflect an increase in global transcriptional activity in the human 
macrophages or a similar decrease in the parasites. The proportion of parasite-
attributable reads also remained constant during L. amazonensis infection, 
consistent with the attenuated growth rate for the species. 
To investigate general trends in the data, principal component analyses 
(PCA) were carried out after accounting for batch effects (Figure 23). A high 
degree of similarity between biological replicates was evident in the PCA plots for 
both Leishmania species and macrophages with similar samples clustering 
together by infection status/timepoint. We note that the spread of samples along 
the first principal component (PC1; X-axis) seems to reflect the global 
transcriptional changes in the cells over time (Figure 23A). Uninfected control 
macrophages showed notable variance, denoting a drift in the transcriptome as 
the cells were maintained in culture and thus validating the use of a matched 
control for each timepoint. Interestingly, cells that had ingested latex beads 
clustered tightly with uninfected cells at the 4 hour timepoint, revealing that 
macrophages are equipped with the cellular components necessary for 
phagocytosis and experience no marked perturbation in their steady-state 




Figure 23: Global expression profile of human macrophages and Leishmania 
parasites during infection. 
A comprehensive principal component analysis (PCA) was conducted to evaluate the 
relationships between samples across timepoints and to visualize sample-sample distances for  
(A) human macrophages (uninfected controls, Leishmania-infected cells, and bead-containing 
cells) and (B-C) the intracellular forms of Leishmania. Each sphere represents an experimental 
sample with increasing size indicating the progression of timepoints from 4 to 72 hpi. Sphere 
color indicates sample type (dark blue for L. major-infected cells/parasites, light blue for L. 
amazonensis-infected cells/parasites, orange for bead-containing cells, and black for uninfected 
cells). In panel A, the clouds highlight the separation of the Leishmania-infected cluster (blue) 
from the uninfected/bead-containing cluster (orange). All analyses were performed after filtering 
out non- and lowly-expressed genes, quantile normalization, and including experimental batch as 
a covariate in the statistical model. 
infected with either L. major or L. amazonensis, which clustered together and 
distinctly away from other samples, pointing to an apparently unique and 
Leishmania-specific human macrophage response early in the infection (4 hpi). 
As the infection progressed, the separation between Leishmania-infected and 
bead-containing macrophages became less prominent, and by 24 hpi, 
macrophages with persisting parasites resembled those harboring inert particles. 
In addition, both populations displayed a clear trending towards uninfected 
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macrophages in the later timepoints (48 and 72 hpi). The global transcriptional 
patterns for intracellular Leishmania parasites of both species were similar with 4 
hpi samples partitioning away from those observed at later timepoints (Figure 
23B-C). This is consistent with the pronounced and distinct host response to the 
parasite, which also displayed a clear separation between responses at early and 
later infection.  
Discriminating between parasite- and phagocytosis-driven changes in 
human macrophages 
We examined the differential expression of individual human macrophage 
genes following Leishmania infection. In macrophages infected with L. major, the 
largest host response was observed at 4 hpi, with 5713 differentially expressed 
(DE) genes between uninfected and infected macrophages at an adjusted P 
value cutoff of <0.05. Later timepoints showed decreasing numbers of DE genes 
– 4846, 4188, 2142 genes at 24, 48 and 72 hpi, respectively (Figure 24A, top). A 
similar trend was observed in the L. amazonensis infection of the macrophages 
(Figure 24B, top) with smaller numbers of DE genes detected, which reflects a 
slightly reduced statistical power associated with fewer biological replicates. Most 
of the genes that were DE during L. amazonensis infection were also contained 
within the L. major-infected macrophage datasets (see comparative DE analysis 
below). It is also worthwhile noting that among the DE genes in macrophages 
infected with either parasite, the average proportion of up- and down-regulated 
genes was ~40%/60% at 4 hpi and ~50%/50% at the remaining timepoints. While 




Figure 24: Differentially expressed genes in macrophages infected with 
Leishmania species. 
The numbers of differentially expressed (DE) genes in (A) L. major-infected macrophages and (B) 
L. amazonensis-infected macrophages relative to uninfected controls both before and after 
accounting for the phagocytosis effect (top panels and bottom panels, respectively) are depicted 
as horizontal bar plots for 4, 24, 48, and 72 hpi. Box width depicts the number of DE genes 
downregulated (left; purple) and upregulated (right; blue) at an adjusted P value of < 0.05 with the 
total number of down- and up-regulated genes shown. Color shade indicates the proportion of 
genes with > 4-fold differential expression (dark), between 2- and 4-fold differential expression 
(medium), or 2-fold differential expression (light).  
observe a general suppression of gene expression in murine macrophage as 
reported in earlier studies (Buates, 2001; Gregory, 2008). Rather, our results are 
consistent with studies that report similar number of genes up- and down-
regulated upon Leishmania infection (Chaussabel, 2003; Ettinger, 2008; 
Ramírez, 2012; Rodriguez, 2004) and challenge the notion that phagocytosis of 
Leishmania by macrophages induces an overall state of dormancy after uptake. 
In order to evaluate the extent of the phagocytosis effect, differential 
expression analysis was carried out to compare uninfected macrophages to 
bead-containing macrophages at each timepoint. This analysis revealed no DE 
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genes at 4 hpi, consistent with the apparent lack of transcriptional response at 4 
hpi following phagocytosis of beads observed in Figure 23A. A well pronounced 
phagocytosis effect was observed at later timepoints with 3787, 6045, and 2659 
DE genes at 24, 48, and 72 hpi, respectively. In a previous study of the response 
of murine bone marrow-derived macrophages to L. major and L. donovani as 
assessed using microarrays, Gregory et al. (2008) found that macrophages that 
had ingested beads were nearly identical to control macrophages at the one 
timepoint used in the study (24 hpi), and thus did not use the bead-containing 
samples to further account for the effects of phagocytosis. This finding more 
closely matches our results at 4 hpi and may indicate a time offset in the murine 
system relative to the human system. Additionally, the observed differences may 
be reflective of differences in macrophage type and incubation conditions prior to 
phagocytosis. 
Subsequent analyses were aimed at distinguishing between changes that 
constitute a specific response to infection and those attributable to the 
macrophage response to phagocytosis. Series of pairwise analyses were 
conducted at each timepoint (4, 24, 48, and 72 hpi) for macrophages infected 
with either L. major or L. amazonensis evaluated against both matched 
uninfected macrophages and macrophages that had ingested latex beads. Using 
a novel approach based on a dual statistical test to identify genes that were 
differentially regulated not only in infected macrophages relative to uninfected 
cells, but also relative to macrophages that have ingested inert particles, we were 
able to filter out genes that are differentially regulated due to the phagocytosis 
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effect and thereby select genes that were specific to the response of the 
macrophage to Leishmania infection. This resulted in significantly reduced 
numbers of DE genes for each timepoint (Figure 24A-B, bottom panels). 
Remarkably, the parasite-specific response was most pronounced in 
macrophages at 4 hpi (3273 and 2161 DE genes in L. major- and L. 
amazonensis-infected macrophages, respectively) and greatly attenuated in later 
timepoints due to the fact that most of the response was attributable to 
phagocytosis.  
Leishmania-induced remodeling of gene expression in human 
macrophages 
In examining the DE genes after accounting for the phagocytosis effect, 
we detected previously identified elements of the macrophage response to 
Leishmania at 4 hpi. Most recognizable was the upregulation of genes encoding 
inflammatory cytokines including interleukin 1B (IL1B), tumor necrosis factor 
(TNF), TNF superfamily members, and interleukin 6 (IL6), as well as a number of 
inflammatory mediators such as prostaglandin-endoperoxide synthase 2 
(PTGS2), granulocyte-macrophage colony stimulating factor 2 (CSF2), and 
superoxide dismutase 2 (SOD2, L. major only). Some of these gene products 
have been previously implicated during infection by Leishmania major 
(Chaussabel, 2003) or other species of Leishmania in both human or murine 
macrophage systems (Ettinger, 2008; Ramírez, 2012; Rodriguez, 2004). 
Among the top upregulated genes (up to 136-fold in L. major infection and 
196-fold in L. amazonensis infection) at 4 hpi are multiple metallothionein 1 
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family members (G, M, H, E, and A). Metallothioneins are known to have an 
immunomodulatory role (Lynes, 1993) and to be induced by a wide range of 
conditions including exposure to reactive oxygen species (Ghoshal, 2001), and 
were recently shown to affect the host response to Listeria infection (Emeny, 
2015). Although metallothioneins have previously been shown to be highly 
upregulated in macrophages infected with Leishmania (Chaussabel, 2003; 
Ettinger, 2008), their potential role in the establishment of infection is poorly 
understood.  
L. major and L. amazonensis show different behavioral characteristics, 
most notably varying clinical outcomes and distinct organization of the 
intracellular amastigotes within the macrophage (one vacuole per parasite for L. 
major and communal vacuoles that house multiple parasites for L. amazonensis) 
(Kaye, 2011; Real, 2014). We explored whether the two species elicited 
significantly different responses by the macrophage across various timepoints of 
infection using a direct statistical comparison of the gene-level macrophage 
response to each parasite. This revealed that they did not trigger a significantly 
different response in the human macrophage with only 4 genes surfacing as 
differentially expressed at 4 hpi and none at any of the subsequent timepoints. 
 Two of the genes that are DE between L. major-infected and L. 
amazonensis-infected macrophages encode synaptotagmin family members 
(SYT2 and SYT8). Synaptotagmins are membrane proteins that regulate vesicle 
docking and fusion in processes such as exocytosis (Arango Duque, 2013; 
Baram, 1999) and phagocytosis (Arango Duque, 2013; Czibener, 2006; Vinet, 
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2008). While some synaptotagmin family members (SYT5 and SYT11) have 
been implicated in Leishmania infection (Arango Duque, 2014; Vinet, 2009; 
Vinet, 2011), the involvement of SYT2 and SYT8 have not yet been investigated. 
Given the general role of synaptotagmins as regulators of membrane trafficking 
and fusion, it is possible that the higher levels of SYT2 and SYT8 observed 
during L. major infection compared to L. amazonensis infection may be linked to 
differences in the parasitophorous vacuole maintenance throughout the infection 
- L. major divide in membrane-bound compartments with each parasite division 
maintaining singular parasites in a vacuole; conversely, L. amazonensis may 
possibly require fewer fission events to maintain its communal vacuoles. 
Additionally, synaptotagmins are also known to play a role in SNARE activity 
regulation by mediating membrane fusion in a Ca2+-dependent manner 
(Andrews, 2005; Südhof, 2009; Tucker, 2002). Since Leishmania have been 
shown to target SNARES (VAMP8 in particular) in order to modulate antigen 
cross-presentation (Matheoud, 2013), it is possible to speculate that 
transcriptional upregulation of synaptotagmins upon infection by Leishmania may 
be related to their role in the regulation of SNAREs. CMIP, which encodes c-Maf 
inducing protein, and GABRE, which encodes gamma-aminobutyric acid (GABA) 
A receptor epsilon, are also expressed at higher levels in L. major-infected 
macrophages than in L. amazonensis-infected macrophages, though the 
mechanisms by which these genes may differentially interact with or be 
influenced by each parasite species is unclear.  
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Towards defining the signature of mammalian macrophage infection by 
Leishmania  
An important aim of this study was to characterize the human macrophage 
response to infection by Leishmania parasites with the fundamental goal of 
defining shared features regarding how intracellular pathogens modulate their 
host environments. We took an initial step towards uncovering a common 
signature in mammalian macrophages infected with Leishmania by integrating 
our findings with data we collected from the same timepoints in L. major-infected 
murine macrophages (see Chapter 4). 
Since the differential expression dataset collected from murine 
macrophages did not account for the phagocytosis effect, we sought to restrict 
this analysis to orthologous genes that were DE in both human and murine 
macrophages as the result of infection and not phagocytosis. To do this, we 
identified the mouse orthologs of the human genes that constituted the L. major-
specific response and then compared the expression profiles for these (human) 
genes to corresponding DE gene profiles generated for the murine macrophages. 
Of the 3273 genes that were DE in L. major-infected human macrophages at 4 
hpi after accounting for the phagocytosis effect, we identified mouse orthologs for 
3017. The relationship between genes in each host system was best visualized 
using a scatterplot showing the magnitude and direction of differential expression 
for each gene and its ortholog (Figure 25). Of the 1735 genes that were DE in 
both host systems, 1340 were differentially expressed in the same direction in 
both systems and thus constitute a unique signature of L. major infection of 
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Figure 25: Response of human and murine macrophages to L. major infection at 4 
hpi after accounting for the phagocytosis effect. 
The differential expression profile of L. major-infected human macrophages was compared to that 
of L. major-infected murine macrophages (Chapter 4). Orthology mapping to mouse was done for 
the 3,273 human genes identified as differentially expressed at 4 hpi after accounting for the 
phagocytosis effect, and the results compared to the murine expression dataset. A scatterplot 
showing the relationship between fold changes (log2) in mouse (X-axis) and human (Y-axis) is 
shown with each human-mouse gene pair represented by a single point. Some genes duplicates 
were introduced by the orthology mapping process. Points colored in gray represent genes in the 
human dataset with an ortholog that was not significantly DE in the murine dataset. Points 
colored in shades of red represent genes that were significantly DE in both datasets with those 
showing < 2-fold difference (logFC < 1) in either/both host system(s) colored in pink and those 
with > 2-fold difference (logFC > 1) in both host systems colored in red. The numbers of unique 
genes represented by the red and pink points are indicated for each quadrant.  
 mammalian macrophages. Those genes localize in quadrants I (567 genes 
upregulated in both systems) and III (773 genes downregulated in both systems) 
and contain the most highly differentially expressed genes. 
In order to identify known cellular processes within this signature, we used 
a KEGG pathway enrichment analysis of genes commonly up- and down-
regulated in both host systems (Table 8). Many of the KEGG pathways that were 







TNF$signaling$pathway 24 109 2.07E813
NF8kappa$B$signaling$pathway 14 88 1.62E806
NOD8like$receptor$signaling$pathway 11 57 3.07E806
Epstein8Barr$virus$infection 21 198 4.43E806
Hematopoietic$cell$lineage 12 82 2.17E805
Shigellosis 10 61 3.88E805
Chagas$disease$(American$trypanosomiasis) 13 103 4.98E805
Proteoglycans$in$cancer 19 198 5.17E805
Ribosome$biogenesis$in$eukaryotes 11 81 9.64E805
ErbB$signaling$pathway 11 85 1.50E804
HIF81$signaling$pathway 12 104 2.30E804
Toll8like$receptor$signaling$pathway 12 105 2.52E804
Osteoclast$differentiation 13 121 2.61E804
Legionellosis 8 54 4.75E804
Cytokine8cytokine$receptor$interaction 19 248 9.33E804
Pertussis 9 75 1.04E803
VEGF$signaling$pathway 8 61 1.09E803
PI3K8Akt$signaling$pathway 23 335 1.27E803
Herpes$simplex$infection 15 179 1.30E803
FoxO$signaling$pathway 12 127 1.41E803
Mineral$absorption 7 50 1.51E803
Hepatitis$C 12 129 1.61E803
Influenza$A 14 169 2.08E803
Small$cell$lung$cancer 9 84 2.32E803
MAPK$signaling$pathway 18 249 2.41E803
Rheumatoid$arthritis 9 87 2.95E803
Hepatitis$B 12 143 3.82E803
Jak8STAT$signaling$pathway 12 147 4.77E803
Measles 11 130 5.17E803
TGF8beta$signaling$pathway 8 79 5.66E803
Pathways$in$cancer 23 381 6.36E803
HTLV8I$infection 17 254 6.79E803
Central$carbon$metabolism$in$cancer 7 66 7.35E803
Prion$diseases 5 36 7.36E803
Tight$junction 11 137 7.62E803
T$cell$receptor$signaling$pathway 9 101 7.91E803
Fc$epsilon$RI$signaling$pathway 7 68 8.63E803
Salmonella$infection 8 85 8.74E803




Valine,$leucine$and$isoleucine$degradation 10 46 2.52E805
Lysine$degradation 9 51 3.46E804
Progesterone8mediated$oocyte$maturation 12 89 5.19E804
Other$glycan$degradation 5 18 8.77E804
Osteoclast$differentiation 14 121 8.88E804
FoxO$signaling$pathway 14 127 1.43E803
Lysosome 13 120 2.44E803
Glycosphingolipid$biosynthesis$8$globo$series 4 14 2.65E803
Fatty$acid$elongation 5 23 2.87E803
Apoptosis 10 81 2.91E803
Chronic$myeloid$leukemia 9 72 4.27E803
Platelet$activation 13 128 4.29E803
Chagas$disease$(American$trypanosomiasis) 11 103 5.70E803
Fc$gamma$R8mediated$phagocytosis 10 90 6.24E803
Propanoate$metabolism 5 28 6.99E803
Glycosaminoglycan$degradation 4 18 7.04E803




Table 8: KEGG pathways enriched in genes common to human and murine 
macrophages infected with L. major at 4 hpi. 
KEGG pathway analysis was carried out to identify signaling and metabolic pathways over-
represented in genes that constitute the mammalian response to L. major infection at 4 hpi. 
Genes that were commonly regulated in both systems were used as input. For each enriched 
KEGG pathway, the number of DE genes assigned to that pathway, the total number of genes in 
the pathway, and the P value for the enrichment are reported. 
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and signaling. Signaling pathways related to the recognition of pathogen-
associated molecular patterns (PAMPs) (NOD-like receptor, RIG-I-like receptor, 
and TLR signaling) were implicated as were many other immune system 
signaling pathways (cytokine-cytokine receptor interaction, Fc epsilon RI, T cell 
receptor, Jak-STAT, MAPK, NF-kappa B, TNF, VEGF, HIF-1, ErbB, FoxO, PI3K-
Akt, and TGF-beta signaling). Given the effects of many of these pathways on 
cell growth and metabolism, it is not surprising that many have been previously 
implicated in cancer and that a number of cancer-related pathways appear in the 
enriched KEGG pathway lists. KEGG pathways enriched among genes that were 
downregulated in both the human and murine systems are associated with 
energy metabolism (amino acid and glycan degradation), lysosome structure and 
processes, and apoptosis. Interestingly, the FoxO signaling pathway, which is 
involved in the regulation of cell growth, gluconeogenesis, and adipogenesis, 
was enriched among both up- and down-regulated genes, with 12 members of 
the pathway upregulated and 14 others downregulated. 
It is important to note that there is a significant amount of redundancy 
within the gene candidates that drive the enrichment of known pathways. An 
analysis of the overlap between the DE genes contained in different pathways 
revealed that the KEGG enrichment results can be solely attributed to 142 up-
regulated and 85 down-regulated genes. This is explained by the nature of 
KEGG pathways (and similar databases) which reflect finite classifications that 
largely represent areas of research emphasis. Genes driving the KEGG results 
among the 39 upregulated pathways include TNF (22 pathways), PIK3CB (22 
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pathways), IL6 (21 pathways), MAPK8 (20 pathways), NFKBIA (19 pathways), 
MAPK11 (18 pathways), IL1B (17 pathways), MAP2K1 (17 pathways), MYC (12 
pathways), IL1A (10 pathways), TRAF2 (10 pathways), CDKN1A (10 pathways), 
NFKB1B (8 pathways), TlCAM1 (8 pathways), and VEGFA (7 pathways) while 
those driving results among the 17 downregulated pathways include AKT1 (9 
pathways), PIK3CG (9 pathways), PIK3R2 (9 pathways), MAPK14 (5 pathways), 
GNAI1 (4 pathways), HADHA (4 pathways), HEXA (4 pathways), HEXB (4 
pathways), PRKACA (4 pathways), PRKACB (4 pathways), TGFBR1 (4 
pathways), and TFGBR2 (4 pathways). 
Disease-specific KEGG pathways appeared prominently in the enrichment 
analysis lists (including those for Chagas disease, Epstein-Barr virus infection, 
hepatitis, herpes simplex infection, HTLV-I infection, influenza, legionellosis, 
measles, pertussis, salmonella infection, and shigellosis). These enrichments 
were largely driven by redundant gene entries within those pathways as 
described above, and KEGG pathways for individual diseases appear to 
represent a comprehensive assemblage of observations from multiple studies of 
individual genes (rather than a consensus) from different experiments, hosts, cell 
types, and timepoints.  
To further extend the interpretation of our L. major and L. amazonensis 
infection datasets, we attempted to identify some of the common elements in the 
human macrophage response to infection by comparing the datasets reported 
here to previous reports on the infection of human macrophages infected with 
Leptospira interrogans (Xue, 2013), Legionella pneumophila (Price, 2014), and 
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Mycobacterium avium (Blumenthal, 2005). Even though we were unable to 
conduct a comprehensive comparison since expression values were reported 
only for subsets of genes in the published datasets, we were able to make some 
useful observations. A number of cytokines, chemokines, and inflammatory 
mediators upregulated in the L. major and L. amazonensis infections were also 
upregulated in these other systems and therefore constitute a shared response 
to infection. Specifically, IL6 and TNF were upregulated in infections by the other 
3 pathogens, IL1B was also upregulated in M. avium and L. interrogans 
infections, TNFSF9 was also upregulated in M. avium and L. pneumophila 
infections, CCL20 and CXCL3 were also upregulated in L. pneumophila and L. 
interrogans infections, CXCL1 and CXCL5 were also upregulated during L. 
interrogans infection, and PTGS2 was also upregulated during M. avium 
infection. All of these genes except CCL20 and CXCL5 were also upregulated in 
the L. major-infected murine macrophage dataset described in Chapter 4. Most 
of these proteins are proinflammatory in nature (IL6 has both pro- and anti-
inflammatory properties) and play a role in the recruitment and stimulation of a 
range of immune cells. The involvement of this broad repertoire of gene products 
reflects the complex and at times opposing immune responses that occur as 
intracellular pathogens attempt to establish an infection and survive 
intracellularly. 
Identification of differentially expressed genes in Leishmania parasites 
This study provided an opportunity to characterize not only the gene 
expression patterns of human macrophages as they responded to infection by 
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Leishmania parasites, but to simultaneously study changes in the parasites' gene 
expression programs as an intracellular infection was established and 
progressed. Differential expression analysis was carried out for parasite genes to 
determine how Leishmania species modify the expression of their individual 
genes during the transition from metacyclic promastigotes to intracellular 
amastigotes and over the course of an intracellular infection. The largest 
numbers of DE genes were observed as metacyclic promastigotes infected 
human macrophages with 3224 L. major genes and 3896 L. amazonensis genes 
implicated at an adjusted P value cutoff of <0.05 (Figure 26). Significantly fewer 
changes in expression were observed in intracellular parasites across time, with 
356 DE genes and 577 DE genes in L. major and L. amazonensis, respectively, 
during the 4 hpi to 24 hpi transition. Only 3 DE genes were observed for each 
species during the 24 hpi to 48 hpi transition and no genes were DE during the 
 
 
Figure 26: Differentially expressed genes between Leishmania parasite 
developmental stages. 
The numbers of differentially expressed (DE) genes between Leishmania developmental 
stages/timepoints were determined. Box width depicts the number of DE genes downregulated 
(left; purple) and upregulated (right; blue) at an adjusted P value of < 0.05 with the total number 
of down- and up-regulated genes shown. Color shade indicates the proportion of genes with > 4-
fold differential expression (dark), between 2- and 4-fold differential expression (medium), or 2-
fold differential expression (light). 
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48 hpi to 72 hpi transitions. This pattern of expression - large numbers of DE 
genes during the metacyclic to early amastigote transition and decreasing 
numbers of DE genes over time - suggests that the large gene expression 
reprogramming that occurs as extracellular promastigote parasites transform into 
intracellular amastigote parasites generally stabilizes by around 24 hpi. This 
mirrors the changes in host transcriptomes where large changes were observed 
during early infection and many fewer changes were observed at later timepoints 
once the phagocytosis effect was considered (see above and Figure 24A-B lower 
panels). The parallel expression patterns between parasite and host suggest that 
host-pathogen interactions are extensive upon Leishmania entering and 
establishing infection within the cells but are virtually nonexistent by around 24 
hours after infection. 
In an attempt to directly compare gene expression programs between the 
two Leishmania species as they transition from the metacyclic form into 
intracellular forms, we focused our analysis on a set of L. major/L. amazonensis 
(L. mexicana) orthologous gene clusters that were precomputed in EuPathDB 
and include ~98% of L. major genes. A graphical representation of the results is 
shown in Figure 27, where dots correspond to the differential expression levels 
for orthologous genes. The orthology mapping between the two species included 
several one-many relationships because of paralogous gene families and this is 
manifested in the scatterplot as rows and columns of perfectly aligned dots 




Figure 27: Comparison of Leishmania transcriptomes between species. 
Orthology mapping was done to enable the comparison of expression profiles for L. major and L. 
amazonensis genes that were DE upon the infection of human macrophages. Scatterplots 
showing the relationship between parasite gene fold changes (log2) for L. amazonensis parasites 
(X-axis) and L. major parasites (Y-axis) are shown for the metacyclic promastigote to 4 hpi 
intracellular transition (left panel) and the 4 hpi to 24 hpi intracellular transition (right panel). 
Genes upregulated in the second stage/timepoint relative to the first exhibit positive fold changes, 
while downregulated genes exhibit negative fold changes. Genes highlighted in the text are 
noted. Points colored in gray represent genes that were not significantly DE in either system, 
points colored in shades of purple represent genes that were DE in the same direction in both 
systems, points colored in shades of green represent genes that were DE in different directions 
between the systems, and points colored in shades of orange and blue represent genes 
significant only in one system. The numbers of DE genes corresponding to each color are 
included in the legends. NS = not significant 
observed a set of 1,558 unique gene pairs (737 upregulated and 811 
downregulated) that were significantly differentially expressed in the same 
direction in both species during the metacyclic promastigote to 4 hpi intracellular 
transition and representing gene products that underlie a response common to 
both species as they adapt to the human macrophage environment (Figure 27, 
left panel). Two other subsets included transcripts that appeared significantly DE 
in one species but not in the other. Those included 3,947 unique transcripts in 
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total with only a small proportion (10%) that were differentially expressed greater 
than 2-fold in one species or the other. A closer inspection revealed that many of 
the genes that make up these subsets are member of multi-gene families that 
have members belonging to the common expression set (e.g. amastin, GP63, 
kinesin, flagellar attachment zone protein, AAT family members, dynein, cysteine 
peptidase B), and/or were DE in the other Leishmania species during the 4 hpi to 
24 hpi transition, indicating a time offset in what can be considered a common 
response (e.g. cathepsin L-like protease, ATG8). A similar phenomenon was 
apparent during the 4 hpi to 24 hpi intracellular transition (Figure 27, right panel). 
While there were only 60 unique gene pairs that were commonly expressed in 
the same direction, most of the transcripts that appeared to be distinctly DE in 
one of the species were members of multigene families that were part of the 
common response or simply displayed a time-shifted expression pattern. 
The general picture that emerged from the comparison of the two species 
of Leishmania is that the transcriptomes of their orthologous gene sets display 
minimal to non-existent differences within the human macrophage. This finding 
closely aligns with the lack of observed differences in the host response to 
infection by the two Leishmania species (described above). Of the genes that 
were not included in the above analysis because they lacked orthologs in the 
EuPathDB database, one gene emerged that is both highly differentially 
expressed and has supporting evidence of its species-specificity. This gene, the 
virulence factor A2, is present in L. amazonensis but exists only as a 
pseudogene in L. major (Zhang, 2003). It was among the most upregulated 
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genes in L. amazonensis during the metacyclic to 4 hpi transition and was further 
upregulated through 24 hpi. A2 is required for visceral infection by L. donovani 
(Zhang, 2001) and has been implicated in the parasite’s resistance to heat shock 
(McCall, 2012). While L. amazonensis generally causes cutaneous disease, it 
has also been associated with visceral infections (Almeida, 1996). The strong 
upregulation of the A2 gene during early infection detected here is consistent 
with that observation. 
Towards defining the signatures of Leishmania differentiation and 
intracellular survival 
In order to characterize the overall signature of L. major differentiation 
from the metacyclic promastigote developmental stage to intracellular 
amastigotes and during intracellular infection, we compared the patterns of L. 
major gene expression identified in human (this study) to those observed for the 
same timepoints in L. major-infected murine macrophages (Chapter 4). In both 
host systems, large numbers of DE genes were detected in the parasite during 
the metacyclic to early amastigote transition and decreasing numbers of DE 
genes were seen between intracellular timepoints. 
When individual genes were compared between the human and mouse 
analysis, a complex picture emerged (Figure 28). Among the 4,708 genes that 
are DE in L. major during the metacyclic promastigote to 4 hpi intracellular form 
transition in at least one of the hosts, 28% (1,336) represent a common parasite 
expression pattern in both human and mouse infections. A gene ontology (GO) 




Figure 28: Comparison of the L. major transcriptome upon infecting human and 
murine macrophages. 
Scatterplots were used to show a comparison of L. major parasite expression patterns upon 
infecting human vs. murine macrophage (Chapter 4). The relationship between parasite gene fold 
changes (log2) in the mouse system (X-axis) and the human system (Y-axis) are shown for the 
metacyclic promastigote to 4 hpi intracellular transition (left panel) and the 4 hpi to 24 hpi 
intracellular transition (right panel) with each of the 8,479 genes that passed low-count filtering in 
both datasets represented by a single point. Genes upregulated in the second stage/timepoint 
relative to the first exhibit positive fold changes, while downregulated genes exhibit negative fold 
changes. Genes highlighted in the text are noted. Points colored in gray represent genes that 
were not significantly DE in either system, points colored in shades of purple represent genes that 
were DE in the same direction in both systems, points colored in shades of green represent 
genes that were DE in different directions between the systems, and points colored in shades of 
orange and blue represent genes significant only in one system. The numbers of DE genes 
corresponding to each color are included in the legends. NS = not significant 
major genes that were differentially expressed as metacyclic promastigotes infect 
mammalian macrophages over the first 4 hours. Two enriched GO categories 
emerged - peroxiredoxin activity and antioxidant activity - among the 598 L. 
major genes that were commonly upregulated during both human and mouse 
infections (Table 9). Tellingly, only 7 genes - peroxidoxin and 6 tryparedoxin 
peroxidase family members - drove these results. A greater number and range of 
GO categories were enriched among the 738 L. major genes downregulated in 
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both host systems. These 13 GO categories were largely related to signaling, 
microtubule dynamics, and fatty acid biosynthesis. Many of the genes driving the 
GO results for the genes consistently regulated in both systems have been 
previously implicated in Leishmania virulence (i.e. tryparedoxin peroxidase family 
members (Iyer, 2008), casein kinase (Dan-Goor, 2013), adenylate cyclase 
(Biswas, 2011)) or regulation of flagellar dynamics (i.e. calmodulin (Ginger, 
2013), dynein heavy chain (Harder, 2010), kinesin (Blaineau, 2007; Vicente, 
2015), paraflagellar rod protein (Lander, 2015), multiple mitogen-activated 
protein (MAP) and NIMA kinases (Bengs, 2005; Cao, 2009; Erdmann, 2006; 
Wiese, 2003)). 
 Patterns of parasite gene expression that were unique to the human and 
mouse hosts were also clearly detectable and likely reflect the biological  



















Table 9: GO categories enriched among L. major genes in common to human and 
mouse infections. 
GOseq was used to identify GO categories enriched among L. major genes that were DE during 
the metacyclic promastigote to 4 hpi intracellular transition (P value < 0.05). Parasite genes that 
were expressed in the same direction during infection of both human and mouse host systems 
were evaluated with up- and down-regulated genes considered separately. 
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differences inherent to each system. A total of 1,887 L. major genes were 
uniquely regulated in human macrophages (1133 up, 754 down) and 1,626 
respond specifically to the infection of murine macrophages (862 up, 764 down). 
Among the genes that stood out as the most divergent in their behavior in the two 
host systems were META1, GP63, and surface antigen protein 2, which were 
downregulated in human and upregulated in mouse, and RNA-binding protein 5 
and cathepsin L-like proteases, which were upregulated in human and 
downregulated in mouse. Both GP63 and META1 are known to play a role in 
virulence. GP63 is a zinc-dependent metalloprotease found on the surface of the 
parasite that cleaves C3b to iC3b, thus helping the parasite avoid complement-
mediated lysis and promoting parasite entry into the cell via complement 
receptors 1 and 3 (Brittingham, 1995; Mosser, 1985; Olivier, 2012). Entry via 
these receptors has been found to contribute to parasite survival (Da Silva, 1989; 
Mosser, 1987). Additionally, GP63 hydrolyzes host kinase substrates (Corradin, 
1999; Olivier, 2012), and may thus alter the signaling processes of the host cell. 
META1 is known to localize to the flagellar pocket of the procyclic form of the 
parasite and has been implicated in secretory processes (Nourbakhsh, 1996; 
Puri, 2011) and cathepsin-L like proteins have been shown to be key modulators 
of the host immune response (Alexander, 1998; Mottram, 2004) and are 
regarded as possible molecular targets against leishmaniasis (de Sousa, 2015; 
Desai, 2006). The differential expression of these proteins upon infection of 
human and mouse macrophages may reflect differences in the intricacies of 
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host-parasite immune-response/adaptation and/or the complex signaling 
pathways triggered by the parasite in the context of each host system. 
 A GO analysis yielded some additional insights into different parasite 
behavior in the two hosts (Table 10). Several categories related to proton 
transport were enriched among genes that Leishmania upregulated in human 
system, but not in mouse, reflecting an upregulation of the expression of multiple 
vacuolar ATP synthase genes. This difference in the parasite response to the 
host system could be indicative of the relative acidity of the phagosomes in each. 
A number of categories related to ribosomes and translation were also enriched 
among genes that parasites upregulated in human but downregulated in mouse. 
The reason for this difference is unclear. 
As highlighted earlier, the 4 to 24 hpi intracellular form transition of the 
parasite was characterized by considerably smaller numbers of genes that were 
DE and by lower changes of magnitude. Of the 625 L. major genes that were DE 
during that transition in at least one of the hosts, only 28 represent a common 
parasite expression pattern in both human and mouse infections while 328 and 
273 genes were unique to the human and mouse systems, respectively. Despite 
the large number of differences, almost all are less than 2 fold DE and therefore 
represent small changes in the context of the host system.  
Even though our interpretations of the analyses above have focused on 
previously characterized gene products, it is worth noting that significant 
proportions of the DE genes across parasite timepoints encode hypothetical/ 













































Table 10: GO categories enriched among L. major genes unique to human and 
mouse infections. 
GOseq was used to identify GO categories enriched among L. major genes that were DE during 
the metacyclic promastigote to 4 hpi intracellular transition (P value < 0.05). Parasite genes that 
were specific to infection in the human system or specific to infection in the murine system were 
evaluated with up- and down-regulated genes considered separately. 
and 39% and 55% of genes in the 4 hpi to 24 hpi transition for L. major and L. 
amazonensis, respectively. While significant numbers of Leishmania hypothetical 
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genes remain uncharacterized to date, they play an integral role in the parasite’s 
strategy for survival and modulation of functional pathways within the host. 
Conclusion 
RNA-sequencing was used to characterize the transcriptomes of primary 
human macrophages infected with either Leishmania major or Leishmania 
amazonensis and those fed latex beads over a 72-hour time course. This study 
differs from most previous efforts in its use of synchronized primary cells and 
controls designed to assess changes over time relative to both the uninfected 
state and the effects of large particle phagocytosis. The unambiguous mapping 
of reads from infected samples to both host and parasite genomes enabled the 
identification of differentially expressed genes within a dynamic dual biological 
system, and the collection of data from multiple biological replicates allowed 
careful statistical analysis of variation and the detection and removal of batch 
effects. These features provided us with a unique ability to detect biological 
differences between samples and timepoints with high confidence and sensitivity 
and to parse the potential causes of the observed changes. 
 While we found large numbers of differentially expressed genes between 
uninfected and Leishmania-infected cells at each timepoint, additional analyses 
considering expression changes in bead-containing cells reveled that almost all 
of the differences in gene expression from 24-72 hpi were part of a general 
response to phagocytosis, or, perhaps more accurately, "macrophage 
indigestion". Additionally, few differences existed between macrophages infected 
with L. major and those infected with L. amazonensis. Further comparison with 
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differential expression data generated in murine macrophages was used to 
define a signature of mammalian host infection by L. major. KEGG pathways 
enriched among upregulated genes in the signature were specific to immune 
activation and signaling while those enriched among downregulated genes were 
related to energy metabolism, lysosome structure and processes, and apoptosis. 
 Analysis of parasite data revealed a stabilization in the Leishmania 
response to the human intracellular environment for both L. major and L. 
amazonensis after 24 hpi and few meaningful differences were detected between 
the transcriptional programs activated by each species. Only about a third of L. 
major genes were similarly differentially expressed in both human and murine 
host systems, pointing to potentially meaningful differences, especially regarding 
previously identified virulence factors. These findings and the datasets generated 
by this work will be of great use to the Leishmania and macrophage biology 
communities as further attempts are made to understand the complex interplay 
between host and parasite during infection by Leishmania parasites. The 
comprehensive datasets generated in this study will also serve as a reference for 
future studies using different Leishmania strains (or even different pathogens 
altogether) to examine infections of macrophages isolated from multiple sources 
and in various states of activation, polarization, or rest. In conjunction with 
datasets that will be produced for other pathogens, a clearer picture of the 
signature of intracellular infection will emerge, providing additional insights into 
how pathogens are able to evade host defenses and modulate the biological 





In addition to deriving biological insights into Leishmania differentiation 
and infection, the work described here produced significant resources that will be 
of use to the Leishmania and broader host-pathogen research communities – 
specifically, UTR boundaries for a large majority of L. major genes, lists of genes 
that are differentially expressed across life cycle stages by L. major and L. 
amazonensis parasites, and differential expression datasets for murine and 
human macrophages upon Leishmania infection or the ingestion of inert 
particles. While a number of findings were described above regarding the general 
patterns of gene expression, higher-level pathways and processes implicated in 
infection, and the suspected roles of individual genes, additional research is 
needed to more fully mine and follow-up on the information contained in these 
datasets. 
Extend L. major RNA processing/gene regulation analysis 
 In this work, we determined UTR boundaries specific to the procyclic and 
metacyclic promastigote developmental stages for most L. major genes. The 
methods used should be extended to the amastigote stages/timepoints to identify 
and quantify UTR boundaries and their usage. We were unable to detect a 
correlation between differences in the steady-state mRNA levels (as assessed by 
RNA-seq) and differential usage of trans-splicing and polyadenylation sites (i.e. 
different UTR lengths) between the procyclic and metacyclic stages. This could 
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mean that differential engagement of sequence or structural motifs in UTRs by 
regulator proteins, rather than motif composition itself, is responsible for changes 
in steady-state mRNA levels between the stages. The UTRs for all stages should 
be systematically evaluated to identify motifs and to determine potential binding 
partners that may be responsible for the stage-specific differences in expression. 
 Additionally, while RNA-seq is a robust and high-throughput method for 
detecting cellular mRNAs, mRNA levels are not an ideal indicator of the 
biological changes taking place within Leishmania given the multiple levels of 
regulation that occur after transcription. For this reason, the RNA-seq data 
generated here would also be of great use when considered alongside ribosome 
profiling data that have been generated for the L. major procyclic promastigote 
stage (Belew et al., in preparation). A direct comparison of these data types will 
reveal the relationship between steady-state levels of RNAs (as measured by 
RNA-seq) and the rate of translation (as measured by ribosome profiling) to 
provide additional clues for how the parasite regulates cellular protein levels. 
Deepen analysis of gene expression from 0-24 hpi 
The most unexpected findings in this body of work were the lack of 
statistically significant changes in gene expression between subsequent 
timepoints after 24 hpi and that differences between uninfected and infected host 
cells after 24 hpi were attributable almost exclusively to phagocytosis. This adds 
a level of nuance to the existing hypothesis that Leishmania entry into 
macrophages is quiescent – parasite entry does in fact cause a large number of 
changes in host cells which have elements of both pro-inflammatory and anti-
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inflammatory responses, but expression changes plateau by around a day after 
infection. Knowing this now, it would be interesting to collect data from additional 
timepoints during the first day (e.g. 2, 6, 8, 12, 16, and 20 hpi) to further tease 
apart the changes that occur in the very important early stages of infection. The 
collection of these additional timepoints would in turn open new methods for 
analyzing the data beyond the differential expression analyses done so far. 
Specifically, network analyses would be extremely useful for grouping together 
genes that have common expression patterns over time. This should be done 
separately for both parasite and host genes, with subsequent efforts to find 
correlations between parasite and host clusters. It is reasonable to hypothesize 
that some sets of parasite and host genes will show matching patterns of 
expression over time while other sets will show divergent expression patterns or 
reveal a delay in response. Network analyses also have the potential to point to 
the functional roles of hypothetical genes by grouping them with genes of known 
function and inferring guilt-by-association relationships. While network analyses 
can be attempted on the current dataset, the lack of dynamic changes in 
expression after 24 hpi limits our ability to group together genes that are likely 
undergoing co-regulation. An analysis of functional enrichments or motif usage in 
the UTRs of genes in each network cluster has the potential to be particularly 
informative.  
Expand infection systems and conditions studied 
 In this study, we looked at the infection of C57BL/6 murine peritoneal 
macrophages and CD14+ monocyte-derived human macrophages by L. major 
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and/or L. amazonensis. While we found that there were few significant changes 
in parasite genes between the Leishmania species, it would be useful to extend 
this analysis to include other species, especially those that cause visceral 
disease, to identify parasite factors that may contribute to the gross differences in 
disease presentation. The use of gently heat-killed Leishmania would be an 
interesting contrast to the latex beads time course and would show how the 
macrophage responds to the phagocytosis of a particle that it is able to fully 
digest and various other experiments done using inhibitors of various genes 
implicated during infection (e.g. synaptotagmin family members, complement 
receptors) would also be useful for honing in on the roles of each during 
infection. It would also be useful to look at Leishmania infection of the THP1 
human monocytic leukemia cell line, which has been used in many studies of 
pathogens that infect macrophages, to identify similarities and differences related 
to the use of primary vs. transformed cells. Experiments using other phagocytes 
such as dendritic cells or neutrophils (human or murine) should also be done 
since there is evidence that neutrophils are the first cells to encounter and take 
up Leishmania upon inoculation into the host (Peters, 2008), even though they 
are not the ultimate host cell type for the parasite. Data from patient lesion 
samples would also be very interesting to compare against the cell culture-
derived data to determine if any similarities can be detected between an infection 
of synchronized cells of a single type and a true infection that involves 
interactions between multiple cell types. 
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Detect parasite-host protein-protein interactions to derive biological 
mechanisms 
A number of genes were implicated in Leishmania differentiation and in 
the establishment and progression of an intracellular infection. While the 
bioinformatics approaches used here were extremely useful for the global 
identification of differentially expressed genes in both the parasite and its host 
cells, wet bench studies aimed at studying individual or small groups of genes 
are needed to follow-up on these observations. Direct interactions between 
Leishmania and mammalian proteins are responsible for communication between 
host and parasite as Leishmania are phagocytosed by macrophages and 
become contained inside parasitophorous vacuoles. Indeed, some genes in the 
DE lists suggest an interaction between Leishmania and host macrophages that 
affect the receptors by which Leishmania are taken into macrophages, with direct 
implications for their survival (e.g. Leishmania GP63 and host Fcγ receptors). In 
order for Leishmania proteins to interact with the host, the parasite must either 
secrete or display the peptides on their surfaces using 
glycosylphosphatidylinositol (GPI) anchors. The DE datasets should be analyzed 
to detect signal sequences that drive protein secretion or surface anchoring; 
additionally, transmembrane hidden Markov models (TM-HMM) can be used to 
predict trans-membrane proteins that may contain domains that are able to 
interact with host proteins. Genes identified by these analyses can be used as 
baits in yeast-2-hybrid (Y2H) experiments or pull down assays followed by mass 
spectrometry to identify host-pathogen protein-protein interactions. These 
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experiments can be used to identify proteins that interact with hypothetical 
genes, possibly providing evidence as to their function. Perturbations in the 
system – such as those introduced by altering experimental conditions (e.g. 
media components, use of serum for opsonization, etc.) or by removing 
genes/mRNAs using gene knock-outs or siRNA knock-downs - can then be used 
to test how mRNA or protein levels, protein-protein interactions, or the ability of 
Leishmania to infect cells change under various conditions. Findings from these 
studies can be used to develop models for the mechanisms of action of various 
genes that are necessary for infection. Genes involved in host-pathogen 
interactions may prove to be important for virulence of the pathogen and could 
potentially serve as candidates for vaccine or drug development.  
Establish new host-pathogen interaction resources 
Interpretation of the host DE gene lists has been hindered by the lack of 
robust datasets against which to compare the results. Our attempts to perform 
KEGG pathway analyses to identify the higher-level pathways and processes 
associated with Leishmania infection of macrophages were of limited usefulness 
given differences in the studies used to build the KEGG reference datasets. 
Specifically, KEGG pathways have largely been defined based on combinations 
of multiple single or few-gene studies produced under various conditions, and 
because of this, they are of undetermined relevance and reliability. For example, 
a KEGG pathway exists for leishmaniasis, but an examination of the 23 studies 
used to create the KEGG resource reveals a lack of consistency in scope of each 
study that contributes gene(s) to the pathway. Rather than relying on resources 
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such as this, robust RNA-seq datasets like those produced here should serve as 
new "gold standard" pathway/process resources that can be compared to 
datasets produced under other conditions or for other experimental systems. 
Comparison to similar datasets produced for other pathogens that infect 
macrophages, including Mycobacterium sp., Toxoplasma gondii, Francisella 
tularensis, Leptospira interrogans, and Legionella pneumophila, would be very 
useful for determining similarities and differences in how various pathogens are 




 Experimental Procedures 
Leishmania Culture 
Metacyclogenesis and mouse experiments 
Leishmania major (clone V1, MHOM/IL/80/Friedlin) was isolated after passage 
through BALB/c mice. Promastigotes were grown in 50% M199 39% Schneider 
medium along with 10% FBS and 1% of Penicillin/streptomycin at 25°C. L. major 
promastigotes were not split for more than 5 passages to maintain virulence of 
the cultures. Enrichment for metacyclic promastigotes from stationary phase 
cultures was done by Ficoll density gradient centrifugation (Späth, 2001) and by 
negative selection with peanut agglutinin (PNA) (da Silva, 1987). Biological 
replicates each originated from a separate growth and were obtained on different 
days. 
Human experiments 
Leishmania major (clone VI, MHOM/IL/80/Friedlin) and L. amazonensis 
(IFLA/BR/67/PH8) promastigotes were cultivated at 26°C in medium 199 (Gibco, 
Invitrogen) supplemented with 5% penicillin/streptomycin, 0.1% hemin (25 mg/ml 
in 50% triethanolamine), 20% heat-inactivated fetal bovine serum (FBS), 10 mM 
adenine (pH 7.5), and 5 mM L-glutamine. Metacyclic forms of L. major were 
purified by agglutination of stationary-phase promastigote cultures using peanut 
agglutinin (Sigma) (Sacks and Melby, 2001) while enrichment for L. amazonensis 




Peritoneal macrophages were isolated from C57BL/6 mice (7 weeks, female) 
obtained from National Cancer Institute Charles River Laboratories by flushing 
the peritoneal cavity using 10 mL cold DPBS without calcium and magnesium. 
Cells were plated in 6 well plates in 2.5 mL DMEM/F12 media supplemented with 
10% FBS, 1% penicillin/streptomycin, and 1% glutamine to a density of ~2.5 x 
106 cells/well and incubated overnight. Two hours after washing, cells were 
infected with Ficoll-enriched L. major metacyclic promastigotes at a ratio of 5 
parasites per macrophage along with 5% C5-deficient serum collected from 
DBA2 mice. Cells were lysed using the Trizol® reagent (Invitrogen, CA) at 4, 24, 
48, and 72 hours following infection. 
Human macrophages and infection 
Human macrophages were derived from purified monocytes and purchased fully 
differentiated from HemaCare (Van Nuys, CA). Briefly, CD14+ monocytes were 
positively selected via immunomagnetic beads and were cultured in the presence 
of 1000 IU/mL human recombinant human macrophage colony-stimulating factor 
M-CSF for 10 days. The cells were then harvested and transferred into 
hypothermosol (BioLife Solution) and shipped in suspension. Upon arrival, 
approximately 2.5 x 106 macrophages were plated per well in a 6-well plate using 
X-VIVO-15 medium (Lonza) and supplemented with 1000 IU/mL M-CSF (Miltenyi 
Biotech) and incubated for 24 hr at 37°C, 5% CO2. Macrophages were infected 
using a ratio of 10 parasites per macrophage for L. amazonensis and 5 parasites 
per macrophage for L. major for 4 hr at 34°C. Infection was performed in X-VIVO-
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15 medium supplemented with 4% human AB serum. Macrophages were 
allowed to ingest 4.35 micrometer polystyrene beads (Spherotech) at 1:10 ratio 
also in the presence of 4% human AB serum (beads were pre-incubated in AB 
serum for 30 min). The cells were washed 3 times with PBS and further 
incubated at 34°C until the 24, 48 and 72 hpi timepoints. Samples intended for 
counting were fixed for 5 min at room temperature with Bouin solution (71.4% 
saturated picric acid, 23.8% formaldehyde, and 4.8% acetic acid), stained with 
Giemsa, and sequentially dehydrated in acetone, followed by a graded series of 
acetone/xylol (9:1, 7:3, and 3:7) and, finally, xylol. The number of intracellular 
parasites was determined by counting the total macrophages and the total 
intracellular parasites per microscopic field using a Nikon E200 microscope with 
a 100X 1.3 N.A. oil immersion objective. Counts were performed in triplicate for 
each period of infection. 
RNA isolation and cDNA library preparation  
For the metacyclogenesis and mouse experiments, total RNA was isolated using 
the Trizol® reagent (Invitrogen, CA), treated with DNase, and purified using the 
Qiagen RNeasy mini kit. For the human experiments, total RNA was isolated 
from macrophages and the metacyclic material used for the L. major and L. 
amazonensis infections using a NucleoSpin RNA kit (Machery-Nagel) according 
to manufacturer's protocol. RNA integrity was assessed using an Agilent 2100 
bioanalyzer. PolyA-enriched cDNA libraries were generated using the Illumina 
TruSeq Sample Preparation kit (San Diego, CA) and checked for quality and 
quantity using the bioanalyzer and qPCR (KAPA Biosystems). 
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RNA-seq data generation, pre-processing, and quality trimming  
Paired end reads (100 bp) were obtained from the Illumina HiSeq 1500 platform. 
Trimmomatic (Bolger, 2014) was used to remove any remaining Illumina 
adapter sequences from reads and to trim bases off the start or the end of a read 
when the quality score fell below a threshold of 20. Sequence quality metrics 
were assessed using FastQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). 
Mapping cDNA fragments to the reference genome, abundance estimation, 
and data normalization  
TopHat (v 2.0.10) (Trapnell, 2009) was used to align reads to the applicable 
genome(s) with each genome alignment performed independently. Reads from 
uninfected, L. major-infected, L. amazonensis-infected, and bead-containing 
macrophage samples were aligned to the human genome (v. hg19/GRCh37) or 
mouse genome (v. mm10). Reads from L. major-infected or L. amazonensis-
infected samples were additionally aligned to the L. major (v. 6.0) or L. mexicana 
(v. 8.1) genomes, respectively, as were reads from procyclic and metacyclic 
promastigote samples. The L. mexicana genome was used for alignment of L. 
amazonensis-containing samples since it is the most closely related well-
annotated genome that was available. The human and mouse genomes were 
obtained from the UCSC genome browser (http://genome.ucsc.edu) and the 
parasite genomes were obtained from the TriTrypDB database 
(www.tritrypdb.org) (Aslett, 2010). Two mismatches per read were allowed and 
reads were allowed to map only to a single locus. The abundance of reads 
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mapping to each gene feature in the TriTrypDB L. major annotation (v 6.0) was 
determined using HTSeq (Anders, 2014). Each resulting count table was 
restricted to protein-coding genes (8,486 genes for L. major, 8,336 genes for L. 
amazonensis/L. mexicana, 20,956 genes for human, and 23,100 genes for 
mouse). For the L. major metacyclogenesis analysis, a count table was also 
generated that included the above features along with a set of novel open 
reading frames (ORFs) of at least 90 nt in length. These novel ORFs were 
identified by manual annotation of translational evidence from a ribosome 
profiling study of L. major procyclic promastigote samples. Their coordinates are 
provided in Table 12. 
Data quality assessment by statistical sample clustering and visualization 
Multiple approaches were used to evaluate replicates and to visualize sample-
sample distances. Those included Pearson correlation, median pairwise 
correlation analysis, box plots, Principal Component Analysis (PCA) and 
Euclidean distances-based hierarchical clustering. Samples that did not pass the 
following quality assessment procedure were excluded from downstream 
analyses. For each sample, the median pairwise correlation (mpc) to all other 
samples in the dataset was computed. A standard outlier identification method 
(Hoaglin, 1983) was applied to remove samples that have low correlation with the 
other samples. Samples were removed if their median mpc was less than Q1 
(mpc) – 1.5 IQR (mpc) where Q1 (mpc) and IQR (mpc) represent the first quartile 
and inter-quartile range of the mpc across all samples, respectively.  
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Differential expression analysis  
Non-expressed and weakly expressed genes, defined as having less than 1 read 
per million in n of the samples, where n is the size of the smallest group of 
replicates, were removed prior to differential expression analysis (Anders, 2013). 
A quantile normalization scheme was applied to all samples (Bolstad, 2003). 
Following log2 transformation of the data, limma (a Bioconductor package) was 
used to conduct differential expression analyses. limma utilizes a standard 
variance moderated across all genes using a Bayesian model and produces P 
values with greater degrees of freedom (Smyth, 2004). The voom module was 
used to transform the data based on observational level weights derived from the 
mean-variance relationship prior to statistical modeling (Law, 2014). 
Experimental batch effects were adjusted for by including experimental batch as 
a covariate in the statistical model (Leek, 2010). Pairwise contrasts were done 
within limma to identify differentially expressed (DE) genes across timepoints in 
the parasites and within and across timepoints in mouse macrophages and in 
human macrophages both with and without accounting for the effect of 
phagocytosis. DE genes were defined as genes with a Benjamini-Hochberg 
multiple-testing adjusted P value of < 0.05. For comparisons of uninfected vs. 
infected samples without accounting for the effects of phagocytosis, P values 
from a contrast of infected minus uninfected were used as input into BH multiple 
testing adjustment. To determine differential expression while accounting for 
phagocytosis, infected samples were evaluated relative to both bead-containing 
macrophages and uninfected control cells. For each gene, the maximum P value 
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from these two contrasts was selected for input into BH multiple testing 
adjustment.  
Ortholog mapping 
Orthology mapping was done between human and mouse gene identifiers and 
between L. major and L. mexicana gene identifiers. Human-mouse orthologs 
were defined using the bioMaRt package in R (Durinck, 2005). Orthology gene 
tables from TriTrypDB (v 8.1) (Aslett, 2010) were used to match orthologs 
between L. major and L. mexicana.  
Gene ontology (GO) analysis 
Enriched GO categories were identified using the GOseq package in R (Young, 
2010). GOseq was developed specifically to account for transcript length bias in 
GO analyses using RNA-seq data. For each comparison, upregulated and 
downregulated gene sets (no fold change cut-off) were input separately into 
GOseq. A P value cut-off of 0.05 was used. 
KEGG pathway analysis 
KEGG pathway analysis using ConsensusPathDB-mouse or ConsensusPathDB-
human was done to identify signaling and metabolic pathways that were over-
represented in the mouse and human DE gene lists, respectively. For each 
KEGG pathway, a P value was calculated using a hypergeometric test and a 
cutoff of 0.01 was applied to identify enriched KEGG pathways. Genes that were 
DE more than 2-fold in L. major-infected cells relative to controls at each 
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timepoint were used as input with up- and down-regulated genes considered 
separately. 
Trans-splicing site detection and 5´ UTR analysis 
Sequences from each sample were mapped to the L. major genome (v. 6.0) 
using TopHat (v 2.0.10) (Trapnell, 2009). Only one mismatch per read was 
allowed and the paired reads were required to be mapped for an alignment to be 
reported. Reads that did not align to the genome were retained to form a pool of 
candidate spliced leader (SL)-containing reads. These reads were filtered to 
keep only those containing at least 4 bases of the end of the L. major SL 
sequence (AACTAACGCTATTATTGATACAGTTTCTGTACTATATTG) or its 
reverse complement. This target sequence (or its reverse complement) was 
trimmed from the reads and TopHat was used to align the remaining portions to 
the L. major genome. Two mismatches per read were allowed and reads were 
assigned only to a single locus of the gene model annotations provided to 
TopHat (containing previously annotated genes and novel ORFs). The 
alignment coordinates of the trimmed reads were used to retrieve the exact 
locations of the putative trans-splicing sites. The genomic sequence neighboring 
each putative site was compared against the portion of the read that was 
removed. Reads for which the trimmed portion (4-39 nt) did not differ by at least 
two bases from the corresponding genomic sequence were treated as false hits 
and discarded. Putative sites that were located within a previously annotated 
CDS (from TriTrypDB, version 6.0) (Aslett, 2010) or within a novel ORF (as 
defined above) or those with no such feature within 7500 nt downstream of the 
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site were excluded. Trans-splicing sites that remained were assigned to the 
nearest downstream feature. The length of the 5ʹ UTR was defined as the 
distance between the trans-splicing site and the start of the CDS/ORF to which it 
was assigned. Splice acceptor sites were identified for each gene by extracting 
the dinucleotide sequence in the genome upstream of each detected trans-
splicing site using a custom Python script. Sequence composition was plotted 
using WebLogo version 3.3 (Crooks, 2004). The trans-splicing site detection 
pipeline was written in Python and made use of the Ruffus pipeline software 
framework (Goodstadt, 2010) and Biopython library (Cock, 2009). Data 
visualization was done using ggplot2 (Wickham, 2009). 
Polypyrimidine tract characterization  
A custom Python script was used to scan a window of 250 nt upstream of each 
primary trans-splicing site to identify the corresponding polypyrimidine (polyPy) 
tract. A polyPy tract was defined as the longest stretch of sequence consisting of 
pyrimidines, allowing interruption by no more than a single purine. 
Polyadenylation site detection and 3´ UTR analysis 
Identification of the polyadenylation sites was done using a process similar to the 
one used for trans-splicing site detection. The initial filtering step performed on 
unmapped reads identified reads containing at least 4 nt of thymine or at least 4 
nt of adenine residues. This target sequence was trimmed from the reads and 
TopHat was used to align the remaining portions of the reads to the L. major 
genome. Two mismatches per read were allowed and reads were assigned only 
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to a single locus in the gene model annotations provided to TopHat (containing 
previously annotated genes and novel ORFs). The alignment coordinates of the 
trimmed reads were used to retrieve the exact locations of the putative 
polyadenylation sites. The sequence neighboring each putative site was 
compared against the portion of the read that was removed. Any reads for which 
the trimmed portion (4+ nt) did not differ by at least two bases from the 
corresponding genomic sequence were treated as false hits and discarded. 
Putative sites that were located within a previously annotated CDS (from 
TriTrypDB, version 6.0) or within a novel ORF (as defined above) or those with 
no such feature within 7500 nt upstream of the site were excluded. 
Polyadenylation sites that remained were assigned to the nearest downstream 
feature (CDS or novel ORF). The length of the 3ʹ UTR was defined as the 
distance between the stop of the CDS/ORF and the polyadenylation site. 
Sequence composition was plotted using WebLogo version 3.3 (Crooks, 2004). 
The polyadenylation site detection pipeline was written in Python and made use 
of the Ruffus pipeline software framework (Goodstadt, 2010) and Biopython 
library (Cock, 2009). Data visualization was done using ggplot2 (Wickham, 
2009). 
Alternative RNA processing site analysis  
Counts of trans-splicing sites or polyadenylation sites were combined from 
biological replicates for each developmental stage (procyclic promastigotes and 
metacyclic promastigotes). The site with the largest number of reads mapped 
was defined as “primary” for each of the developmental stages. All other sites 
 120 
 
were considered to be “minor” with the most utilized of the minor sites designated 
as the “secondary” site. The ratio of reads mapping to the primary site to those 
mapping to the secondary site (P/S) for a given gene was used to determine the 
dominance (preference) of the primary site for that gene.  
Data access 
Sequence data are available at the NCBI Sequence Read Archive (SRA) under 
accession numbers SRR1460763-SRR1460775, SRR1460724-SRR1460747, 
SRR1460767, SRR1460772, SRR2136702, SRR2136703, SRR2136708, 
SRR2136720, SRR2136722, SRR2155070, SRR2155072- SRR2155075, 
SRR2155078, SRR2155082, SRR2155085, SRR2155101, SRR2155105, 
SRR2155143, SRR2155160-SRR2155166, SRR2156106-SRR2156110, 
SRR2156117, SRR2156270-SRR2156274, SRR2156854-SRR2156856, 
SRR2156858-SRR2156860, SRR2156862-SRR2156863, SRR2163237-
SRR2163240, SRR2163242, SRR2163251, SRR2163256, SRR2163270, 
SRR2163272-SRR2163276, SRR2163278-SRR2163283, SRR2163285-
SRR2163287, SRR2163289-SRR2163292, SRR2163399-SRR2163401, 
SRR2171252, SRR2171252-SRR2171253, and SRR2171255. All components of 
the data quality assessment statistical pipeline, named cbcbSEQ, were done in R 
and can be accessed on GitHub (https://github.com/kokrah/cbcbSEQ/). The code 
used for the trans-splicing and polyadenylation pipelines is freely available at 
https://github.com/elsayed-lab/utr_analysis. The code used to determine 





Appendix 1: Procyclic-metacyclic experimental design 
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Number of reads 
that pass Illumina 
filter
1 HPGL0075 n/a procyclic A 62,051,890
2 HPGL0076 n/a metacyclic (Ficoll) A 52,660,754
3 HPGL0096 SRR1460763 procyclic B 103,466,044
4 HPGL0097 SRR1460764 metacyclic (PNA) B 76,253,690
5 HPGL0098 SRR1460765 metacyclic (Ficoll) B 93,319,752
6 HPGL0164 SRR1460766 procyclic C 46,155,070
7 HPGL0165 SRR1460767 metacyclic (Ficoll) C 45,492,872
8 HPGL0192 SRR1460768 procyclic D 64,505,484
9 HPGL0193 SRR1460769 metacyclic (Ficoll) D 70,178,176
10 HPGL0228 SRR1460770 procyclic E 105,948,882
11 HPGL0229 SRR1460771 metacyclic (PNA) E 77,161,294
12 HPGL0230 SRR1460772 metacyclic (Ficoll) E 84,056,646
13 HPGL0324 SRR1460773 procyclic F 69,215,652
14 HPGL0325 SRR1460774 metacyclic (PNA) F 64,195,828
15 HPGL0326 SRR1460775 metacyclic (Ficoll) F 60,167,474
Total 1,074,829,508
Number of reads 
mapped









% of reads 
containing polyA 
sequence
55,352,314 89.20 n/a n/a n/a n/a
47,712,265 90.60 n/a n/a n/a n/a
92,748,560 89.64 4,095,395 3.96 58,064 0.06
69,557,423 91.22 2,658,344 3.49 56,582 0.07
84,580,995 90.64 3,634,321 3.89 47,581 0.05
42,801,506 92.73 1,772,321 3.84 39,718 0.09
41,811,082 91.91 1,360,561 2.99 44,785 0.10
58,857,640 91.24 2,359,763 3.66 43,034 0.07
63,898,517 91.05 2,439,369 3.48 48,044 0.07
98,120,201 92.61 3,252,367 3.07 49,416 0.05
71,310,256 92.42 2,645,944 3.43 41,414 0.05
77,364,378 92.04 3,034,977 3.61 41,102 0.05
63,766,203 92.13 3,752,380 5.42 13,684 0.02
59,048,832 91.98 3,355,270 5.23 13,606 0.02
55,318,601 91.94 3,064,443 5.09 12,270 0.02
982,248,773 91.39 37,425,455 3.90 509,300 0.05
 
Table 11: Procyclic-metacyclic experimental design. 
Samples are listed using an internal lab sample identifier (HPGL----), which is referenced in the 
record stored at the Short Read Archive (SRA; accession numbers provided), and an additional 
simple identifier (1-15) for clarity in the text and figures. Experimental batches (A-F) are defined 
based on the start date of the experiment with each batch originating from a separate growth of 
cells. The number of reads sequenced, number and percentage of reads mapping to the L. major 
genome (v. 6.0), number and percentage of reads containing evidence of the SL sequence, and 
number and percentage of reads containing evidence of polyadenylation are also included. 
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Appendix 2: Coordinates of novel ORFs 
Table 12: Coordinates of Novel ORFs. 
Novel open reading frames of at least 90 nucleotides in length were identified by manual 
annotation of translational evidence from a ribosome profiling study of L. major procyclic 
promastigote samples. 
Gene ID Chromosome Start coordinateStop coordinate Strand
LmjF.01_108 LmjF.01 75300 75404 -
LmjF.01_20 LmjF.01 110681 111175 +
LmjF.01_22 LmjF.01 114253 114546 +
LmjF.01_28 LmjF.01 136265 136417 +
LmjF.01_30 LmjF.01 142049 142294 +
LmjF.01_34 LmjF.01 153746 153916 +
LmjF.01_49 LmjF.01 197108 197224 +
LmjF.01_50 LmjF.01 198315 198512 +
LmjF.01_51 LmjF.01 198636 198767 +
LmjF.01_54 LmjF.01 204871 205035 +
LmjF.01_55 LmjF.01 204888 206231 +
LmjF.01_67 LmjF.01 243194 243376 +
LmjF.01_68 LmjF.01 243850 244035 +
LmjF.02_121 LmjF.02 336090 336365 +
LmjF.02_126 LmjF.02 349704 349862 +
LmjF.02_128 LmjF.02 2868 3155 -
LmjF.02_129 LmjF.02 2741 2896 -
LmjF.02_134 LmjF.02 16013 16486 -
LmjF.02_139 LmjF.02 23757 23873 -
LmjF.02_150 LmjF.02 73330 73431 -
LmjF.02_167 LmjF.02 145981 146163 -
LmjF.02_169 LmjF.02 149125 149301 -
LmjF.02_174 LmjF.02 164117 164605 -
LmjF.03_220 LmjF.03 62613 62861 +
LmjF.03_230 LmjF.03 105885 106739 +
LmjF.03_242 LmjF.03 152208 152321 +
LmjF.03_244 LmjF.03 160619 161200 +
LmjF.03_252 LmjF.03 193514 193633 +
LmjF.03_260 LmjF.03 225647 225829 +
LmjF.03_278 LmjF.03 288492 288599 -
LmjF.03_294 LmjF.03 363847 364215 -
LmjF.04_338 LmjF.04 105572 105733 +
LmjF.04_351 LmjF.04 170438 170656 -
LmjF.04_353 LmjF.04 178490 178645 -
LmjF.04_360 LmjF.04 200556 200759 -
LmjF.04_368 LmjF.04 238083 238238 -
LmjF.04_381 LmjF.04 277315 277410 -
LmjF.04_400 LmjF.04 342310 342519 -
LmjF.04_410 LmjF.04 372683 372889 -
LmjF.04_421 LmjF.04 397166 397357 -
LmjF.04_440 LmjF.04 457136 457396 -
LmjF.05_448 LmjF.05 10403 10681 +
LmjF.05_449 LmjF.05 11224 11319 +
LmjF.05_454 LmjF.05 23011 23118 +
LmjF.05_470 LmjF.05 70497 70976 +
LmjF.05_472 LmjF.05 77111 77257 +
LmjF.05_473 LmjF.05 77335 77466 +
LmjF.05_475 LmjF.05 81864 82109 +
LmjF.05_480 LmjF.05 88660 88932 +
LmjF.05_492 LmjF.05 119661 120101 +
LmjF.05_497 LmjF.05 138843 138968 +
LmjF.05_504 LmjF.05 156787 157500 +
LmjF.05_529 LmjF.05 247455 247832 +
LmjF.05_532 LmjF.05 263317 263409 +
LmjF.05_538 LmjF.05 285271 285750 +
LmjF.05_541 LmjF.05 292735 293013 +
LmjF.05_547 LmjF.05 306211 306378 +
LmjF.05_561 LmjF.05 358860 359045 +
LmjF.05_574 LmjF.05 396433 396798 +
LmjF.05_577 LmjF.05 405918 406031 +
LmjF.05_579 LmjF.05 411432 411776 +
LmjF.05_583 LmjF.05 423145 423273 -
LmjF.05_584 LmjF.05 424249 424743 -
LmjF.05_592 LmjF.05 461866 461991 +
LmjF.06_598 LmjF.06 16520 16744 -
LmjF.06_615 LmjF.06 68976 69209 -
LmjF.06_624 LmjF.06 95339 96148 -
LmjF.06_636 LmjF.06 131768 131908 +
LmjF.06_648 LmjF.06 169713 169913 +
LmjF.06_653 LmjF.06 181024 181203 +
LmjF.06_665 LmjF.06 221059 221355 +
LmjF.06_677 LmjF.06 277711 277929 +
LmjF.06_683 LmjF.06 301522 301737 +
LmjF.06_686 LmjF.06 326137 326256 +
LmjF.06_730 LmjF.06 479254 479595 +  
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Gene ID Chromosome Start coordinateStop coordinate Strand
LmjF.06_738 LmjF.06 497381 497902 +
LmjF.06_742 LmjF.06 506541 506759 -
LmjF.06_744 LmjF.06 510753 510905 +
LmjF.07_746 LmjF.07 2243 2380 -
LmjF.07_752 LmjF.07 20854 21009 +
LmjF.07_758 LmjF.07 38407 38625 +
LmjF.07_759 LmjF.07 38501 38767 +
LmjF.07_766 LmjF.07 64560 64787 -
LmjF.07_811 LmjF.07 243104 243364 +
LmjF.07_814 LmjF.07 252695 252793 +
LmjF.07_827 LmjF.07 306747 306842 +
LmjF.07_837 LmjF.07 340639 340980 +
LmjF.07_849 LmjF.07 386858 387064 +
LmjF.07_854 LmjF.07 429773 429907 +
LmjF.07_855 LmjF.07 430042 430587 +
LmjF.07_859 LmjF.07 453590 453724 +
LmjF.07_863 LmjF.07 474591 475604 +
LmjF.07_868 LmjF.07 506546 506662 +
LmjF.07_880 LmjF.07 543620 543928 +
LmjF.07_891 LmjF.07 566057 566206 +
LmjF.07_894 LmjF.07 573672 573800 +
LmjF.07_897 LmjF.07 587130 587240 +
LmjF.07_898 LmjF.07 587185 587358 +
LmjF.07_900 LmjF.07 593066 593353 +
LmjF.07_901 LmjF.07 593247 593480 +
LmjF.08_1008 LmjF.08 392394 392492 +
LmjF.08_1020 LmjF.08 436571 436855 -
LmjF.08_1033 LmjF.08 492798 493277 +
LmjF.08_1035 LmjF.08 495251 495427 +
LmjF.08_1040 LmjF.08 507408 507536 +
LmjF.08_1043 LmjF.08 516911 517069 +
LmjF.08_1048 LmjF.08 531238 531375 +
LmjF.08_1049 LmjF.08 531368 531469 +
LmjF.08_1050 LmjF.08 531402 531623 +
LmjF.08_1056 LmjF.08 541834 541941 +
LmjF.08_1057 LmjF.08 542811 544118 +
LmjF.08_1058 LmjF.08 544414 544515 +
LmjF.08_1062 LmjF.08 554975 555178 +
LmjF.08_921 LmjF.08 58067 58369 +
LmjF.08_922 LmjF.08 58676 58999 +
LmjF.08_923 LmjF.08 60807 61148 +
LmjF.08_940 LmjF.08 111881 112120 +
LmjF.08_948 LmjF.08 154201 154308 +
LmjF.08_950 LmjF.08 164345 164452 +
LmjF.08_965 LmjF.08 218722 218904 +
LmjF.08_973 LmjF.08 238798 238965 +
LmjF.08_976 LmjF.08 257665 257898 +
LmjF.08_978 LmjF.08 266223 266663 +
LmjF.08_981 LmjF.08 274422 274601 +
LmjF.08_984 LmjF.08 289943 290044 +
LmjF.08_986 LmjF.08 295799 295927 +
LmjF.08_988 LmjF.08 301711 301815 +
LmjF.08_997 LmjF.08 352965 353087 +
LmjF.09_1073 LmjF.09 6299 6484 +
LmjF.09_1082 LmjF.09 28224 28955 +
LmjF.09_1084 LmjF.09 40338 40820 +
LmjF.09_1085 LmjF.09 40951 41043 +
LmjF.09_1088 LmjF.09 53225 53326 +
LmjF.09_1090 LmjF.09 56433 56549 +
LmjF.09_1102 LmjF.09 78194 78409 +
LmjF.09_1103 LmjF.09 78409 78567 +
LmjF.09_1121 LmjF.09 124955 125314 +
LmjF.09_1132 LmjF.09 155957 156151 +
LmjF.09_1135 LmjF.09 167614 167709 +
LmjF.09_1142 LmjF.09 196413 196610 +
LmjF.09_1144 LmjF.09 199072 199257 +
LmjF.09_1150 LmjF.09 220336 220521 +
LmjF.09_1170 LmjF.09 280086 280292 -
LmjF.09_1177 LmjF.09 317221 317340 -
LmjF.09_1179 LmjF.09 321205 321407 -
LmjF.09_1183 LmjF.09 333011 333175 -
LmjF.09_1204 LmjF.09 385913 386071 -
LmjF.09_1207 LmjF.09 407194 407952 +
LmjF.09_1209 LmjF.09 416139 416408 +
LmjF.09_1210 LmjF.09 416332 416523 +  
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LmjF.09_1250 LmjF.09 536191 536463 -
LmjF.09_1251 LmjF.09 536444 536662 -
LmjF.09_1255 LmjF.09 545381 545656 -
LmjF.10_1273 LmjF.10 15652 15753 -
LmjF.10_1286 LmjF.10 68002 68100 +
LmjF.10_1299 LmjF.10 110871 111002 +
LmjF.10_1307 LmjF.10 133359 133520 +
LmjF.10_1318 LmjF.10 182540 183127 +
LmjF.10_1324 LmjF.10 206493 206693 +
LmjF.10_1326 LmjF.10 211877 211990 +
LmjF.10_1331 LmjF.10 233035 233322 +
LmjF.10_1333 LmjF.10 241236 241328 +
LmjF.10_1352 LmjF.10 329808 329981 -
LmjF.10_1355 LmjF.10 339436 341496 -
LmjF.10_1358 LmjF.10 351210 351398 -
LmjF.10_1362 LmjF.10 365021 365356 -
LmjF.10_1363 LmjF.10 365970 366203 -
LmjF.10_1386 LmjF.10 448939 449037 -
LmjF.10_1400 LmjF.10 488996 489322 -
LmjF.10_1404 LmjF.10 499609 499710 -
LmjF.10_1407 LmjF.10 507063 507278 -
LmjF.10_1411 LmjF.10 513365 513508 -
LmjF.10_1412 LmjF.10 512495 512656 -
LmjF.10_1417 LmjF.10 526964 527110 -
LmjF.10_1420 LmjF.10 530183 530386 -
LmjF.10_1421 LmjF.10 530897 531301 -
LmjF.10_1433 LmjF.10 558882 559106 +
LmjF.11_1460 LmjF.11 58477 58683 +
LmjF.11_1461 LmjF.11 58757 58861 +
LmjF.11_1468 LmjF.11 76083 76637 +
LmjF.11_1477 LmjF.11 112451 112552 +
LmjF.11_1482 LmjF.11 126347 126649 +
LmjF.11_1495 LmjF.11 177970 178116 +
LmjF.11_1500 LmjF.11 192857 193102 +
LmjF.11_1501 LmjF.11 193293 193394 +
LmjF.11_1503 LmjF.11 202072 202290 +
LmjF.11_1505 LmjF.11 207549 207863 +
LmjF.11_1506 LmjF.11 210393 210596 +
LmjF.11_1509 LmjF.11 218361 218684 +
LmjF.11_1511 LmjF.11 232934 233074 +
LmjF.11_1532 LmjF.11 314026 314268 +
LmjF.11_1537 LmjF.11 327389 327706 +
LmjF.11_1538 LmjF.11 328201 328293 +
LmjF.11_1540 LmjF.11 335098 335211 +
LmjF.11_1547 LmjF.11 362870 364081 +
LmjF.11_1561 LmjF.11 412194 412361 +
LmjF.11_1565 LmjF.11 427564 427860 +
LmjF.11_1566 LmjF.11 427628 427981 +
LmjF.11_1567 LmjF.11 433530 433751 +
LmjF.11_1570 LmjF.11 447364 447957 +
LmjF.11_1574 LmjF.11 467632 467847 +
LmjF.11_1582 LmjF.11 486870 487418 +
LmjF.11_1605 LmjF.11 578324 578545 +
LmjF.12_1607 LmjF.12 1861 2577 +
LmjF.12_1608 LmjF.12 2084 2218 +
LmjF.12_1639 LmjF.12 90060 90188 +
LmjF.12_1644 LmjF.12 111234 111479 +
LmjF.12_1649 LmjF.12 137706 137825 +
LmjF.12_1655 LmjF.12 161139 161375 +
LmjF.12_1662 LmjF.12 183196 183294 -
LmjF.12_1667 LmjF.12 210150 210257 -
LmjF.12_1671 LmjF.12 235040 235255 -
LmjF.12_1672 LmjF.12 245380 245595 -
LmjF.12_1676 LmjF.12 292149 292439 +
LmjF.12_1681 LmjF.12 303405 303575 +
LmjF.12_1684 LmjF.12 319163 319357 +
LmjF.12_1702 LmjF.12 376698 378473 +
LmjF.12_1710 LmjF.12 406846 407169 +
LmjF.12_1711 LmjF.12 409010 409918 +
LmjF.12_1712 LmjF.12 409661 409918 +
LmjF.12_1730 LmjF.12 473486 473914 +
LmjF.12_1734 LmjF.12 486488 486895 +
LmjF.12_1742 LmjF.12 517518 517748 +
LmjF.12_1744 LmjF.12 524129 524536 +
LmjF.12_1755 LmjF.12 571648 571755 +  
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LmjF.12_1770 LmjF.12 636127 636408 +
LmjF.12_1783 LmjF.12 672560 673522 +
LmjF.13_1792 LmjF.13 21697 21840 -
LmjF.13_1798 LmjF.13 34292 34732 -
LmjF.13_1799 LmjF.13 35607 35783 -
LmjF.13_1806 LmjF.13 56869 57240 -
LmjF.13_1810 LmjF.13 69781 70047 -
LmjF.13_1814 LmjF.13 78532 78732 -
LmjF.13_1834 LmjF.13 140813 141076 -
LmjF.13_1838 LmjF.13 152824 152946 +
LmjF.13_1839 LmjF.13 153353 153445 +
LmjF.13_1845 LmjF.13 171075 171257 +
LmjF.13_1846 LmjF.13 171578 171685 +
LmjF.13_1847 LmjF.13 171733 171867 +
LmjF.13_1848 LmjF.13 172427 172615 +
LmjF.13_1854 LmjF.13 184247 184690 +
LmjF.13_1860 LmjF.13 198656 199069 +
LmjF.13_1905 LmjF.13 359020 359310 -
LmjF.13_1912 LmjF.13 393022 393300 -
LmjF.13_1922 LmjF.13 413593 413898 -
LmjF.13_1926 LmjF.13 425323 425577 -
LmjF.13_1931 LmjF.13 434985 435446 -
LmjF.13_1932 LmjF.13 437047 437265 -
LmjF.13_1933 LmjF.13 437435 437569 -
LmjF.13_1935 LmjF.13 443405 443560 -
LmjF.13_1936 LmjF.13 443253 443345 -
LmjF.13_1937 LmjF.13 443060 443209 -
LmjF.13_1945 LmjF.13 469909 470046 -
LmjF.13_1953 LmjF.13 503627 503923 -
LmjF.13_1964 LmjF.13 551601 551711 +
LmjF.13_1966 LmjF.13 558691 558789 -
LmjF.13_1971 LmjF.13 572816 572983 -
LmjF.13_1974 LmjF.13 582146 582313 -
LmjF.13_1977 LmjF.13 591645 591824 -
LmjF.14_1991 LmjF.14 4457 4567 +
LmjF.14_1996 LmjF.14 16816 17031 +
LmjF.14_2035 LmjF.14 134974 135123 +
LmjF.14_2043 LmjF.14 169522 169749 -
LmjF.14_2045 LmjF.14 177135 177272 -
LmjF.14_2053 LmjF.14 203333 203581 -
LmjF.14_2054 LmjF.14 204098 204880 -
LmjF.14_2057 LmjF.14 216683 216853 -
LmjF.14_2062 LmjF.14 226190 226387 -
LmjF.14_2067 LmjF.14 239895 240128 -
LmjF.14_2072 LmjF.14 263428 263571 -
LmjF.14_2073 LmjF.14 262933 263070 +
LmjF.14_2078 LmjF.14 285571 285711 -
LmjF.14_2083 LmjF.14 297012 297191 -
LmjF.14_2091 LmjF.14 341241 341378 -
LmjF.14_2096 LmjF.14 363090 363314 -
LmjF.14_2103 LmjF.14 393681 393944 -
LmjF.14_2106 LmjF.14 404441 404647 -
LmjF.14_2113 LmjF.14 418425 418577 -
LmjF.14_2114 LmjF.14 419811 420311 -
LmjF.14_2122 LmjF.14 454237 454350 +
LmjF.14_2125 LmjF.14 476695 476913 +
LmjF.14_2126 LmjF.14 476695 476913 +
LmjF.14_2129 LmjF.14 492510 492827 +
LmjF.14_2154 LmjF.14 569202 569417 +
LmjF.14_2159 LmjF.14 580132 580305 +
LmjF.14_2161 LmjF.14 586647 586817 +
LmjF.14_2162 LmjF.14 587062 587340 +
LmjF.15_2179 LmjF.15 23840 24139 -
LmjF.15_2210 LmjF.15 122991 123191 +
LmjF.15_2248 LmjF.15 291511 291942 +
LmjF.15_2260 LmjF.15 343961 344272 -
LmjF.15_2262 LmjF.15 352004 353059 -
LmjF.15_2264 LmjF.15 362507 362671 -
LmjF.15_2269 LmjF.15 378222 378407 -
LmjF.15_2280 LmjF.15 419770 419931 -
LmjF.15_2283 LmjF.15 426044 426226 -
LmjF.15_2285 LmjF.15 429383 429544 -
LmjF.15_2298 LmjF.15 458033 458314 -
LmjF.15_2303 LmjF.15 463752 464204 -
LmjF.15_2319 LmjF.15 512813 513031 -  
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LmjF.15_2325 LmjF.15 531727 531924 -
LmjF.15_2355 LmjF.15 608359 608547 -
LmjF.16_2373 LmjF.16 21974 22225 -
LmjF.16_2385 LmjF.16 71928 72065 -
LmjF.16_2390 LmjF.16 86236 86379 -
LmjF.16_2433 LmjF.16 231395 231847 -
LmjF.16_2445 LmjF.16 277015 277146 -
LmjF.16_2446 LmjF.16 277279 277476 -
LmjF.16_2474 LmjF.16 400452 400712 +
LmjF.16_2477 LmjF.16 413775 413999 +
LmjF.16_2481 LmjF.16 421938 422372 +
LmjF.16_2483 LmjF.16 429096 430079 +
LmjF.16_2493 LmjF.16 465231 465347 -
LmjF.16_2504 LmjF.16 520917 521219 -
LmjF.16_2531 LmjF.16 641441 641533 -
LmjF.16_2533 LmjF.16 647237 647569 -
LmjF.16_2534 LmjF.16 647237 647569 -
LmjF.16_2550 LmjF.16 711667 712083 +
LmjF.17_2552 LmjF.17 13059 13424 -
LmjF.17_2563 LmjF.17 30495 30647 -
LmjF.17_2585 LmjF.17 123229 123327 -
LmjF.17_2609 LmjF.17 239997 240203 -
LmjF.17_2616 LmjF.17 275946 276266 -
LmjF.17_2650 LmjF.17 409339 409566 -
LmjF.17_2655 LmjF.17 418442 418642 +
LmjF.17_2659 LmjF.17 423627 423884 +
LmjF.17_2664 LmjF.17 446335 446535 +
LmjF.17_2668 LmjF.17 459865 460029 +
LmjF.17_2671 LmjF.17 470319 470570 +
LmjF.17_2676 LmjF.17 503959 504141 +
LmjF.17_2682 LmjF.17 528322 528600 +
LmjF.17_2700 LmjF.17 594656 595075 +
LmjF.17_2714 LmjF.17 636615 636785 +
LmjF.17_2717 LmjF.17 639649 639774 +
LmjF.17_2725 LmjF.17 663858 664577 +
LmjF.18_2733 LmjF.18 5454 6002 -
LmjF.18_2747 LmjF.18 44260 44556 -
LmjF.18_2753 LmjF.18 96600 96743 -
LmjF.18_2761 LmjF.18 119694 119888 -
LmjF.18_2765 LmjF.18 132763 132924 -
LmjF.18_2781 LmjF.18 191537 191986 -
LmjF.18_2790 LmjF.18 215800 215988 -
LmjF.18_2798 LmjF.18 247137 248000 +
LmjF.18_2801 LmjF.18 254683 254943 +
LmjF.18_2802 LmjF.18 256220 256822 +
LmjF.18_2814 LmjF.18 300800 300898 +
LmjF.18_2846 LmjF.18 414571 414783 +
LmjF.18_2850 LmjF.18 425281 425604 +
LmjF.18_2865 LmjF.18 492933 493067 +
LmjF.18_2874 LmjF.18 520283 520417 +
LmjF.18_2885 LmjF.18 553402 553500 +
LmjF.18_2889 LmjF.18 572618 572896 +
LmjF.18_2892 LmjF.18 579167 579331 +
LmjF.18_2893 LmjF.18 582458 583801 +
LmjF.18_2894 LmjF.18 585697 586041 +
LmjF.18_2917 LmjF.18 691562 691738 +
LmjF.18_2930 LmjF.18 722127 722258 +
LmjF.19_2950 LmjF.19 32411 32698 -
LmjF.19_2951 LmjF.19 32214 32498 -
LmjF.19_2957 LmjF.19 54517 54966 -
LmjF.19_2965 LmjF.19 81284 81529 +
LmjF.19_2979 LmjF.19 158573 158887 +
LmjF.19_2997 LmjF.19 223005 223277 +
LmjF.19_2999 LmjF.19 230087 230230 +
LmjF.19_3000 LmjF.19 230277 230423 +
LmjF.19_3004 LmjF.19 263059 263406 +
LmjF.19_3014 LmjF.19 304932 305084 +
LmjF.19_3017 LmjF.19 315264 315431 +
LmjF.19_3018 LmjF.19 315530 315625 +
LmjF.19_3019 LmjF.19 316267 316482 +
LmjF.19_3024 LmjF.19 325082 325177 +
LmjF.19_3042 LmjF.19 360014 360202 +
LmjF.19_3047 LmjF.19 366770 366943 +
LmjF.19_3054 LmjF.19 382655 382816 +
LmjF.19_3059 LmjF.19 395719 395889 +  
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LmjF.19_3062 LmjF.19 407105 407311 +
LmjF.19_3063 LmjF.19 406987 407484 +
LmjF.19_3075 LmjF.19 466828 466989 +
LmjF.19_3088 LmjF.19 529105 529260 +
LmjF.19_3098 LmjF.19 561020 561187 +
LmjF.19_3099 LmjF.19 561947 562501 +
LmjF.19_3101 LmjF.19 567210 567320 +
LmjF.19_3102 LmjF.19 567764 567964 +
LmjF.19_3105 LmjF.19 577105 577206 +
LmjF.19_3109 LmjF.19 589049 589171 +
LmjF.19_3114 LmjF.19 599803 600054 +
LmjF.19_3117 LmjF.19 607282 607374 +
LmjF.19_3130 LmjF.19 644230 644529 +
LmjF.19_3135 LmjF.19 650227 650418 +
LmjF.19_3146 LmjF.19 684352 684468 +
LmjF.19_3150 LmjF.19 696902 697354 +
LmjF.19_3151 LmjF.19 698510 698695 +
LmjF.19_3152 LmjF.19 698646 698771 +
LmjF.20_3165 LmjF.20 37994 38371 -
LmjF.20_3186 LmjF.20 111335 111922 +
LmjF.20_3189 LmjF.20 116568 116699 +
LmjF.20_3193 LmjF.20 127340 127699 +
LmjF.20_3200 LmjF.20 154486 155364 +
LmjF.20_3206 LmjF.20 175571 175684 +
LmjF.20_3210 LmjF.20 182013 182249 +
LmjF.20_3228 LmjF.20 240435 240653 +
LmjF.20_3233 LmjF.20 284034 284630 +
LmjF.20_3235 LmjF.20 300054 300371 +
LmjF.20_3236 LmjF.20 300545 300688 +
LmjF.20_3256 LmjF.20 389823 390137 +
LmjF.20_3266 LmjF.20 445786 445881 +
LmjF.20_3267 LmjF.20 445905 446066 +
LmjF.20_3280 LmjF.20 508514 508654 +
LmjF.20_3293 LmjF.20 558534 558629 +
LmjF.20_3312 LmjF.20 623030 623170 +
LmjF.20_3314 LmjF.20 629765 630016 +
LmjF.20_3320 LmjF.20 648946 649065 +
LmjF.20_3326 LmjF.20 661652 661864 -
LmjF.20_3327 LmjF.20 662064 662219 -
LmjF.20_3346 LmjF.20 718564 718707 -
LmjF.20_3347 LmjF.20 719427 719636 -
LmjF.21_3431 LmjF.21 222179 222307 -
LmjF.21_3432 LmjF.21 221650 222171 -
LmjF.21_3434 LmjF.21 223859 224041 -
LmjF.21_3468 LmjF.21 364852 364968 +
LmjF.21_3484 LmjF.21 418628 418804 +
LmjF.21_3520 LmjF.21 553382 553534 -
LmjF.21_3539 LmjF.21 622129 622299 -
LmjF.21_3544 LmjF.21 628508 628777 -
LmjF.21_3547 LmjF.21 637441 637713 -
LmjF.21_3555 LmjF.21 672358 672456 -
LmjF.21_3560 LmjF.21 683782 683997 -
LmjF.21_3564 LmjF.21 698741 699049 -
LmjF.21_3580 LmjF.21 731092 731466 -
LmjF.22_3599 LmjF.22 10032 10319 +
LmjF.22_3602 LmjF.22 13174 13467 -
LmjF.22_3607 LmjF.22 23382 23861 -
LmjF.22_3612 LmjF.22 49173 49421 -
LmjF.22_3618 LmjF.22 68399 68665 -
LmjF.22_3646 LmjF.22 179715 179810 -
LmjF.22_3659 LmjF.22 218830 219273 -
LmjF.22_3665 LmjF.22 229566 229856 -
LmjF.22_3674 LmjF.22 264753 265016 -
LmjF.22_3675 LmjF.22 268157 268258 -
LmjF.22_3688 LmjF.22 328838 328936 +
LmjF.22_3692 LmjF.22 341723 341878 +
LmjF.22_3693 LmjF.22 345016 345279 +
LmjF.22_3699 LmjF.22 362149 362286 +
LmjF.22_3703 LmjF.22 376335 376547 +
LmjF.22_3706 LmjF.22 384782 385144 +
LmjF.22_3710 LmjF.22 405487 405690 +
LmjF.22_3744 LmjF.22 538893 539480 -
LmjF.22_3750 LmjF.22 571290 571397 -
LmjF.22_3770 LmjF.22 628368 628460 +
LmjF.22_3773 LmjF.22 634724 635710 +  
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LmjF.22_3780 LmjF.22 672680 672796 +
LmjF.22_3785 LmjF.22 682270 682677 +
LmjF.22_3789 LmjF.22 695364 701963 +
LmjF.23_3803 LmjF.23 23243 23347 +
LmjF.23_3808 LmjF.23 43506 43664 +
LmjF.23_3819 LmjF.23 79049 79762 +
LmjF.23_3822 LmjF.23 83916 84179 +
LmjF.23_3839 LmjF.23 128812 129513 +
LmjF.23_3845 LmjF.23 151418 151558 +
LmjF.23_3853 LmjF.23 182985 183653 +
LmjF.23_3873 LmjF.23 245005 245238 -
LmjF.23_3874 LmjF.23 245299 245421 -
LmjF.23_3883 LmjF.23 277976 278086 -
LmjF.23_3886 LmjF.23 293212 294165 -
LmjF.23_3901 LmjF.23 379220 379594 -
LmjF.23_3903 LmjF.23 386824 387168 -
LmjF.23_3911 LmjF.23 411585 411758 -
LmjF.23_3914 LmjF.23 426935 427075 -
LmjF.23_3919 LmjF.23 439816 439923 -
LmjF.23_3921 LmjF.23 454869 455375 -
LmjF.23_3927 LmjF.23 467353 467508 -
LmjF.23_3931 LmjF.23 477090 477218 -
LmjF.23_3934 LmjF.23 488234 488377 -
LmjF.23_3942 LmjF.23 501014 501418 -
LmjF.23_3955 LmjF.23 545674 545787 -
LmjF.23_3968 LmjF.23 578165 578416 +
LmjF.23_3976 LmjF.23 602798 602926 +
LmjF.23_3979 LmjF.23 616169 616366 +
LmjF.23_3981 LmjF.23 619735 619998 +
LmjF.23_3982 LmjF.23 620215 620478 +
LmjF.23_3989 LmjF.23 658003 658212 +
LmjF.23_4010 LmjF.23 721765 721893 +
LmjF.23_4012 LmjF.23 726943 727392 +
LmjF.23_4023 LmjF.23 760711 760965 +
LmjF.24_4094 LmjF.24 250509 250787 +
LmjF.24_4099 LmjF.24 264282 264479 +
LmjF.24_4136 LmjF.24 390235 390909 +
LmjF.24_4137 LmjF.24 392389 393135 +
LmjF.24_4144 LmjF.24 418293 419021 +
LmjF.24_4157 LmjF.24 457136 457267 +
LmjF.24_4167 LmjF.24 485496 485963 +
LmjF.24_4169 LmjF.24 489797 489919 +
LmjF.24_4198 LmjF.24 613487 613783 +
LmjF.24_4212 LmjF.24 657382 657546 -
LmjF.24_4215 LmjF.24 666770 666940 -
LmjF.24_4261 LmjF.24 805848 805952 -
LmjF.24_4262 LmjF.24 806683 806787 -
LmjF.24_4263 LmjF.24 807597 807701 -
LmjF.25_4279 LmjF.25 11694 11933 -
LmjF.25_4285 LmjF.25 22606 22962 -
LmjF.25_4288 LmjF.25 29089 29349 -
LmjF.25_4291 LmjF.25 31550 31720 -
LmjF.25_4294 LmjF.25 37558 37713 -
LmjF.25_4323 LmjF.25 123710 123955 -
LmjF.25_4338 LmjF.25 197208 197540 -
LmjF.25_4345 LmjF.25 210385 210690 -
LmjF.25_4357 LmjF.25 260248 260394 -
LmjF.25_4359 LmjF.25 265010 265474 -
LmjF.25_4361 LmjF.25 267284 267835 -
LmjF.25_4377 LmjF.25 332131 332976 +
LmjF.25_4378 LmjF.25 334316 334741 +
LmjF.25_4396 LmjF.25 397670 397981 +
LmjF.25_4426 LmjF.25 527057 527290 -
LmjF.25_4431 LmjF.25 550595 550750 -
LmjF.25_4440 LmjF.25 576360 576482 -
LmjF.25_4441 LmjF.25 576781 577041 -
LmjF.25_4461 LmjF.25 659305 659397 -
LmjF.25_4463 LmjF.25 663816 664130 -
LmjF.25_4479 LmjF.25 707273 707398 -
LmjF.25_4491 LmjF.25 745007 745204 -
LmjF.25_4545 LmjF.25 880921 881397 +
LmjF.25_4550 LmjF.25 898007 898162 +
LmjF.25_4554 LmjF.25 903271 903393 +
LmjF.25_4556 LmjF.25 908439 908726 +
LmjF.25_4557 LmjF.25 908620 908853 +  
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LmjF.26_4564 LmjF.26 15464 15982 -
LmjF.26_4570 LmjF.26 23329 23508 -
LmjF.26_4585 LmjF.26 58735 58977 -
LmjF.26_4609 LmjF.26 122940 123269 -
LmjF.26_4636 LmjF.26 211169 211762 -
LmjF.26_4641 LmjF.26 229533 229745 -
LmjF.26_4662 LmjF.26 297493 297588 -
LmjF.26_4707 LmjF.26 492712 492975 +
LmjF.26_4711 LmjF.26 522463 522699 +
LmjF.26_4716 LmjF.26 537949 538416 +
LmjF.26_4724 LmjF.26 573222 573857 +
LmjF.26_4738 LmjF.26 613651 613788 +
LmjF.26_4740 LmjF.26 616024 616269 +
LmjF.26_4744 LmjF.26 621941 622357 +
LmjF.26_4745 LmjF.26 622907 623011 +
LmjF.26_4763 LmjF.26 737645 737794 +
LmjF.26_4767 LmjF.26 747329 747568 +
LmjF.26_4772 LmjF.26 759582 759680 +
LmjF.26_4799 LmjF.26 894825 895196 +
LmjF.26_4838 LmjF.26 1028616 1028711 +
LmjF.26_4840 LmjF.26 1032257 1032469 +
LmjF.26_4845 LmjF.26 1047130 1047249 +
LmjF.26_4846 LmjF.26 1047250 1047738 +
LmjF.26_4852 LmjF.26 1061703 1061921 +
LmjF.27_4860 LmjF.27 2769 3149 -
LmjF.27_4876 LmjF.27 39042 39182 -
LmjF.27_4886 LmjF.27 56209 56532 -
LmjF.27_4915 LmjF.27 218674 218811 +
LmjF.27_4938 LmjF.27 297197 297304 +
LmjF.27_4947 LmjF.27 321960 322058 +
LmjF.27_4948 LmjF.27 324096 324389 +
LmjF.27_4960 LmjF.27 369406 369519 +
LmjF.27_4965 LmjF.27 393742 393858 -
LmjF.27_4968 LmjF.27 404639 405034 -
LmjF.27_4994 LmjF.27 499834 500124 -
LmjF.27_4995 LmjF.27 501001 501150 -
LmjF.27_5002 LmjF.27 522967 523143 -
LmjF.27_5018 LmjF.27 571090 571251 +
LmjF.27_5026 LmjF.27 592628 592861 +
LmjF.27_5042 LmjF.27 652580 652738 +
LmjF.27_5044 LmjF.27 655113 655301 +
LmjF.27_5045 LmjF.27 655443 655592 +
LmjF.27_5047 LmjF.27 657578 657772 +
LmjF.27_5058 LmjF.27 717537 717752 +
LmjF.27_5081 LmjF.27 836255 836371 -
LmjF.27_5088 LmjF.27 860992 861156 -
LmjF.27_5114 LmjF.27 946873 947031 -
LmjF.27_5115 LmjF.27 948319 948591 -
LmjF.27_5147 LmjF.27 1108703 1108978 +
LmjF.28_5161 LmjF.28 18568 18687 +
LmjF.28_5165 LmjF.28 33383 33502 +
LmjF.28_5171 LmjF.28 46533 46844 +
LmjF.28_5174 LmjF.28 53169 53297 +
LmjF.28_5175 LmjF.28 53468 53602 +
LmjF.28_5177 LmjF.28 59133 59453 +
LmjF.28_5210 LmjF.28 162314 162445 -
LmjF.28_5213 LmjF.28 177018 177170 -
LmjF.28_5219 LmjF.28 194878 195252 -
LmjF.28_5220 LmjF.28 195932 196156 -
LmjF.28_5232 LmjF.28 247385 247531 -
LmjF.28_5259 LmjF.28 325860 325955 +
LmjF.28_5269 LmjF.28 356788 357234 +
LmjF.28_5271 LmjF.28 362430 362870 +
LmjF.28_5307 LmjF.28 497691 498077 +
LmjF.28_5313 LmjF.28 512498 512701 +
LmjF.28_5320 LmjF.28 540861 541091 +
LmjF.28_5321 LmjF.28 541099 541215 +
LmjF.28_5322 LmjF.28 543194 543304 +
LmjF.28_5323 LmjF.28 543309 543431 +
LmjF.28_5332 LmjF.28 565396 565500 +
LmjF.28_5340 LmjF.28 593705 594034 +
LmjF.28_5344 LmjF.28 603920 604126 -
LmjF.28_5383 LmjF.28 783213 783755 -
LmjF.28_5384 LmjF.28 785857 786171 -
LmjF.28_5386 LmjF.28 796462 796617 -  
 130 
 
Gene ID Chromosome Start coordinateStop coordinate Strand
LmjF.28_5409 LmjF.28 855796 856122 +
LmjF.28_5414 LmjF.28 873612 873725 +
LmjF.28_5415 LmjF.28 873022 873261 +
LmjF.28_5416 LmjF.28 873880 874194 +
LmjF.28_5419 LmjF.28 879816 880046 +
LmjF.28_5439 LmjF.28 952514 952618 +
LmjF.28_5472 LmjF.28 1054881 1054997 -
LmjF.28_5487 LmjF.28 1110389 1110598 -
LmjF.28_5490 LmjF.28 1119601 1119867 -
LmjF.28_5500 LmjF.28 1154797 1155570 -
LmjF.29_5532 LmjF.29 102534 103037 -
LmjF.29_5533 LmjF.29 105309 105680 -
LmjF.29_5548 LmjF.29 153682 153918 -
LmjF.29_5578 LmjF.29 270939 271628 -
LmjF.29_5587 LmjF.29 303429 303548 -
LmjF.29_5596 LmjF.29 330789 331310 -
LmjF.29_5613 LmjF.29 392478 392603 +
LmjF.29_5632 LmjF.29 462844 462987 +
LmjF.29_5641 LmjF.29 501533 501685 +
LmjF.29_5644 LmjF.29 513955 514065 +
LmjF.29_5649 LmjF.29 531237 531524 +
LmjF.29_5658 LmjF.29 631449 631628 +
LmjF.29_5667 LmjF.29 676994 677137 -
LmjF.29_5684 LmjF.29 749984 750280 -
LmjF.29_5717 LmjF.29 859640 860014 -
LmjF.29_5734 LmjF.29 929491 929745 -
LmjF.29_5745 LmjF.29 982742 982837 -
LmjF.29_5749 LmjF.29 992244 992342 -
LmjF.29_5777 LmjF.29 1075281 1075373 +
LmjF.29_5779 LmjF.29 1079507 1079710 +
LmjF.29_5783 LmjF.29 1092543 1092830 +
LmjF.29_5796 LmjF.29 1128590 1128682 +
LmjF.29_5797 LmjF.29 1130176 1130364 +
LmjF.29_5809 LmjF.29 1169377 1169532 +
LmjF.29_5820 LmjF.29 1193346 1193567 +
LmjF.30_5826 LmjF.30 3511 3921 -
LmjF.30_5836 LmjF.30 27478 27846 -
LmjF.30_5839 LmjF.30 37984 38076 -
LmjF.30_5846 LmjF.30 52157 52399 -
LmjF.30_5851 LmjF.30 62613 63149 -
LmjF.30_5884 LmjF.30 165514 165639 -
LmjF.30_5896 LmjF.30 205310 205552 -
LmjF.30_5900 LmjF.30 213272 213886 -
LmjF.30_5909 LmjF.30 225965 226486 -
LmjF.30_5932 LmjF.30 286667 286825 +
LmjF.30_5956 LmjF.30 377085 377540 +
LmjF.30_5964 LmjF.30 403326 403592 +
LmjF.30_5978 LmjF.30 446104 446232 +
LmjF.30_5989 LmjF.30 488721 488906 +
LmjF.30_5993 LmjF.30 509584 509811 +
LmjF.30_5994 LmjF.30 516765 517199 +
LmjF.30_5997 LmjF.30 525189 525329 +
LmjF.30_6006 LmjF.30 545633 545809 +
LmjF.30_6007 LmjF.30 547754 547888 +
LmjF.30_6034 LmjF.30 617231 617452 +
LmjF.30_6043 LmjF.30 641964 642134 +
LmjF.30_6060 LmjF.30 722220 722372 +
LmjF.30_6063 LmjF.30 730009 730107 +
LmjF.30_6069 LmjF.30 749100 749285 +
LmjF.30_6078 LmjF.30 782363 783034 +
LmjF.30_6086 LmjF.30 805843 806043 -
LmjF.30_6091 LmjF.30 834520 834630 -
LmjF.30_6092 LmjF.30 836452 836859 -
LmjF.30_6109 LmjF.30 903633 903944 -
LmjF.30_6115 LmjF.30 928397 928498 -
LmjF.30_6135 LmjF.30 1009117 1009239 -
LmjF.30_6141 LmjF.30 1024307 1024717 -
LmjF.30_6147 LmjF.30 1033976 1034077 -
LmjF.30_6165 LmjF.30 1079227 1079370 -
LmjF.30_6176 LmjF.30 1107826 1108050 -
LmjF.30_6205 LmjF.30 1214568 1214672 -
LmjF.30_6227 LmjF.30 1288884 1289387 +
LmjF.30_6234 LmjF.30 1314082 1314360 +
LmjF.30_6238 LmjF.30 1320895 1321521 +
LmjF.30_6253 LmjF.30 1358433 1358588 +  
 131 
 
Gene ID Chromosome Start coordinateStop coordinate Strand
LmjF.30_6262 LmjF.30 1382044 1382136 +
LmjF.30_6264 LmjF.30 1389754 1389999 +
LmjF.31_6279 LmjF.31 28489 28740 -
LmjF.31_6291 LmjF.31 53651 53776 -
LmjF.31_6317 LmjF.31 149183 149401 -
LmjF.31_6346 LmjF.31 249183 249359 -
LmjF.31_6347 LmjF.31 250484 250606 -
LmjF.31_6353 LmjF.31 271888 272007 -
LmjF.31_6355 LmjF.31 278862 279320 -
LmjF.31_6365 LmjF.31 311657 311815 -
LmjF.31_6366 LmjF.31 314762 315199 -
LmjF.31_6372 LmjF.31 334569 334820 -
LmjF.31_6374 LmjF.31 345010 345921 -
LmjF.31_6377 LmjF.31 361432 362343 -
LmjF.31_6379 LmjF.31 371246 371485 -
LmjF.31_6381 LmjF.31 374768 374866 -
LmjF.31_6388 LmjF.31 404914 405030 -
LmjF.31_6400 LmjF.31 451625 451759 -
LmjF.31_6402 LmjF.31 458381 458515 -
LmjF.31_6403 LmjF.31 458988 459194 -
LmjF.31_6404 LmjF.31 459635 459901 -
LmjF.31_6417 LmjF.31 516172 516339 -
LmjF.31_6425 LmjF.31 584579 585256 -
LmjF.31_6445 LmjF.31 714872 714988 -
LmjF.31_6452 LmjF.31 763758 764342 -
LmjF.31_6460 LmjF.31 774843 775013 -
LmjF.31_6472 LmjF.31 815080 815307 -
LmjF.31_6476 LmjF.31 830485 830766 -
LmjF.31_6477 LmjF.31 835978 836469 -
LmjF.31_6485 LmjF.31 874807 874983 -
LmjF.31_6489 LmjF.31 888636 888839 -
LmjF.31_6490 LmjF.31 892030 892509 -
LmjF.31_6491 LmjF.31 893894 895051 -
LmjF.31_6493 LmjF.31 904472 904693 -
LmjF.31_6494 LmjF.31 907110 907610 -
LmjF.31_6497 LmjF.31 923555 923743 -
LmjF.31_6502 LmjF.31 938638 938892 -
LmjF.31_6504 LmjF.31 948638 948916 -
LmjF.31_6507 LmjF.31 958736 959134 -
LmjF.31_6510 LmjF.31 974171 974362 -
LmjF.31_6528 LmjF.31 1051831 1051950 -
LmjF.31_6534 LmjF.31 1094511 1094708 -
LmjF.31_6539 LmjF.31 1118926 1119126 -
LmjF.31_6551 LmjF.31 1157449 1157631 -
LmjF.31_6552 LmjF.31 1163514 1163666 -
LmjF.31_6583 LmjF.31 1273984 1274109 -
LmjF.31_6599 LmjF.31 1335460 1335960 -
LmjF.31_6600 LmjF.31 1337797 1337988 -
LmjF.31_6616 LmjF.31 1379543 1379767 -
LmjF.31_6625 LmjF.31 1417384 1417485 -
LmjF.31_6632 LmjF.31 1433266 1433730 -
LmjF.31_6637 LmjF.31 1443464 1443610 -
LmjF.32_6654 LmjF.32 12916 13044 -
LmjF.32_6655 LmjF.32 13154 13267 -
LmjF.32_6657 LmjF.32 15906 16313 -
LmjF.32_6663 LmjF.32 26330 26521 -
LmjF.32_6673 LmjF.32 54755 54928 -
LmjF.32_6681 LmjF.32 72864 72986 -
LmjF.32_6683 LmjF.32 73791 74030 -
LmjF.32_6719 LmjF.32 197223 197348 +
LmjF.32_6733 LmjF.32 228486 228734 +
LmjF.32_6748 LmjF.32 278523 278945 +
LmjF.32_6750 LmjF.32 288007 288222 +
LmjF.32_6753 LmjF.32 303230 303478 +
LmjF.32_6758 LmjF.32 324524 324718 +
LmjF.32_6766 LmjF.32 344566 344940 +
LmjF.32_6775 LmjF.32 393728 393958 +
LmjF.32_6803 LmjF.32 483095 483334 +
LmjF.32_6804 LmjF.32 483545 483709 +
LmjF.32_6807 LmjF.32 490734 490958 +
LmjF.32_6808 LmjF.32 492718 493101 +
LmjF.32_6811 LmjF.32 501111 501248 +
LmjF.32_6832 LmjF.32 577072 577215 -
LmjF.32_6834 LmjF.32 584438 584647 -
LmjF.32_6843 LmjF.32 609543 609641 -  
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LmjF.32_6865 LmjF.32 680526 680663 -
LmjF.32_6874 LmjF.32 709162 709281 -
LmjF.32_6888 LmjF.32 752872 753144 -
LmjF.32_6899 LmjF.32 787074 787208 -
LmjF.32_6906 LmjF.32 804421 804522 -
LmjF.32_6916 LmjF.32 841775 842152 -
LmjF.32_6923 LmjF.32 861193 861348 -
LmjF.32_6945 LmjF.32 949586 949684 -
LmjF.32_6951 LmjF.32 960860 961027 -
LmjF.32_6952 LmjF.32 966516 966740 -
LmjF.32_6956 LmjF.32 979339 980139 -
LmjF.32_6972 LmjF.32 1045104 1045859 -
LmjF.32_6987 LmjF.32 1097752 1098168 -
LmjF.32_7004 LmjF.32 1161019 1161147 -
LmjF.32_7010 LmjF.32 1173277 1174002 +
LmjF.32_7012 LmjF.32 1174241 1174351 +
LmjF.32_7013 LmjF.32 1177162 1177695 +
LmjF.32_7014 LmjF.32 1178115 1178330 +
LmjF.32_7026 LmjF.32 1210135 1210245 +
LmjF.32_7039 LmjF.32 1259010 1259255 +
LmjF.32_7042 LmjF.32 1268617 1268823 +
LmjF.32_7050 LmjF.32 1314654 1315043 +
LmjF.32_7058 LmjF.32 1338987 1339202 +
LmjF.32_7068 LmjF.32 1387272 1387541 +
LmjF.32_7073 LmjF.32 1402015 1402239 +
LmjF.32_7106 LmjF.32 1500702 1501307 +
LmjF.32_7132 LmjF.32 1565617 1565901 +
LmjF.32_7133 LmjF.32 1566491 1566679 +
LmjF.32_7140 LmjF.32 1596351 1596704 +
LmjF.32_7142 LmjF.32 1600951 1601208 +
LmjF.33_7170 LmjF.33 70742 70879 -
LmjF.33_7174 LmjF.33 78560 78763 -
LmjF.33_7201 LmjF.33 181566 181943 -
LmjF.33_7204 LmjF.33 185730 185990 -
LmjF.33_7206 LmjF.33 190020 190157 -
LmjF.33_7207 LmjF.33 192236 192943 -
LmjF.33_7213 LmjF.33 209032 209127 -
LmjF.33_7221 LmjF.33 232640 232747 -
LmjF.33_7233 LmjF.33 264068 264253 -
LmjF.33_7234 LmjF.33 264012 264263 -
LmjF.33_7235 LmjF.33 264486 264653 -
LmjF.33_7240 LmjF.33 272910 273224 +
LmjF.33_7242 LmjF.33 272957 273493 +
LmjF.33_7259 LmjF.33 323981 324364 +
LmjF.33_7261 LmjF.33 333320 333424 +
LmjF.33_7294 LmjF.33 434166 434312 +
LmjF.33_7296 LmjF.33 442631 442849 +
LmjF.33_7301 LmjF.33 459297 459506 +
LmjF.33_7304 LmjF.33 481625 481759 +
LmjF.33_7305 LmjF.33 481785 481958 +
LmjF.33_7319 LmjF.33 525888 526103 +
LmjF.33_7335 LmjF.33 583100 583201 +
LmjF.33_7336 LmjF.33 588524 588910 +
LmjF.33_7343 LmjF.33 612828 613430 +
LmjF.33_7348 LmjF.33 627958 628332 +
LmjF.33_7353 LmjF.33 663733 663954 +
LmjF.33_7365 LmjF.33 742969 743112 +
LmjF.33_7370 LmjF.33 754185 754439 +
LmjF.33_7380 LmjF.33 782259 782600 +
LmjF.33_7383 LmjF.33 793708 793827 +
LmjF.33_7396 LmjF.33 832722 833105 +
LmjF.33_7407 LmjF.33 859658 860182 +
LmjF.33_7416 LmjF.33 892722 892973 +
LmjF.33_7420 LmjF.33 911331 911444 +
LmjF.33_7421 LmjF.33 916223 916531 +
LmjF.33_7429 LmjF.33 945613 945729 +
LmjF.33_7432 LmjF.33 954344 954562 +
LmjF.33_7440 LmjF.33 992287 992505 +
LmjF.33_7449 LmjF.33 1023674 1023904 +
LmjF.33_7450 LmjF.33 1023380 1023508 +
LmjF.33_7454 LmjF.33 1032371 1032637 +
LmjF.33_7459 LmjF.33 1057320 1057580 +
LmjF.33_7464 LmjF.33 1073630 1074520 +
LmjF.33_7470 LmjF.33 1094581 1094901 +
LmjF.33_7501 LmjF.33 1219899 1221326 +  
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LmjF.33_7506 LmjF.33 1243800 1244342 +
LmjF.33_7515 LmjF.33 1289644 1290105 +
LmjF.33_7521 LmjF.33 1300512 1300856 +
LmjF.33_7522 LmjF.33 1302311 1302985 +
LmjF.33_7523 LmjF.33 1305980 1306234 +
LmjF.33_7524 LmjF.33 1310341 1310955 +
LmjF.33_7525 LmjF.33 1314985 1315320 +
LmjF.33_7526 LmjF.33 1316916 1317284 +
LmjF.33_7527 LmjF.33 1319105 1319386 +
LmjF.33_7528 LmjF.33 1320502 1321179 +
LmjF.33_7529 LmjF.33 1323981 1324133 +
LmjF.33_7530 LmjF.33 1324130 1324384 +
LmjF.33_7531 LmjF.33 1328456 1329109 +
LmjF.33_7532 LmjF.33 1331221 1331472 +
LmjF.33_7533 LmjF.33 1333103 1333468 +
LmjF.33_7536 LmjF.33 1367027 1367122 +
LmjF.33_7543 LmjF.33 1419498 1419839 +
LmjF.33_7547 LmjF.33 1441882 1441983 +
LmjF.33_7555 LmjF.33 1487380 1487475 +
LmjF.33_7559 LmjF.33 1525876 1526025 +
LmjF.33_7560 LmjF.33 1526031 1526255 +
LmjF.33_7563 LmjF.33 1534126 1534269 +
LmjF.33_7571 LmjF.33 1551991 1552173 +
LmjF.33_7574 LmjF.33 1559966 1560109 +
LmjF.33_7575 LmjF.33 1560224 1561138 +
LmjF.33_7576 LmjF.33 1561773 1561901 +
LmjF.33_7584 LmjF.33 1577475 1577702 +
LmjF.34_7585 LmjF.34 3520 3627 -
LmjF.34_7591 LmjF.34 17041 17751 +
LmjF.34_7614 LmjF.34 91749 91958 +
LmjF.34_7616 LmjF.34 96814 97035 +
LmjF.34_7633 LmjF.34 152654 152821 +
LmjF.34_7639 LmjF.34 191561 191719 +
LmjF.34_7641 LmjF.34 196668 197066 +
LmjF.34_7648 LmjF.34 235203 235400 +
LmjF.34_7655 LmjF.34 258547 258849 +
LmjF.34_7656 LmjF.34 261107 261568 +
LmjF.34_7663 LmjF.34 303090 303368 -
LmjF.34_7689 LmjF.34 392611 392811 +
LmjF.34_7694 LmjF.34 408337 408480 +
LmjF.34_7705 LmjF.34 456122 456214 +
LmjF.34_7711 LmjF.34 496793 497002 -
LmjF.34_7720 LmjF.34 524418 524957 -
LmjF.34_7728 LmjF.34 551098 551328 -
LmjF.34_7729 LmjF.34 551277 551570 -
LmjF.34_7730 LmjF.34 551611 552171 -
LmjF.34_7753 LmjF.34 652640 652774 -
LmjF.34_7760 LmjF.34 678223 678324 -
LmjF.34_7761 LmjF.34 678090 678245 -
LmjF.34_7765 LmjF.34 691013 691144 -
LmjF.34_7767 LmjF.34 692857 693042 -
LmjF.34_7769 LmjF.34 696893 697150 -
LmjF.34_7772 LmjF.34 701626 702021 -
LmjF.34_7813 LmjF.34 874419 875024 -
LmjF.34_7815 LmjF.34 877547 877708 -
LmjF.34_7824 LmjF.34 915966 916916 -
LmjF.34_7839 LmjF.34 980128 980298 -
LmjF.34_7866 LmjF.34 1086900 1087097 -
LmjF.34_7880 LmjF.34 1163684 1163992 +
LmjF.34_7894 LmjF.34 1229804 1230139 +
LmjF.34_7898 LmjF.34 1237690 1237929 +
LmjF.34_7905 LmjF.34 1269808 1270020 +
LmjF.34_7982 LmjF.34 1529138 1529254 +
LmjF.34_8004 LmjF.34 1594167 1594367 +
LmjF.34_8019 LmjF.34 1630662 1630766 +
LmjF.34_8034 LmjF.34 1671199 1671570 +
LmjF.34_8035 LmjF.34 1671199 1671570 +
LmjF.34_8039 LmjF.34 1689603 1689815 +
LmjF.34_8040 LmjF.34 1691974 1692117 +
LmjF.34_8067 LmjF.34 1780258 1780500 +
LmjF.35_8115 LmjF.35 7688 7810 -
LmjF.35_8121 LmjF.35 19701 20405 -
LmjF.35_8122 LmjF.35 20598 20849 -
LmjF.35_8145 LmjF.35 72768 73385 +
LmjF.35_8153 LmjF.35 92057 92233 +  
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LmjF.35_8157 LmjF.35 102552 102995 +
LmjF.35_8159 LmjF.35 111077 112000 +
LmjF.35_8168 LmjF.35 139595 140566 +
LmjF.35_8173 LmjF.35 247758 248342 +
LmjF.35_8181 LmjF.35 287149 287658 +
LmjF.35_8185 LmjF.35 301592 301978 +
LmjF.35_8190 LmjF.35 331226 331471 +
LmjF.35_8199 LmjF.35 356546 356833 +
LmjF.35_8206 LmjF.35 372298 372579 +
LmjF.35_8209 LmjF.35 383704 383991 +
LmjF.35_8212 LmjF.35 392494 392664 +
LmjF.35_8242 LmjF.35 511163 511321 +
LmjF.35_8249 LmjF.35 542292 542462 +
LmjF.35_8255 LmjF.35 557578 558132 +
LmjF.35_8262 LmjF.35 571602 571766 +
LmjF.35_8269 LmjF.35 590186 590347 +
LmjF.35_8283 LmjF.35 652624 652800 -
LmjF.35_8285 LmjF.35 649781 650113 -
LmjF.35_8287 LmjF.35 659091 659258 -
LmjF.35_8296 LmjF.35 685830 685943 -
LmjF.35_8303 LmjF.35 711040 711234 -
LmjF.35_8323 LmjF.35 756958 757113 +
LmjF.35_8344 LmjF.35 833018 833284 +
LmjF.35_8354 LmjF.35 877847 877972 +
LmjF.35_8421 LmjF.35 1131910 1132059 -
LmjF.35_8422 LmjF.35 1131765 1131923 -
LmjF.35_8424 LmjF.35 1138950 1139450 -
LmjF.35_8427 LmjF.35 1152336 1152440 -
LmjF.35_8429 LmjF.35 1156802 1156984 -
LmjF.35_8441 LmjF.35 1196139 1196639 -
LmjF.35_8458 LmjF.35 1254516 1254848 -
LmjF.35_8459 LmjF.35 1256287 1256589 -
LmjF.35_8468 LmjF.35 1292593 1293399 -
LmjF.35_8469 LmjF.35 1293462 1293656 -
LmjF.35_8482 LmjF.35 1339793 1339984 -
LmjF.35_8483 LmjF.35 1339881 1339994 -
LmjF.35_8528 LmjF.35 1483673 1483768 -
LmjF.35_8534 LmjF.35 1507040 1507264 -
LmjF.35_8582 LmjF.35 1668024 1668197 +
LmjF.35_8639 LmjF.35 1883459 1883575 +
LmjF.35_8652 LmjF.35 1925329 1925985 +
LmjF.35_8655 LmjF.35 1936843 1937154 +
LmjF.35_8677 LmjF.35 2013532 2013726 +
LmjF.35_8683 LmjF.35 2026034 2026297 +
LmjF.35_8685 LmjF.35 2036303 2036485 +
LmjF.35_8686 LmjF.35 2036403 2036660 +
LmjF.35_8687 LmjF.35 2037086 2037343 +
LmjF.35_8697 LmjF.35 2052367 2052462 +
LmjF.35_8703 LmjF.35 2066649 2066936 +
LmjF.36_8706 LmjF.36 3057 3290 -
LmjF.36_8716 LmjF.36 27722 28474 -
LmjF.36_8739 LmjF.36 88109 88282 -
LmjF.36_8748 LmjF.36 109146 109421 -
LmjF.36_8750 LmjF.36 113226 113603 -
LmjF.36_8752 LmjF.36 116705 116977 -
LmjF.36_8780 LmjF.36 195130 195285 +
LmjF.36_8793 LmjF.36 278971 279117 +
LmjF.36_8810 LmjF.36 357841 358062 +
LmjF.36_8821 LmjF.36 408361 408513 +
LmjF.36_8839 LmjF.36 454548 454679 +
LmjF.36_8844 LmjF.36 465629 465847 +
LmjF.36_8847 LmjF.36 471444 471545 +
LmjF.36_8848 LmjF.36 473984 474910 +
LmjF.36_8858 LmjF.36 502251 502367 -
LmjF.36_8859 LmjF.36 502548 502817 -
LmjF.36_8873 LmjF.36 562958 563098 -
LmjF.36_8876 LmjF.36 570044 570160 -
LmjF.36_8891 LmjF.36 647433 647693 -
LmjF.36_8911 LmjF.36 726209 726394 -
LmjF.36_8925 LmjF.36 766358 766480 -
LmjF.36_8926 LmjF.36 768283 768750 -
LmjF.36_8933 LmjF.36 785300 785515 +
LmjF.36_8938 LmjF.36 801872 802165 +
LmjF.36_8940 LmjF.36 809192 809506 +
LmjF.36_8945 LmjF.36 825526 825642 +  
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Gene ID Chromosome Start coordinateStop coordinate Strand
LmjF.36_8947 LmjF.36 832242 832715 +
LmjF.36_8953 LmjF.36 847825 848001 +
LmjF.36_8977 LmjF.36 938578 938694 +
LmjF.36_8980 LmjF.36 952996 953910 +
LmjF.36_8981 LmjF.36 954569 954913 +
LmjF.36_9003 LmjF.36 1038671 1038826 -
LmjF.36_9009 LmjF.36 1064136 1064288 -
LmjF.36_9011 LmjF.36 1084782 1084937 -
LmjF.36_9013 LmjF.36 1086056 1086373 -
LmjF.36_9025 LmjF.36 1129887 1130135 -
LmjF.36_9026 LmjF.36 1131248 1131577 -
LmjF.36_9032 LmjF.36 1153798 1154010 -
LmjF.36_9037 LmjF.36 1167774 1168001 -
LmjF.36_9043 LmjF.36 1187998 1188240 -
LmjF.36_9048 LmjF.36 1210882 1211073 -
LmjF.36_9050 LmjF.36 1213140 1213460 -
LmjF.36_9067 LmjF.36 1244192 1244782 -
LmjF.36_9069 LmjF.36 1247798 1248163 -
LmjF.36_9078 LmjF.36 1271328 1271660 -
LmjF.36_9090 LmjF.36 1308305 1308832 -
LmjF.36_9097 LmjF.36 1330640 1330972 -
LmjF.36_9098 LmjF.36 1330640 1330972 -
LmjF.36_9107 LmjF.36 1341383 1341532 -
LmjF.36_9117 LmjF.36 1364886 1365023 -
LmjF.36_9124 LmjF.36 1384817 1385164 -
LmjF.36_9150 LmjF.36 1443089 1443190 +
LmjF.36_9173 LmjF.36 1521065 1521169 +
LmjF.36_9174 LmjF.36 1521186 1521569 +
LmjF.36_9178 LmjF.36 1530894 1530986 +
LmjF.36_9196 LmjF.36 1590191 1590316 +
LmjF.36_9197 LmjF.36 1590725 1590820 +
LmjF.36_9198 LmjF.36 1590922 1591164 +
LmjF.36_9211 LmjF.36 1656043 1656531 +
LmjF.36_9215 LmjF.36 1673744 1673896 +
LmjF.36_9224 LmjF.36 1716495 1716641 +
LmjF.36_9240 LmjF.36 1767587 1767703 +
LmjF.36_9253 LmjF.36 1804405 1804536 +
LmjF.36_9255 LmjF.36 1807821 1808138 +
LmjF.36_9257 LmjF.36 1815545 1815769 +
LmjF.36_9261 LmjF.36 1826404 1826865 +
LmjF.36_9269 LmjF.36 1853699 1853824 +
LmjF.36_9289 LmjF.36 1921984 1922226 -
LmjF.36_9307 LmjF.36 1979234 1979332 -
LmjF.36_9308 LmjF.36 1980690 1980821 -
LmjF.36_9327 LmjF.36 2054519 2054746 -
LmjF.36_9330 LmjF.36 2060464 2060745 -
LmjF.36_9347 LmjF.36 2111532 2111687 -
LmjF.36_9372 LmjF.36 2193280 2193531 -
LmjF.36_9380 LmjF.36 2213553 2213696 -
LmjF.36_9400 LmjF.36 2289198 2289302 -
LmjF.36_9406 LmjF.36 2310785 2310970 -
LmjF.36_9415 LmjF.36 2342137 2342271 -
LmjF.36_9416 LmjF.36 2343096 2343245 -
LmjF.36_9418 LmjF.36 2347826 2347930 -
LmjF.36_9419 LmjF.36 2347649 2347804 -
LmjF.36_9422 LmjF.36 2355651 2356004 -
LmjF.36_9426 LmjF.36 2365418 2365945 -
LmjF.36_9436 LmjF.36 2396231 2396374 -
LmjF.36_9440 LmjF.36 2407793 2408038 -
LmjF.36_9447 LmjF.36 2440572 2440724 -
LmjF.36_9451 LmjF.36 2462399 2462629 -
LmjF.36_9453 LmjF.36 2465939 2466082 -
LmjF.36_9460 LmjF.36 2484516 2484968 -
LmjF.36_9487 LmjF.36 2567032 2567313 -
LmjF.36_9494 LmjF.36 2583135 2583392 -
LmjF.36_9498 LmjF.36 2595086 2595283 -
LmjF.36_9515 LmjF.36 2645478 2645816 -
LmjF.36_9520 LmjF.36 2657059 2657193 -




Appendix 3: Mouse infection experimental design 
Sample ID SRA accession Infection 
status/timepoint
Batch Number of reads 
that pass Illumina 
Number of reads 
after  trimming
HPGL0165 SRR1460767 metacyclic A 45,492,872 44,325,986
HPGL0166 SRR1460724 uninfected, 4 hrs A 40,524,394 39,910,722
HPGL0167 SRR1460725 infected, 4 hrs A 90,990,046 88,980,750
HPGL0168 SRR1460726 uninfected, 24 hrs A 48,172,914 47,278,686
HPGL0169 SRR1460727 infected, 24 hrs A 100,702,572 98,641,188
HPGL0170 SRR1460728 uninfected, 48 hrs A 47,092,436 46,134,592
HPGL0171 SRR1460729 infected, 48 hrs A 104,431,682 102,285,498
HPGL0172 SRR1460730 uninfected, 72 hrs A 42,210,532 41,341,096
HPGL0173 SRR1460731 infected, 72 hrs A 72,318,516 70,901,794
HPGL0230 SRR1460772 metacyclic B 84,056,646 82,084,958
HPGL0231 SRR1460732 uninfected, 4 hrs B 96,215,864 94,854,552
HPGL0232 SRR1460733 infected, 4 hrs B 92,160,718 90,299,686
HPGL0233 SRR1460734 uninfected, 24 hrs B 82,830,256 81,677,132
HPGL0234 SRR1460735 infected, 24 hrs B 103,092,448 101,118,460
HPGL0235 SRR1460736 uninfected, 48 hrs B 81,211,534 80,061,410
HPGL0236 SRR1460737 infected, 48 hrs B 111,687,434 109,753,574
HPGL0237 SRR1460738 uninfected, 72 hrs B 92,915,856 91,606,470
HPGL0238 SRR1460739 infected, 72 hrs B 138,070,730 135,814,536
HPGL0329 SRR2136702 metacyclic C 64,860,308 63,200,662
HPGL0388 SRR1460740 uninfected, 4 hrs C 126,914,156 122,765,288
HPGL0389 SRR1460741 infected, 4 hrs C 109,064,742 105,845,790
HPGL0390 SRR1460742 uninfected, 24 hrs C 100,298,240 97,739,428
HPGL0391 SRR1460743 infected, 24 hrs C 120,601,610 116,947,098
HPGL0392 SRR1460744 uninfected, 48 hrs C 116,767,874 113,646,410
HPGL0393 SRR1460745 infected, 48 hrs C 106,096,990 102,294,678
HPGL0394 SRR1460746 uninfected, 72 hrs C 106,521,540 101,703,022
HPGL0395 SRR1460747 infected, 72 hrs C 122,268,922 110,361,056
Number of reads 
mapped - mouse
% of reads 
mapped - mouse
Number of reads 
mapped - L. major
% of reads 
mapped - L. major
% macrophages 
infected
# parasites per 
100 macrophages
n/a n/a 41,811,082 94.3 n/a n/a
38,605,849 96.7 n/a n/a n/a n/a
51,799,068 58.2 33,630,041 37.8 unknown unknown
45,655,539 96.6 n/a n/a n/a n/a
73,902,795 74.9 20,709,933 21.0 unknown unknown
44,569,557 96.6 n/a n/a n/a n/a
83,340,313 81.5 14,995,629 14.7 unknown unknown
40,014,106 96.8 n/a n/a n/a n/a
63,595,008 89.7 4,795,444 6.8 unknown unknown
n/a n/a 77,364,378 94.2 n/a n/a
92,101,618 97.1 n/a n/a n/a n/a
39,344,747 43.6 46,979,374 52.0 100.0 407
79,383,322 97.2 n/a n/a n/a n/a
64,280,705 63.6 33,073,618 32.7 89.8 194
77,743,701 97.1 n/a n/a n/a n/a
90,222,254 82.2 15,852,226 14.4 79.6 226
89,142,777 97.3 n/a n/a n/a n/a
119,555,532 88.0 12,313,978 9.1 88.9 279
n/a n/a 59,727,854 94.5 n/a n/a
117,718,796 95.9 n/a n/a n/a n/a
87,737,777 82.9 13,715,013 13.0 100.0 716
95,367,829 97.6 n/a n/a n/a n/a
102,128,561 87.3 10,499,445 9.0 60.0 150
110,780,532 97.5 n/a n/a n/a n/a
92,253,573 90.2 4,919,065 4.8 69.1 204
94,661,771 93.1 n/a n/a n/a n/a
97,588,136 88.4 3,856,201 3.5 72.6 201
 
Table 13: Mouse infection experimental design. 
Samples are listed using a sample identifier (HPGL----), which is referenced in the record stored 
at the SRA. Sample type is provided as metacyclic (contains only L. major metacyclic 
promastigote RNA), uninfected (contains only mouse RNA), or infected (contains both mouse and 
L. major RNA). Experimental batches (A, B, and C) are defined based on the start date of the 
experiment. The number of reads sequenced, number of reads that passed quality trimming, and 
number and percentage of trimmed reads that mapped to the mouse (mm10) and/or L. major 
genomes (v. 6.0) are provided, as are the percentage of infected macrophages and number of 
parasites observed per 100 macrophages for the 2 replicates for which these data were collected. 
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Appendix 4: Human infection experimental design 
Table 14: Human infection experimental design. 
Samples are listed using an internal lab sample identifier (HPGL----), which is referenced in the 
record stored at the Short Read Archive (SRA; accession numbers specified). Sample type is 
provided as metacyclic (contains only Leishmania metacyclic promastigote RNA, “LM” for L. 
major or “LA” for L. amazonensis), uninfected (contains only human RNA), infected (contains both 
human RNA and Leishmania RNA), or beads (contains only human RNA). Experimental batches 
(A-F) are defined based on the start date of the experiment with each batch originating from a 
separate growth of cells. The patient identifier indicates the human donor who supplied the 
monocytes used for the experiment. The percentage of infected human macrophages and 
number of parasites observed per 100 macrophages are reported, as are the number of reads 
sequenced, number of reads that passed quality trimming, and number and percentage of 
trimmed reads that mapped to the human (hg19) and/or Leishmania (L. major v. 6.0 or L. 









HPGL0364 SRR2136703 LM/metacyclic A:n/a n/a n/a
HPGL0365 SRR2155070 uninfected,/4/hrs A:H2 n/a n/a
HPGL0366 SRR2155072 LMDinfected,/4/hrs A:H2 100.0 524
HPGL0367 SRR2155073 uninfected,/24/hrs A:H2 n/a n/a
HPGL0368 SRR2155074 LMDinfected,/24/hrs A:H2 92.0 1220
HPGL0369 SRR2155075 uninfected,/48/hrs A:H2 n/a n/a
HPGL0370 SRR2155078 LMDinfected,/48/hrs A:H2 100.0 1778
HPGL0371 SRR2155082 uninfected,/72/hrs A:H2 n/a n/a
HPGL0372 SRR2155085 LMDinfected,/72/hrs A:H2 91.0 1896
HPGL0374 SRR2136708 LM/metacyclic B:n/a n/a n/a
HPGL0375 SRR2155101 uninfected,/4/hrs B:H3 n/a n/a
HPGL0376 SRR2155105 LMDinfected,/4/hrs B:H3 100.0 842
HPGL0377 SRR2155143 uninfected,/24/hrs B:H3 n/a n/a
HPGL0378 SRR2155160 LMDinfected,/24/hrs B:H3 100.0 2011
HPGL0379 SRR2155161 uninfected,/48/hrs B:H3 n/a n/a
HPGL0380 SRR2155162 LMDinfected,/48/hrs B:H3 98.0 2471
HPGL0381 SRR2155163 uninfected,/72/hrs B:H3 n/a n/a
HPGL0382 SRR2155164 LMDinfected,/72/hrs B:H3 96.0 1753
HPGL0397 SRR2136720 LM/metacyclic C:n/a n/a n/a
HPGL0398 SRR2155165 uninfected,/4/hrs C:H4 n/a n/a
HPGL0399 SRR2155166 LMDinfected,/4/hrs C:H4 96.0 752
HPGL0400 SRR2156106 uninfected,/24/hrs C:H4 n/a n/a
HPGL0401 SRR2156107 LMDinfected,/24/hrs C:H4 90.0 1245
HPGL0402 SRR2156108 uninfected,/48/hrs C:H4 n/a n/a
HPGL0403 SRR2156109 LMDinfected,/48/hrs C:H4 96.0 1996
HPGL0404 SRR2156110 uninfected,/72/hrs C:H4 n/a n/a











HPGL0435 SRR2171253 LA/metacyclic D:n/a n/a n/a
HPGL0436 SRR2156270 uninfected,/4/hrs D:H5 n/a n/a
HPGL0437 SRR2156271 LADinfected,/4/hrs D:H5 75.0 453
HPGL0438 SRR2156272 beads,/4/hrs D:H5 n/a n/a
HPGL0439 SRR2156273 uninfected,/24/hrs D:H5 n/a n/a
HPGL0440 SRR2156274 LADinfected,/24/hrs D:H5 73.0 304
HPGL0441 SRR2156854 beads,/24/hrs D:H5 n/a n/a
HPGL0442 SRR2156855 uninfected,/48/hrs D:H5 n/a n/a
HPGL0443 SRR2156856 LADinfected,/48/hrs D:H5 65.0 225
HPGL0444 SRR2156858 beads,/48/hrs D:H5 n/a n/a
HPGL0445 SRR2156859 uninfected,/72/hrs D:H5 n/a n/a
HPGL0446 SRR2156860 LADinfected,/72/hrs D:H5 55.0 246
HPGL0452 SRR2156862 beads,/72/hrs D:H5 n/a n/a
HPGL0454 SRR2171254 LA/metacyclic E:n/a n/a n/a
HPGL0456 SRR2171252 LM/metacyclic E:n/a n/a n/a
HPGL0457 SRR2156863 uninfected,/4/hrs E:H2 n/a n/a
HPGL0458 SRR2163237 LADinfected,/4/hrs E:H2 100.0 1164
HPGL0459 SRR2163238 LMDinfected,/4/hrs E:H2 96.0 752
HPGL0460 SRR2163239 beads,/4/hrs E:H2 n/a n/a
HPGL0461 SRR2163240 uninfected,/24/hrs E:H2 n/a n/a
HPGL0462 SRR2163242 LADinfected,/24/hrs E:H2 100.0 1723
HPGL0463 SRR2163251 LMDinfected,/24/hrs E:H2 93.0 1527
HPGL0464 SRR2163256 beads,/24/hrs E:H2 n/a n/a
HPGL0465 SRR2163270 uninfected,/48/hrs E:H2 n/a n/a
HPGL0466 SRR2163272 LADinfected,/48/hrs E:H2 95.0 1455
HPGL0467 SRR2163273 LMDinfected,/48/hrs E:H2 91.0 2485
HPGL0468 SRR2163274 beads,/48/hrs E:H2 n/a n/a
HPGL0469 SRR2163275 uninfected,/72/hrs E:H2 n/a n/a
HPGL0470 SRR2163276 LADinfected,/72/hrs E:H2 98.0 1149
HPGL0492 SRR2171255 LA/metacyclic F:n/a n/a n/a
HPGL0494 SRR2136722 LM/metacyclic F:n/a n/a n/a
HPGL0495 SRR2163278 uninfected,/4/hrs F:H3 n/a n/a
HPGL0496 SRR2163279 LADinfected,/4/hrs F:H3 61.0 156
HPGL0497 SRR2163280 LMDinfected,/4/hrs F:H3 69.0 237
HPGL0498 SRR2163281 beads,/4/hrs F:H3 n/a n/a
HPGL0499 SRR2163282 uninfected,/24/hrs F:H3 n/a n/a
HPGL0500 SRR2163283 LADinfected,/24/hrs F:H3 70.0 202
HPGL0501 SRR2163285 LMDinfected,/24/hrs F:H3 71.0 243
HPGL0502 SRR2163286 beads,/24/hrs F:H3 n/a n/a
HPGL0503 SRR2163287 uninfected,/48/hrs F:H3 n/a n/a
HPGL0504 SRR2163289 LADinfected,/48/hrs F:H3 71.0 195
HPGL0505 SRR2163290 LMDinfected,/48/hrs F:H3 60.0 186
HPGL0506 SRR2163291 beads,/48/hrs F:H3 n/a n/a
HPGL0507 SRR2163292 uninfected,/72/hrs F:H3 n/a n/a
HPGL0508 SRR2163399 LADinfected,/72/hrs F:H3 82.0 284
HPGL0509 SRR2163400 LMDinfected,/72/hrs F:H3 62.0 258





Sample ID # reads passing Illumina filter
# reads after  
trimming
# reads mapped - 
human
% reads map - 
human
# reads mapped - 
Leish.
% reads map - 
Leishmania
HPGL0364 78,758,128 75,672,222 n/a n/a 72,113,919 95.30
HPGL0365 91,388,692 88,599,546 82,744,345 93.4 n/a n/a
HPGL0366 86,023,690 83,531,092 57,118,665 68.4 22,370,540 26.8
HPGL0367 85,514,140 83,432,828 79,367,982 95.1 n/a n/a
HPGL0368 72,432,090 69,867,190 50,790,608 72.7 15,839,498 22.7
HPGL0369 77,830,926 76,033,626 71,860,400 94.5 n/a n/a
HPGL0370 78,550,138 76,390,670 58,163,491 76.1 13,096,474 17.1
HPGL0371 79,985,738 77,733,188 72,054,284 92.7 n/a n/a
HPGL0372 67,952,622 65,888,202 51,427,294 78.1 11,428,289 17.3
HPGL0374 78,737,648 75,494,056 n/a n/a 71,993,760 95.36
HPGL0375 78,471,106 76,111,004 71,737,258 94.3 n/a n/a
HPGL0376 83,905,020 81,439,468 53,650,676 65.9 23,925,977 29.4
HPGL0377 76,653,764 74,425,690 69,948,299 94.0 n/a n/a
HPGL0378 76,572,998 74,313,368 42,840,828 57.6 18,783,218 25.3
HPGL0379 76,283,630 74,104,972 69,384,638 93.6 n/a n/a
HPGL0380 75,140,814 72,663,760 49,226,213 67.7 20,019,048 27.6
HPGL0381 73,605,514 71,071,712 67,162,430 94.5 n/a n/a
HPGL0382 71,380,904 69,295,114 49,294,945 71.1 16,888,389 24.4
HPGL0397 97,701,708 92,092,826 n/a n/a 85,865,457 93.24
HPGL0398 100,195,200 96,731,678 89,365,001 92.4 n/a n/a
HPGL0399 90,467,044 87,516,500 72,210,158 82.5 11,113,911 12.7
HPGL0400 98,373,732 94,028,218 86,604,115 92.1 n/a n/a
HPGL0401 85,316,742 81,857,110 64,375,678 78.6 12,366,309 15.1
HPGL0402 86,638,390 84,086,304 78,432,710 93.3 n/a n/a
HPGL0403 98,025,186 94,787,210 77,527,704 81.8 12,446,371 13.1
HPGL0404 104,376,924 100,715,178 92,856,028 92.2 n/a n/a
HPGL0405 89,000,552 84,864,346 61,622,607 72.6 16,923,589 19.9
HPGL0435 88,108,512 85,602,946 n/a n/a 55,592,305 64.94
HPGL0436 87,679,330 86,252,844 81,956,083 95.0 n/a n/a
HPGL0437 98,036,962 96,501,364 77,319,838 80.1 10,321,591 10.7
HPGL0438 64,871,106 63,825,098 60,629,949 95.0 n/a n/a
HPGL0439 51,292,194 50,291,050 47,140,587 93.7 n/a n/a
HPGL0440 54,855,220 54,035,386 46,743,009 86.5 3,299,237 6.1
HPGL0441 55,086,382 54,242,308 51,571,492 95.1 n/a n/a
HPGL0442 79,454,644 78,067,616 74,307,932 95.2 n/a n/a
HPGL0443 85,079,824 83,475,144 71,611,331 85.8 5,562,379 6.7
HPGL0444 95,550,506 93,420,086 88,784,659 95.0 n/a n/a
HPGL0445 71,491,834 70,297,022 66,254,603 94.2 n/a n/a
HPGL0446 79,552,452 78,237,034 64,119,530 82.0 7,390,792 9.4
HPGL0452 86,600,982 85,198,052 81,416,206 95.6 n/a n/a
HPGL0454 87,184,878 85,009,962 n/a n/a 57,045,902 67.10
HPGL0456 102,691,716 99,950,410 n/a n/a 95,206,399 95.25
HPGL0457 107,773,908 102,908,504 96,570,364 93.8 n/a n/a
HPGL0458 99,857,328 97,489,652 54,703,033 56.1 26,626,832 27.3
HPGL0459 86,248,244 84,299,440 55,033,854 65.3 24,434,847 29.0
HPGL0460 98,522,766 93,688,002 87,781,217 93.7 n/a n/a
HPGL0461 103,760,218 100,592,660 95,298,430 94.7 n/a n/a
HPGL0462 89,674,336 87,415,806 39,536,537 45.2 30,840,179 35.3
HPGL0463 89,165,916 84,658,058 56,051,998 66.2 23,740,347 28.0
HPGL0464 98,425,396 96,227,604 90,804,430 94.4 n/a n/a
HPGL0465 99,389,800 95,816,874 91,110,475 95.1 n/a n/a
HPGL0466 98,728,132 95,668,548 46,719,663 48.8 32,161,999 33.6
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